UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
			For the quarterly period ended ~~March 31,~~June 30, 2021
			OR
☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
			For the transition period from__________________ to _______________

Commission File Number

Registrant; State of Incorporation; Address and Telephone Number

IRS Employer Identification No.

1-11178

Revlon, Inc.

13-3662955

Delaware

One New York Plaza

New York, New York 10004

212-527-4000

33-59650

Revlon Consumer Products Corporation

13-3662953

Delaware

One New York Plaza

New York, New York 10004

212-527-4000

Securities registered pursuant to Section 12(b) or 12(g) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Revlon, Inc.

Class A Common Stock

REV

New York Stock Exchange

Revlon Consumer Products Corporation

None

N/A

Indicate by check mark whether the registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.


Revlon, Inc.	Yes ☒	No ☐
Revlon Consumer Products Corporation	Yes ☐	No ☒

Indicate by check mark whether the registrants have submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ¨

Indicate by check mark whether each registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller Reporting Company

Emerging Growth Company

Revlon, Inc.

Yes ☐ No ☒

Yes ☒ No ☐

Yes ☐ No ☒

Yes

☒

No ☐

Yes

☐

No ☒

Revlon Consumer Products Corporation

Yes ☐ No ☒

Yes ☒ No ☐

Yes

☒

No ☐

Yes

☐

No ☒

If an emerging growth company, indicate by check mark if the registrants have elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether each registrant is a shell company (as defined in Rule 12b-2 of the Act).


Revlon, Inc.	Yes	☐	No ☒
Revlon Consumer Products Corporation	Yes	☐	No ☒

Number of shares of common stock outstanding as of ~~March 31,~~June 30, 2021:


Revlon, Inc. Class A Common Stock:			~~53,486,372~~53,652,757
Revlon Consumer Products Corporation Common Stock:			5,260

At such date, (i) 46,223,321 shares of Revlon, Inc. Class A Common Stock were beneficially owned by MacAndrews & Forbes Incorporated and certain of its affiliates; and (ii) all shares of Revlon Consumer Products Corporation ("Products Corporation") Common Stock were held by Revlon, Inc.

Products Corporation meets the conditions set forth in General Instructions H(1)(a) and (b) of Form 10-Q as, among other things, all of Products Corporation's equity securities are owned directly by Revlon, Inc., which is a reporting company under the Securities Exchange Act of 1934, as amended, and which filed with the SEC on ~~May 10,~~August 5, 2021 all of the material required to be filed pursuant to Section 13, 14 or 15(d) thereof. Products Corporation is therefore filing this Form 10-Q with a reduced disclosure format applicable to Products Corporation.

REVLON, INC. AND SUBSIDIARIES

INDEX


PART I - Financial Information
Item 1.	Financial Statements of Revlon, Inc. and Subsidiaries
	Consolidated Balance Sheets as of ~~March 31,~~June 3 0 , 2021 (Unaudited) and December 31, 2020	2
	Unaudited Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended ~~March 31,~~J une 3 0 , 2021 and 2020	3
	Unaudited Consolidated Statement of Stockholders' Deficiency for the Three and Six Months Ended ~~March 31,~~June 3 0 , 2021 and 2020	4
	Unaudited Consolidated Statements of Cash Flows for the ~~Three~~ Six Months Ended ~~March 31,~~June 3 0 , 2021 and 2020	5
	Financial Statements of Revlon Consumer Products Corporation and Subsidiaries
	Consolidated Balance Sheets as of ~~March 31,~~June 3 0 , 2021 (Unaudited) and December 31, 2020	7
	Unaudited Consolidated Statements of Operations and Comprehensive Loss for the Three and Six Months Ended ~~March 31,~~June 3 0 , 2021 and 2020	8
	Unaudited Consolidated Statement of Stockholders' Deficiency for the Three and Six Months Ended ~~March 31,~~June 3 0 , 2021 and 2020	9
	Unaudited Consolidated Statements of Cash Flows for the ~~Three~~Six Months Ended ~~March 31,~~June 3 0 , 2021 and 2020	10
	Combined Notes to Unaudited Consolidated Financial Statements	12
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	4245
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	5362
Item 4.	Controls and Procedures	5463

PART II - Other Information
Item 1.	Legal Proceedings	5766
Item 1A.	Risk Factors	5766
Item 5.	Other Information	5766
Item 6.	Exhibits	5766
	Signatures

Table of Contents

REVLON, INC. AND SUBSIDIARIES

PART I - FINANCIAL INFORMATION

REVLON, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(dollars in millions, except share and per share amounts)

March 31, 2021 December 31, 2020
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 85.6 $ 97.1
Trade receivables, less allowance for doubtful accounts of $12.3 and $13.0 as of March 31, 2021 and December 31, 2020, respectively 315.6 352.3
Inventories, net 441.2 462.6
Prepaid expenses and other assets 141.7 134.4
Total current assets 984.1 1,046.4
Property, plant and equipment, net of accumulated depreciation of $539.5 and $528.9 as of March 31, 2021 and December 31, 2020, respectively 335.6 352.0
Deferred income taxes 23.6 25.7
Goodwill 563.2 563.7
Intangible assets, net of accumulated amortization and impairment of $303.8 and $296.8 as of March 31, 2021 and December 31, 2020, respectively 419.5 430.8
Other assets 104.9 109.1
Total assets $ 2,430.9 $ 2,527.7
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current liabilities:
Short-term borrowings $ 0.3 $ 2.5
Current portion of long-term debt 107.2 217.5
Accounts payable 195.6 203.3
Accrued expenses and other current liabilities 402.7 420.9
Total current liabilities 705.8 844.2
Long-term debt 3,266.8 3,105.0
Long-term pension and other post-retirement plan liabilities 196.7 212.4
Other long-term liabilities 220.3 228.1
Stockholders’ deficiency:
Class A Common Stock, par value $0.01 per share: 900,000,000 shares authorized; 58,240,762 and 56,742,513 shares issued as of March 31, 2021 and December 31, 2020, respectively 0.5 0.5
Additional paid-in capital 1,085.4 1,082.3
Treasury stock, at cost: 1,892,108 and 1,774,200 shares of Class A Common Stock as of March 31, 2021 and December 31, 2020, respectively (37.6) (35.2)
Accumulated deficit (2,727.7) (2,631.7)
Accumulated other comprehensive loss (279.3) (277.9)
Total stockholders’ deficiency (1,958.7) (1,862.0)
Total liabilities and stockholders’ deficiency $ 2,430.9 $ 2,527.7


	June 30, 2021		December 31, 2020
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	109.8	$	97.1
Trade receivables, less allowance for doubtful accounts of $9.4 and $13.0 as of June 30, 2021 and December 31, 2020, respectively	314.3		352.3
Inventories, net	441.9		462.6
Prepaid expenses and other assets	135.2		134.4
Total current assets	1,001.2		1,046.4
Property, plant and equipment, net of accumulated depreciation of $549.1 and $528.9 as of June 30, 2021 and December 31, 2020, respectively	321.6		352.0
Deferred income taxes	23.8		25.7
Goodwill	563.3		563.7
Intangible assets, net of accumulated amortization and impairment of $312.6 and $296.8 as of June 30, 2021 and December 31, 2020, respectively	411.9		430.8
Other assets	97.0		109.1
Total assets	$	2,418.8	$	2,527.7

LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current liabilities:
Short-term borrowings	$	0.8	$	2.5
Current portion of long-term debt	129.7		217.5
Accounts payable	197.0		203.3
Accrued expenses and other current liabilities	403.9		420.9

Total current liabilities	731.4		844.2
Long-term debt	3,299.4		3,105.0
Long-term pension and other post-retirement plan liabilities	191.5		212.4
Other long-term liabilities	216.5		228.1

Stockholders’ deficiency:
Class A Common Stock, par value $0.01 per share: 900,000,000 shares authorized; 58,508,756 and 56,742,513 shares issued as of June 30, 2021 and December 31, 2020, respectively	0.5		0.5
Additional paid-in capital	1,088.8		1,082.3
Treasury stock, at cost: 1,991,147 and 1,774,200 shares of Class A Common Stock as of June 30, 2021 and December 31, 2020, respectively	(37.6)		(35.2)
Accumulated deficit	(2,795.4)		(2,631.7)
Accumulated other comprehensive loss	(276.3)		(277.9)
Total stockholders’ deficiency	(2,020.0)		(1,862.0)
Total liabilities and stockholders’ deficiency	$	2,418.8	$	2,527.7

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(dollars in millions, except share and per share amounts)

Three Months Ended March 31,
2021 2020
Net sales $ 445.0 $ 453.0
Cost of sales 191.2 197.8
      Gross profit 253.8 255.2
Selling, general and administrative expenses 260.5 289.4
Acquisition, integration and divestiture costs 0.6 2.1
Restructuring charges and other, net 5.4 24.8
Impairment charges 0 124.3
Loss on divested assets 0 0.8
      Operating loss (12.7) (186.2)
Other expenses:
   Interest expense, net 58.9 48.4
   Amortization of debt issuance costs 8.7 4.0
   Foreign currency losses, net 3.3 16.6
   Miscellaneous, net 1.2 (4.1)
      Other expenses 72.1 64.9
Loss from operations before income taxes (84.8) (251.1)
Provision for (benefit from) income taxes 11.2 (37.2)
Net loss $ (96.0) $ (213.9)
Other comprehensive income (loss):
   Foreign currency translation adjustments (4.9) (5.2)
   Amortization of pension related costs, net of tax(a)(b)
3.5 2.5
Other comprehensive loss, net (1.4) (2.7)
Total comprehensive loss $ (97.4) $ (216.6)
Basic and Diluted (loss) earnings per common share: $ (1.79) $ (4.02)
Weighted average number of common shares outstanding:
      Basic 53,653,449 53,167,453
      Diluted 53,653,449 53,167,453


	Three Months Ended June 30,				Six Months Ended June 30,

	2021		2020		2021		2020

Net sales	$	497.4	$	347.6	$	942.4	$	800.6
Cost of sales	196.3		168.6		387.5		366.4
Gross profit	301.1		179.0		554.9		434.2
Selling, general and administrative expenses	279.4		196.3		539.9		485.7
Acquisition, integration and divestiture costs	0.6		1.2		1.2		3.3
Restructuring charges and other, net	8.4		20.7		13.8		45.5
Impairment charges	0		19.8		0		144.1
(Gain) loss on divested assets	(1.8)		(0.2)		(1.8)		0.6
Operating income (loss)	14.5		(58.8)		1.8		(245.0)
Other expenses:
Interest expense, net	61.9		60.9		120.8		109.3

Amortization of debt issuance costs	13.3		6.0		22.0		10.0
Gain on early extinguishment of debt	0		(11.9)		0		(11.9)
Foreign currency (gains) losses, net	(1.7)		2.3		1.6		18.9
Miscellaneous, net	1.5		20.6		2.7		16.5
Other expenses	75.0		77.9		147.1		142.8
Loss from operations before income taxes	(60.5)		(136.7)		(145.3)		(387.8)
Provision for (benefit from) income taxes	7.2		(9.9)		18.4		(47.1)


Net loss	$	(67.7)	$	(126.8)	$	(163.7)	$	(340.7)
Other comprehensive income (loss):
Foreign currency translation adjustments	(0.5)		10.3		(5.4)		5.1
Amortization of pension related costs, net of tax(a)(b)	3.5		4.0		7.0		6.5





Other comprehensive loss, net	3.0		14.3		1.6		11.6
Total comprehensive loss	$	(64.7)	$	(112.5)	$	(162.1)	$	(329.1)


Basic and Diluted (loss) earnings per common share:	$	(1.25)	$	(2.37)	$	(3.04)	$	(6.39)









Weighted average number of common shares outstanding:
Basic	54,015,794		53,471,004		53,835,622		53,319,228
Diluted	54,015,794		53,471,004		53,835,622		53,319,228

(a) Net of tax ~~expense~~benefit of NaN and ~~$0.3~~$1.5 million for the three months ended ~~March 31,~~June 30, 2021 and 2020, respectively, and net of tax benefit of NaN and $1.2 million for the six months ended June 30, 2021 and 2020, respectively.

(b) This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY

(dollars in millions, except share and per share amounts)


	Common Stock		Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholders’ Deficiency

Balance, January 1, 2021	$	0.5	$	1,082.3	$	(35.2)	$	(2,631.7)	$	(277.9)	$	(1,862.0)
Treasury stock acquired, at cost (a)	—		—		(2.4)		—		—		(2.4)
Stock-based compensation amortization	—		3.1		—		—		—		3.1
Net loss	—		—		—		(96.0)		—		(96.0)
Other comprehensive (loss) income, net (b)	—		—		—		—		(1.4)		(1.4)
Balance, March 31, 2021	0.5		1,085.4		(37.6)		(2,727.7)		(279.3)		(1,958.7)










Treasury stock acquired, at cost (a)	—		—		0		—		—		0
Stock-based compensation amortization	—		3.4		—		—		—		3.4
Net loss	—		—		—		(67.7)		—		(67.7)
Other comprehensive (loss) income, net (b)	—		—		—		—		3.0		3.0
Balance at June 30, 2021	$	0.5	$	1,088.8	$	(37.6)	$	(2,795.4)	$	(276.3)	$	(2,020.0)

Common Stock Additional Paid-In Capital Treasury Stock Accumulated Deficit Accumulated Other Comprehensive (Loss) Income Total Stockholders’ Deficiency
Balance, January 1, 2021 $ 0.5 $ 1,082.3 $ (35.2) $ (2,631.7) $ (277.9) $ (1,862.0)
Treasury stock acquired, at cost (a)
— — (2.4) — — (2.4)
Stock-based compensation amortization — 3.1 — — — 3.1
Net loss — — — (96.0) — (96.0)
Other comprehensive (loss) income, net (b)
— — — — (1.4) (1.4)
Balance, March 31, 2021 $ 0.5 $ 1,085.4 $ (37.6) $ (2,727.7) $ (279.3) $ (1,958.7)


		Common Stock		Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholders’ Deficiency			Common Stock		Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholders’ Deficiency
Balance, January 1, 2020	Balance, January 1, 2020	$	0.5	$	1,071.9	$	(33.5)	$	(2,012.7)	$	(247.4)	$	(1,221.2)	Balance, January 1, 2020	$	0.5	$	1,071.9	$	(33.5)	$	(2,012.7)	$	(247.4)	$	(1,221.2)
Treasury stock acquired, at cost (a)														Treasury stock acquired, at cost (a)	—		—		(0.4)		—		—		(0.4)
Stock-based compensation amortization														Stock-based compensation amortization	—		2.4		—		—		—		2.4
Net loss														Net loss	—		—		—		(213.9)		—		(213.9)
Other comprehensive (loss) income, net (b)														Other comprehensive (loss) income, net (b)	—		—		—		—		(2.7)		(2.7)
Balance, March 31, 2020														Balance, March 31, 2020	0.5		1,074.3		(33.9)		(2,226.6)		(250.1)		(1,435.8)
Treasury stock acquired, at cost (a)														Treasury stock acquired, at cost (a)	—		—		(1.3)		—		—		(1.3)
Stock-based compensation amortization														Stock-based compensation amortization	—		1.1		—		—		—		1.1
Net loss														Net loss	—		—		—		(126.8)		—		(126.8)
Other comprehensive (loss) income, net (b)														Other comprehensive (loss) income, net (b)	—		—		—		—		14.3		14.3
Balance, June 30, 2020														Balance, June 30, 2020	$	0.5	$	1,075.4	$	(35.2)	$	(2,353.4)	$	(235.8)	$	(1,548.5)

Treasury stock acquired, at cost (a)		—		—		(0.4)		—		—		(0.4)
Stock-based compensation amortization		—		2.4		—		—		—		2.4
Net loss		—		—		—		(213.9)		—		(213.9)
Other comprehensive (loss) income, net (b)		—		—		—		—		(2.7)		(2.7)
Balance, March 31, 2020		$	0.5	$	1,074.3	$	(33.9)	$	(2,226.6)	$	(250.1)	$	(1,435.8)

(a) Pursuant to the share withholding provisions of the Fourth Amended and Restated Revlon, Inc. Stock Plan (as amended, the "Stock Plan"), the Company withheld an aggregate of ~~162,496~~NaN and ~~14,977~~79,554 shares of Revlon Class A Common Stock during the three months ended ~~March 31,~~June 30, 2021 and 2020, respectively, and 162,496 and 94,531 shares of Revlon Class A Common Stock during the six months ended June 30, 2021 and 2020, respectively, to satisfy certain minimum statutory tax withholding requirements related to the vesting of restricted shares and restricted stock units ("RSUs") for certain senior executives and employees. These withheld shares were recorded as treasury stock using the cost method, at a weighted-average price per share of ~~$14.95~~NaN and ~~$23.47~~$11.76 during the three months ended ~~March 31,~~June 30, 2021 and 2020, respectively, and $14.95 and $13.62 during the six months ended June 30, 2021 and 2020, respectively, based on the closing price of Revlon Class A Common Stock as reported on the New York Stock Exchange (the "NYSE") consolidated tape on each respective vesting date, for a total of approximately ~~$2.4 million~~NaN and ~~$0.4~~$1.2 million during the three months ended ~~March 31,~~June 30, 2021 and 2020, ~~respectively.~~respectively, and $2.4 million and $1.6 million during the six months ended June 30, 2021 and 2020. See Note 11, "Stock Compensation Plan," for details regarding restricted stock awards and RSUs under the Stock Plan.

(b) See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, respectively.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in millions)


	Six Months Ended June 30,
	2021		2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(163.7)	$	(340.7)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	65.6		73.2
Foreign currency losses from re-measurement	1.6		18.9
Amortization of debt discount	0.6		0.8
Stock-based compensation amortization	6.5		3.5
Impairment charges	0		144.1
Provision for (benefit from) deferred income taxes	3.5		(56.6)
Gain on early extinguishment of debt	0		(11.9)
Amortization of debt issuance costs	22.0		10.0

(Gain) loss on divested assets	(1.8)		0.6
Pension and other post-retirement cost	2.3		2.7

Paid-in-kind interest expense on the 2020 BrandCo Facilities	9.3		1.5
Change in assets and liabilities:
Decrease in trade receivables	36.6		126.3
Decrease (increase) in inventories	14.4		(70.6)
Increase in prepaid expenses and other current assets	(1.2)		(7.4)
Decrease in accounts payable	(0.1)		(13.3)
Decrease in accrued expenses and other current liabilities	(21.5)		(23.5)
Decrease in deferred revenue	(2.8)		0
Pension and other post-retirement plan contributions	(17.2)		(5.5)
Purchases of permanent displays	(8.9)		(12.7)
Other, net	15.5		(3.6)
Net cash used in operating activities	(39.3)		(164.2)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(2.9)		(2.7)


Proceeds from the sale of certain assets	2.1		0
Net cash used in investing activities	(0.8)		(2.7)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(6.7)		(7.0)
Borrowings on term loans	305.0		880.0
Repayments on term loans (a)	(176.1)		(337.9)


Net (repayments) borrowings under the revolving credit facilities	(36.8)		(22.9)





Payment of financing costs	(15.8)		(101.2)

Tax withholdings related to net share settlements of restricted stock and RSUs	(2.4)		(1.6)

Other financing activities	(0.2)		(1.0)
Net cash provided by financing activities	67.0		408.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1.0)		(2.1)
Net decrease in cash, cash equivalents and restricted cash	25.9		239.4
Cash, cash equivalents and restricted cash at beginning of period (b)	102.5		104.5
Cash, cash equivalents and restricted cash at end of period (b)	$	128.4	$	343.9
Supplemental schedule of cash flow information:
Cash paid during the period for:
Interest	$	117.6	$	105.9
Income taxes, net of refunds	6.6		8.0

Supplemental schedule of non-cash investing and financing activities:

Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	$	0	$	809.8



Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	0		29.1
Paid-in-kind interest capitalized to the 2020 BrandCo Facilities	9.3		0

Three Months Ended March 31,
2021 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (96.0) $ (213.9)
Adjustments to reconcile net loss to net cash used in operating activities:
   Depreciation and amortization 33.3 36.8
   Foreign currency losses from re-measurement 3.3 16.6
   Amortization of debt discount 0.4 0.4
   Stock-based compensation amortization 3.1 2.4
Impairment charges 0 124.3
Benefit from deferred income taxes 1.7 (37.2)
   Amortization of debt issuance costs 8.7 4.0
   Loss on divested assets 0 0.8
   Pension and other post-retirement cost 1.3 1.2
Paid-in-kind interest expense on the 2020 BrandCo Facilities 4.6 0
   Change in assets and liabilities:
Decrease in trade receivables 33.7 84.6
Decrease (increase) in inventories 18.7 (42.5)
Increase in prepaid expenses and other current assets (8.4) (23.3)
Increase in accounts payable 2.8 14.9
Decrease in accrued expenses and other current liabilities (22.5) (34.8)
Decrease in deferred revenue (1.3) 0
Pension and other post-retirement plan contributions (13.7) (3.6)
Purchases of permanent displays (5.8) (7.0)
Other, net 7.7 (1.3)
Net cash used in operating activities (28.4) (77.6)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures (0.7) (1.8)
Net cash used in investing activities (0.7) (1.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft (10.6) (6.4)
Borrowings under the SISO Term Loan Facility 100.0 0
Net (repayments) borrowings under the Amended 2016 Revolving Credit Facility (59.3) 69.1
Borrowings under the 2021 Foreign Asset-Based Term Facility 75.0 0
Repayments of the 2018 Foreign Asset-Based Term Facility (58.9) 0
Repayments under the 2016 Term Loan Facility (2.3) (4.5)
Payment of financing costs (11.8) (0.3)
Tax withholdings related to net share settlements of restricted stock and RSUs (2.4) (0.4)
Other financing activities (0.1) (0.1)
Net cash provided by financing activities 29.6 57.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1.3) (3.3)
   Net decrease in cash, cash equivalents and restricted cash
(0.8) (25.3)
   Cash, cash equivalents and restricted cash at beginning of period (a)
102.5 104.5
   Cash, cash equivalents and restricted cash at end of period (a)
$ 101.7 $ 79.2
Supplemental schedule of cash flow information:
   Cash paid during the period for:
Interest $ 64.6 $ 62.9
Income taxes, net of refunds (1.0) 1.0

(a)

Repayments on term loans for the six months ended June 30, 2020 includes the repayment of the 2019 Term Loan Facility, repayment under the 2018 Foreign Asset-Based Term Loan and repayments under the 2016 Term Loan Facility of $200.0 million, $31.4 million and $6.9 million, respectively, as well as repurchases of the 5.75% Senior Notes of $99.6 million. During 2020, the Company used a portion of the proceeds from the 2020 BrandCo Facility to repurchase and subsequently cancel a portion of its 5.75% Senior Notes. See Note 8, "Debt" in the Company's 2020 Form 10-K for additional information.

Table of Contents

Supplemental schedule of non-cash investing and financing activities:
Paid-in-kind interest capitalized to the 2020 BrandCo Facilities 4.6 0

~~(a)~~(b)These amounts include restricted cash of ~~$16.1~~$18.6 million and ~~$16.4~~$5.4 million as of ~~March 31,~~June 30, 2021 and 2020, respectively. The balance as of ~~March 31,~~June 30, 2021 represents: (i) cash on deposit in lieu of a mandatory prepayment and loan proceeds held in escrow until certain collateral perfection requirements are satisfied under the 2021 Foreign Asset-Based Term Agreement; and (ii) cash on deposit to support outstanding undrawn letters of credit. The balance as of ~~March 31,~~June 30, 2020 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; ~~(ii) restricted cash under the terms of 2019 Term Loan Agreement;~~ and (ii) cash on deposit to support outstanding undrawn letters of credit. These balances were included within prepaid expenses and other current assets and other assets in the Company's Consolidated Balance Sheets as of ~~March 31,~~June 30, 2021 and ~~March 31,~~June 30, 2020, respectively.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(dollars in millions, except share and per share amounts)

March 31, 2021 December 31, 2020
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 85.6 $ 97.1
Trade receivables, less allowance for doubtful accounts of $12.3 and $13.0 as of March 31, 2021 and December 31, 2020, respectively 315.6 352.3
Inventories, net 441.2 462.6
Prepaid expenses and other assets 137.6 130.5
Receivable from Revlon, Inc. 173.5 170.0
Total current assets 1,153.5 1,212.5
Property, plant and equipment, net of accumulated depreciation of $539.5 and $528.9 as of March 31, 2021 and December 31, 2020, respectively 335.6 352.0
Deferred income taxes 23.9 34.1
Goodwill 563.2 563.7
Intangible assets, net of accumulated amortization and impairment of $303.8 and $296.8 as of March 31, 2021 and December 31, 2020, respectively 419.5 430.8
Other assets 104.9 109.1
Total assets $ 2,600.6 $ 2,702.2
LIABILITIES AND STOCKHOLDER'S DEFICIENCY
Current liabilities:
Short-term borrowings $ 0.3 $ 2.5
Current portion of long-term debt 107.2 217.5
Accounts payable 195.6 203.3
Accrued expenses and other current liabilities 405.7 423.2
Total current liabilities 708.8 846.5
Long-term debt 3,266.8 3,105.0
Long-term pension and other post-retirement plan liabilities 196.7 212.4
Other long-term liabilities 224.5 241.3
Stockholder's deficiency:
Products Corporation Preferred stock, par value $1.00 per share; 1,000 shares authorized; 546 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 54.6 54.6
Products Corporation Common Stock, par value $1.00 per share; 10,000 shares authorized; 5,260 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 0 0
Additional paid-in capital 1,010.0 1,006.9
Accumulated deficit (2,581.5) (2,486.6)
Accumulated other comprehensive loss (279.3) (277.9)
Total stockholder's deficiency (1,796.2) (1,703.0)
Total liabilities and stockholder's deficiency $ 2,600.6 $ 2,702.2


	June 30, 2021		December 31, 2020
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	109.8	$	97.1
Trade receivables, less allowance for doubtful accounts of $9.4 and $13.0 as of June 30, 2021 and December 31, 2020, respectively	314.3		352.3
Inventories, net	441.9		462.6
Prepaid expenses and other assets	131.1		130.5
Receivable from Revlon, Inc.	175.1		170.0
Total current assets	1,172.2		1,212.5
Property, plant and equipment, net of accumulated depreciation of $549.1 and $528.9 as of June 30, 2021 and December 31, 2020, respectively	321.6		352.0
Deferred income taxes	32.6		34.1
Goodwill	563.3		563.7
Intangible assets, net of accumulated amortization and impairment of $312.6 and $296.8 as of June 30, 2021 and December 31, 2020, respectively	411.9		430.8
Other assets	97.0		109.1
Total assets	$	2,598.6	$	2,702.2

LIABILITIES AND STOCKHOLDER'S DEFICIENCY
Current liabilities:
Short-term borrowings	$	0.8	$	2.5
Current portion of long-term debt	129.7		217.5
Accounts payable	197.0		203.3
Accrued expenses and other current liabilities	415.7		423.2

Total current liabilities	743.2		846.5
Long-term debt	3,299.4		3,105.0
Long-term pension and other post-retirement plan liabilities	191.5		212.4
Other long-term liabilities	220.4		241.3

Stockholder's deficiency:
Products Corporation Preferred stock, par value $1.00 per share; 1,000 shares authorized; 546 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	54.6		54.6
Products Corporation Common Stock, par value $1.00 per share; 10,000 shares authorized; 5,260 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	0		0
Additional paid-in capital	1,013.4		1,006.9
Accumulated deficit	(2,647.6)		(2,486.6)
Accumulated other comprehensive loss	(276.3)		(277.9)
Total stockholder's deficiency	(1,855.9)		(1,703.0)
Total liabilities and stockholder's deficiency	$	2,598.6	$	2,702.2

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(dollars in millions)

Three Months Ended March 31,
2021 2020
Net sales $ 445.0 $ 453.0
Cost of sales 191.2 197.8
      Gross profit 253.8 255.2
Selling, general and administrative expenses 259.5 287.4
Acquisition, integration and divestiture costs 0.6 2.1
Restructuring charges and other, net 5.4 24.8
Impairment charges 0 124.3
Loss on divested assets 0 0.8
      Operating loss (11.7) (184.2)
Other expenses:
   Interest expense, net 58.9 48.4
   Amortization of debt issuance costs 8.7 4.0
   Foreign currency losses, net 3.3 16.6
   Miscellaneous, net 1.2 (4.1)
      Other expenses 72.1 64.9
Loss from operations before income taxes (83.8) (249.1)
Benefit from income taxes 11.1 (36.9)
Net loss $ (94.9) $ (212.2)
Other comprehensive income (loss):
   Foreign currency translation adjustments (4.9) (5.2)
   Amortization of pension related costs, net of tax(a)(b)
3.5 2.5
Other comprehensive loss, net (1.4) (2.7)
Total comprehensive loss $ (96.3) $ (214.9)


	Three Months Ended June 30,				Six Months Ended June 30,
	June 30,
	2021		2020		2021		2020

Net sales	$	497.4	$	347.6	$	942.4	$	800.6
Cost of sales	196.3		168.6		387.5		366.4
Gross profit	301.1		179.0		554.9		434.2
Selling, general and administrative expenses	277.7		194.4		537.2		481.8
Acquisition, integration and divestiture costs	0.6		1.2		1.2		3.3
Restructuring charges and other, net	8.4		20.7		13.8		45.5
Impairment charges	0		19.8		0		144.1
(Gain) loss on divested assets	(1.8)		(0.2)		(1.8)		0.6
Operating loss	16.2		(56.9)		4.5		(241.1)
Other expenses:
Interest expense, net	61.9		60.9		120.8		109.3

Amortization of debt issuance costs	13.3		6.0		22.0		10.0
Gain on early extinguishment of debt	0		(11.9)		0		(11.9)
Foreign currency (gains) losses, net	(1.7)		2.3		1.6		18.9
Miscellaneous, net	1.5		20.6		2.7		16.5
Other expenses	75.0		77.9		147.1		142.8
Loss from operations before income taxes	(58.8)		(134.8)		(142.6)		(383.9)
Provision for (benefit from) from income taxes	7.3		(9.6)		18.4		(46.5)


Net loss	$	(66.1)	$	(125.2)	$	(161.0)	$	(337.4)
Other comprehensive income (loss):
Foreign currency translation adjustments	(0.5)		10.3		(5.4)		5.1
Amortization of pension related costs, net of tax(a)(b)	3.5		4.0		7.0		6.5





Other comprehensive loss, net	3.0		14.3		1.6		11.6
Total comprehensive loss	$	(63.1)	$	(110.9)	$	(159.4)	$	(325.8)

(a)Net of tax ~~expense~~benefit of NaN and ~~$0.3~~$1.5 million for the three months ended ~~March 31,~~June 30, 2021 and 2020, respectively, and net of tax benefit of NaN and $1.2 million for the six months ended June 30, 2021 and 2020, respectively.

(b)This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIENCY

(dollars in millions)


	Preferred Stock		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholder's Deficiency

Balance, January 1, 2021	$	54.6	$	1,006.9	$	(2,486.6)	$	(277.9)	$	(1,703.0)
Stock-based compensation amortization	—		3.1		—		—		3.1
Net loss	—		—		(94.9)		—		(94.9)
Other comprehensive (loss) income, net (a)	—		—		—		(1.4)		(1.4)
Balance, March 31, 2021	54.6		1,010.0		(2,581.5)		(279.3)		(1,796.2)








Stock-based compensation amortization	—		3.4		—		—		3.4
Net loss	—		—		(66.1)		—		(66.1)
Other comprehensive (loss) income, net (a)	—		—		—		3.0		3.0
Balance, June 30, 2021	$	54.6	$	1,013.4	$	(2,647.6)	$	(276.3)	$	(1,855.9)

Preferred Stock Additional Paid-In Capital Accumulated Deficit Accumulated Other Comprehensive (Loss) Income Total Stockholder's Deficiency
Balance, January 1, 2021 $ 54.6 $ 1,006.9 $ (2,486.6) $ (277.9) $ (1,703.0)
Stock-based compensation amortization — 3.1 — — 3.1
Net loss — — (94.9) — (94.9)
Other comprehensive (loss) income, net (a)
— — — (1.4) (1.4)
Balance, March 31, 2021 $ 54.6 $ 1,010.0 $ (2,581.5) $ (279.3) $ (1,796.2)


		Preferred Stock		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholder's Deficiency			Preferred Stock		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholder's Deficiency

Balance, January 1, 2020	Balance, January 1, 2020	$	54.6	$	996.5	$	(1,893.1)	$	(247.4)	$	(1,089.4)	Balance, January 1, 2020	$	54.6	$	996.5	$	(1,893.1)	$	(247.4)	$	(1,089.4)
Stock-based compensation amortization												Stock-based compensation amortization	—		2.4		—		—		2.4
Net loss												Net loss	—		—		(212.2)		—		(212.2)
Other comprehensive (loss) income, net (a)												Other comprehensive (loss) income, net (a)	—		—		—		(2.7)		(2.7)
Balance, March 31, 2020												Balance, March 31, 2020	54.6		998.9		(2,105.3)		(250.1)		(1,301.9)
Stock-based compensation amortization												Stock-based compensation amortization	—		1.1		—		—		1.1
Net loss												Net loss	—		—		(125.2)		—		(125.2)
Other comprehensive (loss) income, net (a)												Other comprehensive (loss) income, net (a)	—		—		—		14.3		14.3
Balance, June 30, 2020												Balance, June 30, 2020	$	54.6	$	1,000.0	$	(2,230.5)	$	(235.8)	$	(1,411.7)

Stock-based compensation amortization		—		2.4		—		—		2.4
Net loss		—		—		(212.2)		—		(212.2)
Other comprehensive (loss) income, net (a)		—		—		—		(2.7)		(2.7)
Balance, March 31, 2020		$	54.6	$	998.9	$	(2,105.3)	$	(250.1)	$	(1,301.9)

(a)See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, respectively.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in millions)


	Six Months Ended June 30,
	2021		2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(161.0)	$	(337.4)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	65.6		73.2
Foreign currency losses from re-measurement	1.6		18.9
Amortization of debt discount	0.6		0.8
Stock-based compensation amortization	6.5		3.5
Impairment charges	0		144.1
Benefit from deferred income taxes	4.0		(55.7)
Gain on early extinguishment of debt	0		(11.9)
Amortization of debt issuance costs	22.0		10.0

(Gain) loss on divested assets	(1.8)		0.6
Pension and other post-retirement cost	2.3		2.7

Paid-in-kind interest expense on the 2020 BrandCo Facilities	9.3		1.5
Change in assets and liabilities:
Decrease in trade receivables	36.6		126.3
Decrease (increase) in inventories	14.4		(70.6)
Increase in prepaid expenses and other current assets	(6.3)		(13.0)
Decrease in accounts payable	(0.1)		(13.3)
Decrease in accrued expenses and other current liabilities	(21.5)		(22.1)
Decrease in deferred revenue	(2.8)		0
Pension and other post-retirement plan contributions	(17.2)		(5.5)
Purchases of permanent displays	(8.9)		(12.7)
Other, net	17.4		(3.6)
Net cash used in operating activities	(39.3)		(164.2)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(2.9)		(2.7)
Proceeds from the sale of certain assets	2.1		0
Net cash used in investing activities	(0.8)		(2.7)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(6.7)		(7.0)
Borrowings on term loans	305.0		880.0
Repayments on term loans (a)	(176.1)		(337.9)


Net (repayments) borrowings under the revolving credit facilities	(36.8)		(22.9)



Payment of financing costs	(15.8)		(101.2)

Tax withholdings related to net share settlements of restricted stock and RSUs	(2.4)		(1.6)

Other financing activities	(0.2)		(1.0)
Net cash provided by financing activities	67.0		408.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1.0)		(2.1)
Net decrease in cash, cash equivalents and restricted cash	25.9		239.4
Cash, cash equivalents and restricted cash at beginning of period (b)	102.5		104.5
Cash, cash equivalents and restricted cash at end of period (b)	$	128.4	$	343.9
Supplemental schedule of cash flow information:
Cash paid during the period for:
Interest	$	117.6	$	105.9
Income taxes, net of refunds	6.6		8.0

Supplemental schedule of non-cash investing and financing activities:

Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	$	0	809.8



Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	0		29.1
Paid-in-kind interest capitalized to the 2020 BrandCo Facilities	9.3		0

Three Months Ended March 31,
2021 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (94.9) $ (212.2)
Adjustments to reconcile net loss to net cash used in operating activities:
   Depreciation and amortization 33.3 36.8
   Foreign currency losses from re-measurement 3.3 16.6
   Amortization of debt discount 0.4 0.4
   Stock-based compensation amortization 3.1 2.4
Impairment charges 0 124.3
  Benefit from deferred income taxes 1.9 (36.9)
   Amortization of debt issuance costs 8.7 4.0
   Loss on divested assets 0 0.8
   Pension and other post-retirement cost 1.3 1.2
Paid-in-kind interest expense on the 2020 BrandCo Facilities 4.6 0
   Change in assets and liabilities:
Decrease in trade receivables 33.7 84.6
Decrease (increase) in inventories 18.7 (42.5)
Increase in prepaid expenses and other current assets (11.8) (25.6)
Increase in accounts payable 2.8 14.9
Decrease in accrued expenses and other current liabilities (22.5) (34.6)
Decrease in deferred revenue (1.3) 0
Pension and other post-retirement plan contributions (13.7) (3.6)
Purchases of permanent displays (5.8) (7.0)
Other, net 9.8 (1.2)
Net cash used in operating activities (28.4) (77.6)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures (0.7) (1.8)
Net cash used in investing activities (0.7) (1.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft (10.6) (6.4)
Borrowings under the SISO Term Loan Facility 100.0 0
Net (repayments) borrowings under the Amended 2016 Revolving Credit Facility (59.3) 69.1
Borrowings under the 2021 Foreign Asset-Based Term Facility 75.0 0
Repayments of the 2018 Foreign Asset-Based Term Facility (58.9) 0
Repayments under the 2016 Term Loan Facility (2.3) (4.5)
Payment of financing costs (11.8) (0.3)
Tax withholdings related to net share settlements of restricted stock and RSUs (2.4) (0.4)
Other financing activities (0.1) (0.1)
Net cash provided by financing activities 29.6 57.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1.3) (3.3)
   Net decrease in cash, cash equivalents and restricted cash (0.8) (25.3)
   Cash, cash equivalents and restricted cash at beginning of period (a)
102.5 104.5
   Cash, cash equivalents and restricted cash at end of period (a)
$ 101.7 $ 79.2
Supplemental schedule of cash flow information:
   Cash paid during the period for:
Interest $ 64.6 $ 62.9
Income taxes, net of refunds (1.0) 1.0

(a)

Table of Contents

Supplemental schedule of non-cash investing and financing activities:
Paid-in-kind interest capitalized to the 2020 BrandCo Facilities 4.6 0
Facility to repurchase and subsequently cancel a portion of its 5.75% Senior Notes. See Note 8, "Debt" in the Company's 2020 Form 10-K for additional information.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revlon, Inc. ("Revlon" and together with its subsidiaries, the "Company") conducts its business exclusively through its direct wholly-owned operating subsidiary, Revlon Consumer Products Corporation ("Products Corporation") and its subsidiaries. Revlon is an indirect majority-owned subsidiary of MacAndrews & Forbes Incorporated (together with certain of its affiliates other than the Company, "MacAndrews & Forbes"), a corporation beneficially owned by Ronald O. Perelman. Mr. Perelman is Chairman of Revlon's and Products Corporation's Board of Directors.

The Company is a leading global beauty company with an iconic portfolio of brands that develops, manufactures, markets, distributes and sells an extensive array of color cosmetics; hair color, hair care and hair treatments; fragrances; skin care; beauty tools; men’s grooming products; anti-perspirant deodorants; and other beauty care products across a variety of distribution channels.

The accompanying Consolidated Financial Statements are unaudited. In management's opinion, all adjustments necessary for a fair presentation of the Company's financial information have been made. The Unaudited Consolidated Financial Statements include the Company's accounts after the elimination of all material intercompany balances and transactions.

Certain prior year amounts have been reclassified to conform to the current year presentation.

The preparation of the Company's Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the Consolidated Financial Statements in the period they are determined to be necessary. Significant estimates made in the accompanying Consolidated Financial Statements include, but are not limited to: expected sales returns; certain assumptions related to the valuation of acquired intangible and long-lived assets and the recoverability of goodwill, intangible and long-lived assets; income taxes, including deferred tax valuation allowances and reserves for estimated tax liabilities; and certain estimates and assumptions used in the calculation of the net periodic benefit (income) costs and the projected benefit obligations for the Company’s pension and other post-retirement plans, including the expected long-term return on pension plan assets and the discount rate used to value the Company’s pension benefit obligations. The Unaudited Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and related notes contained in Revlon's Annual Report on Form 10-K for the fiscal year ended December 31, 2020 ("2020 Form 10-K").

The Company's results of operations and financial position for the interim periods are not indicative of those to be expected for the full year.

Liquidity and Ability to Continue as a Going Concern

The ongoing COVID-19 pandemic has continued to adversely impact the Company’s business in 2021. The COVID-19 pandemic’s adverse impact has resulted in significant and extended quarantines, stay-at-home orders and other social distancing measures; closures and bankruptcies of retailers, beauty salons, spas, offices and manufacturing facilities; increased levels of unemployment; travel and transportation restrictions leading to declines in consumer traffic in key shopping and tourist areas around the globe; and import and export restrictions. These adverse conditions have resulted in the general slowdown of the global economy, in turn contributing to declines in net sales within some of the Company’s reporting segments and regions. However, as COVID-19 restrictions are lifted, the Company is seeing a resumption in consumer spending and consumption. The Company continues to closely monitor the associated impacts and take appropriate actions in an effort to mitigate the COVID-19 pandemic’s negative effects on the Company’s operations and financial results.

Each reporting period, the Company assesses its ability to continue as a going concern for one year from the date the financial statements are issued. At ~~March 31,~~June 30, 2021, the Company had a liquidity position of ~~$129.6~~$153.1 million, consisting of: (i) ~~$85.6~~$109.8 million of unrestricted cash and cash equivalents (with approximately ~~$77.2~~$97.3 million held outside the U.S.); (ii) ~~$50.7~~$53.5 million in available borrowing capacity under the Amendment ~~No.7~~No.8 to the Amended 2016 Revolving Credit Facility (which had ~~$229.6~~$282.1 million drawn at such ~~date and an availability reserve of $20 million required to be maintained at all times when Products Corporation’s consolidated fixed charge ratio in effect exceeds 1.0 to 1.0)~~date); and less (iii) approximately ~~$6.7~~$10.2 million of outstanding checks. The Company's evaluation includes its ability to meet its future contractual obligations and other conditions and events that may impact its liquidity.

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

~~continued cost control initiatives as well as funds provided by selling certain assets or other strategic transactions in connection~~ with the Company's ongoing Strategic Review. If sales continue to decline, the Company’s cost control initiatives may include reductions in discretionary spend and reductions in investments in capital and permanent displays. Management believes that the debt transactions completed in the first ~~quarter~~half of 2021, along with existing cash and cash equivalents and cost control initiatives provides the Company with sufficient liquidity to meet its obligations and maintain business operations for the next twelve months.

However, there can be no assurance that available funds will be sufficient to meet the Company’s cash requirements on a consolidated basis, as, among other things, the Company’s liquidity can be impacted by a number of factors, including its level of sales, costs and expenditures, as well as accounts receivable and inventory, which serve as the principal variables impacting the amount of liquidity available under the Amended 2016 Revolving Credit Facility and the 2021 Foreign Asset-Based Term Facility. For example, subject to certain exceptions, revolving loans under the Amended 2016 Revolving Credit Facility and term loans under the 2021 Foreign Asset-Based Term Facility must be prepaid to the extent that such outstanding loans exceed the applicable borrowing base, consisting of certain accounts receivable, inventory and real estate.

Recently Evaluated and/or Adopted Accounting Pronouncements

In December 2019, the Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocations, calculating income taxes in interim periods and how a company accounts for future events. This ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. The Company adopted this guidance as of January 1, 2021. The adoption of this new guidance did not have any significant impacts on the Company’s results of operations, financial condition and/or financial statement disclosures.

Recently Issued Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new guidance under ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is in the process of assessing the impact, if any, that ASU No. 2020-04 is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which was subsequently amended in November 2018 through ASU No. 2018-19, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. In November 2019, the FASB issued ASU No. 2019-10, which, among other things, deferred the application of the new guidance on credit losses for smaller reporting companies ("SRC") to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This guidance will be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (i.e., a modified-retrospective approach). Under the above-mentioned deferral, the Company expects to adopt ASU No. 2016-03, and the related ASU No. 2018-19 amendments, beginning as of January 1, 2023 and is in the process of assessing the impact, if any, that this new guidance is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

2. RESTRUCTURING CHARGES

Revlon Global Growth Accelerator Program

On May 10, 2021, the Company announced that it was expanding the existing Revlon 2020 Restructuring Program through 2023. The Company renamed the revised program the Revlon Global Growth Accelerator (“RGGA”). RGGA includes a reinvestment strategy to strengthen our brands and drive long-term profitable margin and revenue growth through realized incremental productivity initiatives and enhanced capabilities.

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

~~2. RESTRUCTURING CHARGES~~

The major initiatives underlying RGGA include:

•Strategic Growth: Boost organic sales growth behind our strategic pillars – brands, markets, and channels – to deliver an approximate mid-single digit compound average annual growth rate through 2023;

•Operating Efficiencies: Drive additional operational efficiencies and cost savings to fuel investments in revenue growth; and

•Build Capabilities: Enhance capabilities and up-skill employees in order to evolve our culture to promote agility and deliver transformational change.

~~Revlon 2020 Restructuring Program~~

Since inception and through

~~As a result of the Revlon 2020 Restructuring Program, the~~June 30, 2021, the Company expects to eliminate approximately 975 positions worldwide, including approximately 625 current employees and approximately 350 open positions, of which approximately 935 were eliminated by March 31, 2021. While certain aspects of the Revlon 2020 Restructuring Program may be subject to consultations with employees, works councils, unions and/or governmental authorities, the Company substantially completed the employee-related actions in 2020 and expects to complete the other consolidation and outsourcing actions during 2021 and 2022.

~~In connection with implementing the Revlon 2020 Restructuring Program, the Company recognized since the inception of the program approximately $76.1 million of total~~recorded pre-tax restructuring and related charges of $86.0 million in connection with RGGA, consisting primarily of ~~employee-related costs, such as~~(i) $64.3 million of employee severance, ~~retention~~other personnel benefits and other ~~contractual termination benefits. The Company expects~~costs; and (ii) $21.7 million of lease and other restructuring-related charges that ~~substantially all~~were recorded within Selling, general & administrative expenses ("SG&A") and Cost of the restructuring and related charges under the Revlon 2020 Restructuring Program will be paid in cash, with $51.5 million of the total charges paid in 2020, $10.9 million paid during the first three months of 2021 and with the remaining balance expected to be paid primarily during the remainder of 2021.sales.

A summary of the ~~Revlon 2020 Restructuring Program~~RGGA charges incurred since its inception in March 2020 and through ~~March 31,~~June 30, 2021 is presented in the following table:

Restructuring Charges and Other, Net
Employee Severance and Other Personnel Benefits Other Costs Total Restructuring Charges Leases (a) Other Related Charges (b) Total Restructuring and Related Charges
Charges incurred through December 31, 2020 $ 48.6 $ 1.9 $ 50.5 $ 12.6 $ 5.7 $ 68.8
Charges incurred during the three months ended March 31, 2021 1.9 3.5 5.4 1.3 0.6 7.3
Cumulative charges incurred through March 31, 2021 $ 50.5 $ 5.4 $ 55.9 $ 13.9 $ 6.3 $ 76.1



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits		Other Costs		Total Restructuring Charges		Leases (a)		Other Related Charges (b)		Total Restructuring and Related Charges
Charges incurred through December 31, 2020	$	48.6	$	1.9	$	50.5	$	12.6	$	5.7	$	68.8
Charges incurred during the six months ended June 30, 2021	3.0		10.8		13.8		2.6		0.8		17.2
Cumulative charges incurred through June 30, 2021	$	51.6	$	12.7	$	64.3	$	15.2	$	6.5	$	86.0

(a) Lease-related charges are recorded within SG&A in the Company’s Consolidated Statement of Operations and Comprehensive Loss.

(b) Other related charges are recorded within SG&A and cost of sales in the Company’s Consolidated Statement of Operations and Comprehensive Loss.

A summary of the ~~2020 Restructuring Charges~~RGGA restructuring charges incurred since its inception in March 2020 and through ~~March 31,~~June 30, 2021 by reportable segment is presented in the following table:

Charges incurred in the three months ended March 31, 2021 Cumulative charges incurred through March 31, 2021
Revlon $ 1.5 $ 22.2
Elizabeth Arden 1.9 11.3
Portfolio 0.9 14.5
Fragrances 1.1 7.9
Total $ 5.4 $ 55.9



	Charges incurred in the six months ended June 30, 2021		Cumulative charges incurred through June 30, 2021
Revlon	$	3.9	$	24.6
Elizabeth Arden	5.1		14.5
Portfolio	2.3		15.9
Fragrances	2.5		9.3
Total	$	13.8	$	64.3

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Restructuring Reserve

The liability balance and related activity for each of the Company's restructuring programs are presented in the following table:

Utilized, Net
Liability
Balance at January 1, 2021 Expense, Net Foreign Currency Translation

Cash

Non-cash
Liability Balance at March 31, 2021
Revlon 2020 Restructuring Program:
Employee severance and other personnel benefits $ 12.6 $ 1.9 $ 0 $ (7.6) $ 0 $ 6.9
Other 0 3.5 0 (3.3) 0 0.2
Total Revlon 2020 Restructuring Program 12.6 5.4 0 (10.9) 0 7.1
Other immaterial actions:
Employee severance and other personnel benefits 1.2 0 (0.1) (0.1) 0 1.0
Total restructuring reserve $ 13.8 $ 5.4 $ (0.1) $ (11.0) $ 0 $ 8.1



							Utilized, Net
	Liability Balance at January 1, 2021		Expense, Net		Foreign Currency Translation		Cash		Non-cash		Liability Balance at June 30, 2021
RGGA:
Employee severance and other personnel benefits	$	12.6	$	3.0	$	0	$	(11.0)	$	0	$	4.6
Other	0		10.8		0		(10.8)		0		0
Total RGGA	12.6		13.8		0		(21.8)		0		4.6






Other immaterial actions:
Employee severance and other personnel benefits	1.2		0		0		(0.3)		0		0.9
Other	0		0		0		0		0		0
Total other immaterial actions	1.2		0		0		(0.3)		0		0.9
Total restructuring reserve	$	13.8	$	13.8	$	0	$	(22.1)	$	0	$	5.5

All of the restructuring reserve balances were included within accrued expenses and other current liabilities in the Company's Consolidated Balance Sheets.

3. INVENTORIES

The Company's net inventory balances consisted of the following:

March 31, December 31,
2021 2020
Finished goods 337.3 $ 356.7
Raw materials and supplies 87.9 97.1
Work-in-process 16.0 8.8
$ 441.2 $ 462.6


	June 30,		December 31,
	2021		2020
Finished goods	315.8		$	356.7
Raw materials and supplies	103.9		97.1
Work-in-process	22.2		8.8
	$	441.9	$	462.6

4. PROPERTY, PLANT AND EQUIPMENT

The Company's property, plant and equipment, net balances consisted of the following:

March 31, December 31,
2021 2020
Land and improvements $ 11.0 $ 11.4
Building and improvements 46.7 48.3
Machinery and equipment 93.3 98.7
Office furniture, fixtures and capitalized software 73.9 76.2
Leasehold improvements 20.4 21.3
Construction-in-progress 5.3 9.1
Right-of-Use assets 85.0 87.0
Property, plant and equipment and Right-of-Use assets, net $ 335.6 $ 352.0



	June 30,		December 31,
	2021		2020
Land and improvements	$	11.1	$	11.4
Building and improvements	45.8		48.3
Machinery and equipment	90.7		98.7
Office furniture, fixtures and capitalized software	68.3		76.2
Leasehold improvements	19.6		21.3
Construction-in-progress	5.4		9.1
Right-of-Use assets	80.7		87.0
Property, plant and equipment and Right-of-Use assets, net	$	321.6	$	352.0

Depreciation and amortization expense on property, plant and equipment and right-of-use assets for the three months ended ~~March 31,~~June 30, 2021 and ~~March 31,~~June 30, 2020 was $17.1 million and ~~$17.0~~$23.9 million, respectively. Depreciation and amortization expense on property, plant and equipment and right-of-use assets for the six months ended June 30, 2021 and June 30, 2020 was $34.2 million and $40.9 million, respectively. Accumulated depreciation and amortization was ~~$539.5~~$549.1 million and $528.9 million as of ~~March 31,~~June 30, 2021 and December 31, 2020, respectively.

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

5. GOODWILL AND INTANGIBLE ASSETS, NET

In accordance with ASC Topic 350, “Intangibles – Goodwill and Other,” the Company performs its annual impairment test during the fourth quarter of each year. The Company also reviews goodwill for impairment whenever events or changes in circumstances indicate that the carrying value of its goodwill may not be recoverable. After the close of each interim quarter, management assesses whether there exists any indicators of impairment requiring the Company to perform an interim goodwill impairment analysis.

As of ~~March 31,~~June 30, 2021, the Company assessed that no indicators of impairment existed requiring the performance of a goodwill interim impairment analysis. NaN goodwill impairment charges were recorded during the ~~quarter~~three and six months ended ~~March 31,~~June 30, 2021.

The following table presents the changes in goodwill by segment for the ~~three~~six months ended ~~March 31,~~June 30, 2021:

Revlon Portfolio Elizabeth Arden Fragrances Total
Balance at January 1, 2021 $ 265.4 $ 87.9 $ 89.5 $ 120.9 $ 563.7
Foreign currency translation adjustment (0.2) (0.1) (0.1) (0.1) (0.5)
Balance at March 31, 2021 $ 265.2 $ 87.8 $ 89.4 $ 120.8 $ 563.2
Cumulative goodwill impairment charges(a)
$ (166.2)



	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total




Balance at January 1, 2021	$	265.4	$	87.9	$	89.5	$	120.9	$	563.7
Foreign currency translation adjustment	(0.1)		(0.1)		(0.1)		(0.1)		(0.4)


Balance at June 30, 2021	$	265.3	$	87.8	$	89.4	$	120.8	$	563.3

Cumulative goodwill impairment charges(a)									$	(166.2)

(a) Amount refers to cumulative goodwill impairment charges related to impairments recognized in 2015, 2017, 2018 and 2020.

For the three and six months ended ~~March 31,~~June 30, 2020, the Company recorded goodwill impairment charges of ~~$99.8~~$11.2 million ~~($73.9~~and $111.0 million, ~~in the Company's Portfolio segment and $25.9 million in the Company's Elizabeth Arden segment).~~respectively.

Intangible Assets, Net

Finite-Lived Intangibles

In accordance with ASC Topic 360, the Company makes judgments about the recoverability of its purchased finite-lived intangible assets whenever events or changes in circumstances indicate that an impairment to its finite-lived intangible assets may exist. The Company also considers several indicators of impairment, including, among other factors, the following: (i) whether there exists any significant adverse change in the extent or manner in which a long-lived asset and/or asset group is being used; (ii) whether there exists any projection or forecast demonstrating losses associated with the use of a long-lived asset and/or asset group; and (iii) whether there exists a current expectation that, more likely than not, a long-lived asset and/or asset group will be sold or otherwise disposed of significantly before the end of its previously-estimated useful life. The carrying amount of a finite-lived intangible asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the finite-lived intangible asset and/or asset group and the impairment loss is measured as the amount by which the carrying amount of the finite-lived intangible asset exceeds its fair value.

As of ~~March 31,~~June 30, 2021, the Company assessed that no indicators of impairment existed requiring the performance of a finite-lived intangibles interim impairment analysis.

~~NaN~~As a result, 0 impairment charges were recognized related to the carrying value of any of the Company's finite-lived intangible assets ~~as a result as of March 31,~~for the three and six months ended June 30, 2021 and ~~March 31, 2020.~~2020, respectively.

Indefinite-Lived Intangibles

As of ~~March 31,~~June 30, 2021, the Company assessed that no indicators of impairment existed requiring the performance of an indefinite-lived intangibles interim impairment analysis. NaN intangibles impairment charges were recorded during the three and six months ended ~~March 31,~~June 30, 2021.

For the three and six months ended ~~March 31,~~June 30, 2020, the Company recorded indefinite-lived intangible assets impairment charges of ~~$24.5~~$8.6 million ~~($2.5~~and $33.1 million, ~~in the Company's Portfolio segment and $22.0 million in the Company's Elizabeth Arden segment).~~respectively.

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The following tables present details of the Company's total intangible assets as of ~~March 31,~~June 30, 2021 and December 31, 2020:

March 31, 2021
Gross Carrying Amount Accumulated Amortization Impairment Net Carrying Amount Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses $ 271.7 $ (131.8) $ 0 $ 139.9 12
Customer relationships 249.2 (113.7) 0 135.5 11
Patents and internally-developed intellectual property 23.6 (16.0) 0 7.6 5
Distribution rights 31.0 (7.9) 0 23.1 14
Other 1.3 (1.3) 0 0 0
Total finite-lived intangible assets $ 576.8 $ (270.7) $ 0 $ 306.1
Indefinite-lived intangible assets:
Trade names $ 146.5 N/A $ (33.1) $ 113.4
Total indefinite-lived intangible assets $ 146.5 N/A $ (33.1) $ 113.4
Total intangible assets $ 723.3 $ (270.7) $ (33.1) $ 419.5
December 31, 2020
Gross Carrying Amount Accumulated Amortization Impairment Net Carrying Amount Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses $ 272.8 $ (128.6) $ 0 $ 144.2 12
Customer relationships 249.9 (110.7) 0 139.2 11
Patents and internally-developed intellectual property 23.6 (15.6) 0 8.0 5
Distribution rights 31.0 (7.5) 0 23.5 14
Other 1.3 (1.3) 0 0 0
Total finite-lived intangible assets $ 578.6 $ (263.7) $ 0 $ 314.9
Indefinite-lived intangible assets:
Trade names $ 149.0 N/A $ (33.1) $ 115.9
Total indefinite-lived intangible assets $ 149.0 N/A $ (33.1) $ 115.9
Total intangible assets $ 727.6 $ (263.7) $ (33.1) $ 430.8


	June 30, 2021
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	272.0	$	(136.2)	$	0	$	135.8	12
Customer relationships	249.4		(117.2)		0		132.2		10
Patents and internally-developed intellectual property	23.6		(16.5)		0		7.1		5
Distribution rights	31.0		(8.3)		0		22.7		13
Other	1.3		(1.3)		0		0		0
Total finite-lived intangible assets	$	577.3	$	(279.5)	$	0	$	297.8

Indefinite-lived intangible assets:
Trade names	$	147.2	N/A		$	(33.1)	$	114.1
Total indefinite-lived intangible assets	$	147.2	N/A		$	(33.1)	$	114.1

Total intangible assets	$	724.5	$	(279.5)	$	(33.1)	$	411.9

	December 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:
Trademarks and licenses	$	272.8	$	(128.6)	$	0	$	144.2	12
Customer relationships	249.9		(110.7)		0		139.2		11
Patents and internally-developed intellectual property	23.6		(15.6)		0		8.0		5
Distribution rights	31.0		(7.5)		0		23.5		14
Other	1.3		(1.3)		0		0		0
Total finite-lived intangible assets	$	578.6	$	(263.7)	$	0	$	314.9

Indefinite-lived intangible assets:
Trade names	$	149.0	N/A		$	(33.1)	$	115.9
Total indefinite-lived intangible assets	$	149.0	N/A		$	(33.1)	$	115.9

Total intangible assets	$	727.6	$	(263.7)	$	(33.1)	$	430.8

Amortization expense for finite-lived intangible assets was ~~$8.4~~$8.6 million and ~~$8.5~~$8.2 million for the three months ended ~~March 31,~~June 30, 2021 and 2020, respectively, and $17.0 million and $16.7 million for the six months ended June 30, 2021 and 2020, respectively.

The following table reflects the estimated future amortization expense for each period presented, a portion of which is subject to exchange rate fluctuations, for the Company's finite-lived intangible assets as of March 31, 2021:

Estimated Amortization Expense
2021 $ 25.0
2022 30.5
2023 28.3
2024 26.0
2025 24.8
Thereafter 171.5
Total $ 306.1

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)



	Estimated Amortization Expense
2021	$	16.6
2022	32.6
2023	30.9
2024	27.6
2025	26.4
Thereafter	163.7
Total	$	297.8

6. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

The Company's accrued expenses and other current liabilities consisted of the following:

March 31, December 31,
2021 2020
Sales returns and allowances $ 82.8 $ 95.5
Advertising, marketing and promotional costs 94.0 96.3
Taxes (a)
50.4 41.8
Compensation and related benefits 40.8 50.1
Interest 23.3 29.6
Professional services and insurance 20.6 18.6
Short-term lease liability 17.3 16.6
Freight and distribution costs 15.6 9.5
Restructuring reserve 8.1 13.8
Software 3.3 3.1
Other 46.5 46.0
Total $ 402.7 $ 420.9


	June 30,		December 31,
	2021		2020
Sales returns and allowances	$	68.6	$	95.5
Advertising, marketing and promotional costs	102.0		96.3
Taxes (a)	49.2		41.8
Compensation and related benefits	49.1		50.1
Interest	30.9		29.6
Professional services and insurance	18.9		18.6
Short-term lease liability	15.7		16.6
Freight and distribution costs	14.7		9.5
Restructuring reserve	5.5		13.8
Software	3.2		3.1
Other	46.1		46.0
Total	$	403.9	$	420.9

(a) Accrued Taxes for Products Corporation as of ~~March 31,~~June 30, 2021 and December 31, 2020 were ~~$47.6~~$61.0 million and $44.8 million,

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

7. DEBT

The table below details the Company's debt balances, net of discounts and debt issuance costs.

March 31, December 31,
2021 2020
Amended 2016 Revolving Credit Facility (Tranche A) due 2023
$ 74.7 $ 136.7
SISO Term Loan Facility due 2023 95.8 0
2021 Foreign Asset-Based Term Facility due 2023 71.9 0
2020 ABL FILO Term Loans due 2023 50.0 50.0
2020 Troubled-debt-restructuring: future interest 53.5 57.8
2020 BrandCo Term Loan Facility due 2025 1,730.1 1,719.8
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025, net of discounts and debt issuance costs 871.9 874.8
2018 Foreign Asset-Based Term Facility due 2021, net of debt issuance costs 0 57.7
6.25% Senior Notes due 2024, net of debt issuance costs 425.8 425.4
Spanish Government Loan due 2025 0.3 0.3
Debt $ 3,374.0 $ 3,322.5
Less current portion (107.2) (217.5)
Long-term debt $ 3,266.8 $ 3,105.0
Short-term borrowings (*)
$ 0.3 $ 2.5


	June 30,		December 31,
	2021		2020
Amended 2016 Revolving Credit Facility (Tranche A) due 2024	$	100.4	$	136.7
SISO Term Loan Facility due 2024	125.4		0
2021 Foreign Asset-Based Term Facility due 2024	70.1		0

2020 ABL FILO Term Loans due 2023	50.0		50.0
2020 Troubled-debt-restructuring: future interest	49.8		57.8
2020 BrandCo Term Loan Facility due 2025	1,736.3		1,719.8
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025	870.6		874.8
2018 Foreign Asset-Based Term Facility due 2021	0		57.7

6.25% Senior Notes due 2024	426.2		425.4
Spanish Government Loan due 2025	0.3		0.3


Debt	$	3,429.1	$	3,322.5
Less current portion	(129.7)		(217.5)
Long-term debt	$	3,299.4	$	3,105.0

Short-term borrowings (*)	$	0.8	$	2.5

(*)The weighted average interest rate on these short-term borrowings outstanding at ~~March 31,~~June 30, 2021 and December 31, 2020 was 11.4% and 11.7%, respectively.

Amendment No. 8 to the Amended 2016 Revolving Credit Agreement: Tranche A - Revolving Credit Facility and Second-In, Second-Out ("SISO") Term Loan Facility

On May 7, 2021, Products Corporation entered into Amendment No. 8 to the Amended 2016 Revolving Credit Agreement (“Amendment No. 8”). Amendment No. 8, among other things, made certain amendments pursuant to which: (i) the maturity date applicable to the “Tranche A” revolving loans and SISO facility (as defined further below in this section within "Amendment No. 7 to the Amended 2016 Revolving Credit Agreement: Tranche A - Revolving Credit Facility and SISO Term Loan Facility") is extended from June 8, 2023 to May 7, 2024, subject to a springing maturity to the earlier of: (x) 91 days prior to the maturity of the Company’s term loan facility due September 7, 2023, to the extent such term loans are then outstanding, and (y) to the extent the Company’s first-in, last-out term loans (the “2020 ABL FILO Term Loans”) are then outstanding, the earliest stated maturity of the 2020 ABL FILO Term Loans; (ii) the commitments under the “Tranche A” revolving facility are reduced from $300 million to $270 million and under the SISO Facility are upsized from $100 million to $130 million, (iii) the financial covenant is changed from (A)(x) a minimum excess availability requirement of $20 million when the fixed charge coverage ratio is greater than 1.00x or (y) a minimum excess availability requirement of $30 million when the fixed charge coverage ratio is less than 1.00x to (B) a springing minimum fixed charge coverage ratio of 1.00x when excess availability is less than $27.5 million, (iv) certain advance rates in respect of the borrowing base under the credit agreement are increased, and (v) the perpetual cash dominion requirement is replaced with a springing cash dominion requirement triggered only when excess availability is less than $45 million. In addition, Amendment No. 8 increased the interest rate margin applicable to the “Tranche A” revolving loans to 3.75% from a range of 2.50-3.00% and decreased the LIBOR “floor” applicable thereto from 1.75% to 0.50%.

On May 7, 2021, the Company also entered into a successor agent appointment and agency transfer agreement pursuant to which MidCap Funding IV Trust ("MidCap") succeeded Citibank, N.A. as the collateral agent and administrative agent for the Amended 2016 Revolving Credit Agreement. Products Corporation has paid certain customary fees to MidCap and the lenders under the Amended 2016 Revolving Credit Facility in connection with Amendment No. 8.

Amendment No. 8 included an extinguishment, as defined by ASC 470, Debt, with the prior lenders under the Company's Tranche A Revolving Credit facility and the substitution of ~~both dates.~~such lenders under the revolving credit facility with a new lender, MidCap, with which the Company had no prior loans outstanding. In connection with this transaction:

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

•Fees of $0.8 million paid to the old lenders that were extinguished under the Tranche A Revolving Credit facility were expensed within SG&A on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2021;

•Deferred financing costs associated with the extinguished, old lenders prior to the effective date of Amendment No. 8, amounting to approximately $4.7 million, were expensed within "Amortization of debt issuance costs” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2021; and

•Fees of approximately $2.1 million paid to the new lender and third parties were recorded as deferred financing costs and are amortized in accordance with the straight-line method over the revised term of Tranche A through May 7, 2024.

The above-mentioned Amendment No. 8 also included an extinguishment and a modification of a term loan in connection with the existing SISO facility. More specifically, in accordance with ASC 470, Debt:

•Extinguishment accounting was applied to one existing prior lender, which is no longer involved with the SISO facility after Amendment No. 8. In connection with such extinguishment, deferred financing costs of approximately $1.4 million were expensed within "Amortization of debt issuance costs” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2021; and

•Modification accounting was applied to those exiting lenders for which the cash flow effect between the amount owed to them before and after the consummation of Amendment No. 8, on a present value basis, was less than 10% and, thus, the debt instruments were not considered to be substantially different. In connection with such modification, fees of approximately $0.9 million paid to the lenders were recorded as deferred financing costs and are amortized to interest expense (together with previously exiting deferred financing costs associated with these lenders of approximately $4.0 million), in accordance with the new effective interest rate computed over the revised term of the SISO facility. Additionally, approximately $0.4 million of fees paid to third parties were expensed within SG&A on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2021.

Amendment No. 7 to the Amended 2016 Revolving Credit Agreement: Tranche A - Revolving Credit Facility and SISO Term Loan Facility

On March 8, 2021, Products Corporation entered into Amendment No. 7 to the Amended 2016 Revolving Credit Agreement (“Amendment No. 7”). Amendment No. 7, among other things, made certain amendments pursuant to which: (i) the maturity date applicable to the “Tranche A” revolving loans under the Amended 2016 Revolving Credit Agreement iswas extended from September 7, 2021 to June 8, 2023; (ii) the commitments under the “Tranche A” revolving facility ~~are~~were reduced from $400 million to $300 million; and (iii) a new $100 million senior secured second-in, second-out term loan facility maturing June 8, 2023 (the “SISO Facility”) ~~has been~~was established and Products Corporation ~~has~~ borrowed $100 million of term loans thereunder. Except as to pricing, maturity, enforcement priority and certain voting rights, the terms of the SISO Facility are substantially consistent with the first-in, last-out “Tranche B” term loan facility under the Amended 2016 Revolving Credit Agreement, including as to guarantees and collateral.

Term loans under the SISO Facility accrue interest at the LIBOR rate, subject to a floor of 1.75%, plus a margin of 5.75%. In addition, Amendment No. 7 ~~increases~~increased the interest rate margin applicable to the “Tranche A” revolving loans by 0.50% to a range of 2.50% to 3.0%, depending on average excess revolving availability. Products Corporation ~~has~~ paid certain customary fees to Citibank, N.A. and the lenders under the Amended 2016 Revolving Credit Facility in connection with Amendment No. 7.

~~The above-mentioned~~ Amendment No. 7 represented an exchange of an existing revolving credit agreement with a new revolving credit agreement with the same lenders as defined by ASC 470, Debt, under the revolving credit facility. All pre-existing unamortized deferred financing costs associated with the old revolving credit agreement of approximately $0.8 million were added to the newly incurred deferred financing costs of approximately $4.2 million and their total of approximately $5.1 million ~~will~~started to be amortized in accordance with the straight-line method over the term of Tranche A through June 8, 2023. Additionally, approximately $4.3 million of new deferred financing costs were incurred in connection with the SISO Facility with the new lenders, which are amortized in accordance with the effective interest method over the term of the facility.

1920

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

2021 Foreign Asset-Based Term Facility

On March 2, 2021 (the “2021 ABTL Closing Date”), Revlon Finance LLC (the “ABTL Borrower”), a wholly owned indirect subsidiary of ~~Revlon Consumer~~ Products Corporation, ~~(“Products Corporation”),~~ certain foreign subsidiaries of Products Corporation party thereto as guarantors, the lenders party thereto and Blue Torch Finance LLC, as administrative agent and collateral agent (the “ABTL Agent”), entered into an Asset-Based Term Loan Credit Agreement (the “2021 Foreign Asset-Based Term Agreement”, and the term loan facility thereunder, the “2021 Foreign Asset-Based Term Facility”).

Principal and Maturity: The 2021 Foreign Asset-Based Term Facility provides for a U.S. dollar-denominated senior secured asset-based term loan facility in an aggregate principal amount of $75 million, the full amount of which was funded on the closing of the facility. On the 2021 ABTL Closing Date, approximately $7.5 million of the proceeds of the 2021 Foreign Asset-Based Term Facility were deposited in an escrow account by the ABTL Agent pending completion of certain post-closing perfection actions with respect to certain foreign real property of the guarantors constituting collateral securing the 2021 Foreign Asset-Based Term Facility. The 2021 Foreign Asset-Based Term Facility has an uncommitted incremental facility pursuant to which it may be increased from time to time by up to the amount of the borrowing base in effect at the time such incremental facility is incurred, subject to certain conditions and the agreement of the lenders providing such increase. The proceeds of the loans under the 2021 Foreign Asset-Based Term Facility were used: (i) to repay in full the obligations under the Asset-Based Term Loan Credit Agreement, dated as of July 9, 2018, as amended, among the ABTL Borrower, the other subsidiaries of Products Corporation party thereto, the lenders party thereto and Citibank, N.A., as administrative agent and collateral agent (the “ABTL Refinancing”); (ii) to pay fees and expenses in connection with the 2021 Foreign Asset-Based Term Facility and the ABTL Refinancing; and (iii) for working capital and other general corporate purposes. The 2021 Foreign Asset-Based Term Facility matures on March 2, 2024, subject to a springing maturity date of August 1, 2023 if, on such date, any principal amount of loans under the 2016 Term Loan Agreement due September 7, 2023 remain outstanding.

The 2021 Foreign Asset-Based Term Agreement requires the maintenance of a borrowing base supporting the borrowing thereunder, to be evidenced with the delivery of biweekly borrowing base certificates customary for facilities of this type, with more frequent reporting required upon the triggering of certain events. The borrowing base calculation under the 2021 Foreign Asset-Based Term Facility is based on the sum of: (i) 80% of eligible accounts receivable; (ii) 65% of the net orderly liquidation value of eligible finished goods inventory; and (iii) 45% of the mortgage value of eligible real property, in each case with respect to certain of Products Corporation’s subsidiaries organized in Australia, Bermuda, Germany, Italy, Spain and Switzerland (the “ABTL Borrowing Base Guarantors”). The borrowing bases in each jurisdiction are subject to certain customary availability reserves set by the ABTL Agent.

Guarantees and Security: The 2021 Foreign Asset-Based Term Facility is guaranteed by the Borrowing Base Guarantors, as well as by the direct parent entities of each ABTL Borrowing Base Guarantor (not including Revlon, Inc. or Products Corporation) on a limited recourse basis (the “ABTL Parent Guarantors”) and by certain subsidiaries of Products Corporation organized in Mexico (the “ABTL Other Guarantors” and, together with the ABTL Borrower and the ABTL Borrowing Base Guarantors, the “ABTL Loan Parties”). The obligations of the ABTL Loan Parties and the ABTL Parent Guarantors under the 2021 Foreign Asset-Based Term Facility are secured by first-ranking pledges of the equity of each ABTL Loan Party (other than the Other Guarantors), the inventory and accounts receivable of the ABTL Borrowing Base Guarantors, the material bank accounts of each Loan Party, the material intercompany indebtedness owing to any Loan Party (including any intercompany loans made with the proceeds of the 2021 Foreign Asset-Based Term Facility) and certain other material assets of the ABTL Borrowing Base Guarantors, subject to customary exceptions and exclusions. The 2021 Foreign Asset-Based Term Facility includes a cash dominion feature customary for transactions of this type.

Interest and Fees: Interest is payable on each interest payment date as set forth in the 2021 Foreign Asset-Based Term Agreement, and in any event at least quarterly, and accrues on borrowings under the 2021 Foreign Asset-Based Term Facility at a rate per annum equal to the LIBOR rate, with a floor of 1.50%, plus an applicable margin equal to 8.50%. The ABTL Borrower is obligated to pay certain fees and expenses in connection with the 2021 Foreign Asset-Based Term Facility, including a fee payable to Blue Torch Finance LLC for its services as Agent. Loans under the 2021 Foreign Asset-Based Term Facility may be prepaid without premium or penalty, subject to a prepayment premium equal to 3.0% of the aggregate principal amount of loans prepaid or repaid during the first year after the 2021 ABTL Closing Date, 2.0% of the aggregate principal amount of loans prepaid or repaid during the second year after the 2021 ABTL Closing Date and 1.0% of the aggregate principal amount of loans prepaid or repaid thereafter.

2021

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

incur additional debt; (ii) incur liens; (iii) sell, transfer or dispose of assets; (iv) make investments; (v) make dividends and distributions on, or repurchases of, equity; (vi) make prepayments of contractually subordinated or junior lien debt; (vii) enter into certain transactions with their affiliates, including amending certain material intercompany agreements or trade terms; (viii) enter into sale-leaseback transactions; (ix) change their lines of business; (x) restrict dividends from their subsidiaries or restrict liens; (xi) change their fiscal year; and (xii) modify the terms of certain debt. The ABTL Parent Guarantors are subject to certain customary holding company covenants. The ability of the Loan Parties to make certain intercompany asset sales, investments, restricted payments and prepayments of intercompany debt is contingent on certain "cash movement conditions" or "payment conditions" being met, which among other things, require a certain level of liquidity for the applicable Loan Party to effect such type of transactions. The 2021 Foreign Asset-Based Term Agreement also contains a financial covenant requiring the ABTL Loan Parties to maintain a minimum average balance of cash and cash equivalents of $3.5 million, tested monthly, based on the last 10 business days of each month, subject to certain cure rights. The 2021 Foreign Asset-Based Term Agreement also contains certain customary representations, warranties and events of default.

Prepayments: The ABTL Borrower must prepay loans under the 2021 Foreign Asset-Based Term Facility to the extent that outstanding loans exceed the borrowing base. In lieu of a mandatory prepayment, the Loan Parties may deposit cash into a designated U.S. bank account with the ABTL Agent that is subject to a control agreement (such cash, the “Qualified Cash”). If an event of default occurs and is continuing, the Qualified Cash may be applied, at the ABTL Agent’s option, to prepay the loans under the 2021 Foreign Asset-Based Term Facility. If the borrowing base subsequently exceeds the outstanding loans, the ABTL Borrower can withdraw Qualified Cash from such bank account to the extent of such excess. In addition, the 2021 Foreign Asset-Based Term Facility is subject to mandatory prepayments from the net proceeds from the incurrence by the Loan Parties of debt not permitted thereunder.

As a result of the ABTL Refinancing and the closing of the 2021 Foreign Asset-Based Term Facility without the participation of MacAndrews & Forbes as a lender, ~~M&F’s~~MacAndrews & Forbes’ commitment in respect of the New European ABL FILO Facility under the 2020 Restated Line of Credit Facility terminated on the ABTL Closing Date in accordance with its terms.

The proceeds from the 2021 Foreign Asset-Based Term Facility were used to extinguish the entire amount outstanding under the 2018 Foreign Asset-Based Term Facility as of the closing date, which was due on July 9, 2021. In connection with such extinguishment, approximately NaN and $1.0 million of pre-existing unamortized deferred financing costs were expensed within "Amortization of Debt Issuance Costs" on the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three ~~months~~and six month periods ended ~~March 31,~~June 30, 2021. In accordance with the terms of the 2021 ~~ABTL credit agreement,~~Foreign Asset-Based Term Agreement, approximately $13.8 million of the proceeds from the transaction are held in escrow and are recorded within "Prepaid expenses and ~~Other Assets"~~other assets" on the Company's Unaudited Consolidated Balance Sheet as of ~~March 31,~~June 30, 2021.

The Company incurred approximately $3.2 million of new debt issuance costs in connection with the closing of the 2021 Foreign Asset-Based Term Facility, which are amortized to interest expense in accordance with the effective interest method over the term of the facility.

2020 Troubled Debt Restructuring

As a result of the 5.75% Senior Notes Exchange Offer, and following the applicability of the Troubled Debt Restructuring guidance in ASC 470, Debt, the Company recorded $57.8 million of future interest payments. During the three and six months ended ~~March 31,~~June 30, 2021, the Company recorded ~~$3.6~~$4.3 million and $7.9 million, respectively, of amortization of such future interest as an offset within "Interest ~~Expense,~~expense, net" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss.

2122

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Covenants

Products Corporation was in compliance with all applicable covenants under the 2020 BrandCo Credit Agreement, 2016 Credit Agreements, the 2021 Foreign Asset-Based Term Facility, as well as with all applicable covenants under its 6.25% Senior Notes Indenture, in each case as of ~~March 31,~~June 30, 2021. At ~~March 31,~~June 30, 2021, the aggregate principal amounts outstanding and availability under Products Corporation’s various revolving credit facilities were as follows:


		Commitment		Borrowing Base		Aggregate principal amount outstanding at March 31, 2021		Availability at March 31, 2021 (a)			Commitment		Borrowing Base		Aggregate principal amount outstanding at June 30, 2021		Availability at June 30, 2021 (a)
Tranche A Revolving Credit Facility	Tranche A Revolving Credit Facility	$	300.0	$	150.3	$	79.6	$	50.7	Tranche A Revolving Credit Facility	$	270.0	$	155.6	$	102.1	$	53.5
SISO Term Loan Facility	SISO Term Loan Facility	100.0		100.0		100.0		0		SISO Term Loan Facility	130.0		130.0		130.0		0

2020 ABL FILO Term Loans	2020 ABL FILO Term Loans	50.0		48.5		$	50.0	$	0	2020 ABL FILO Term Loans	50.0		44.3		$	50.0	$	0

(a) Availability as of ~~March 31,~~June 30, 2021 is based upon the Tranche A Revolving borrowing base then in effect under Amendment ~~No.7~~No.8 to the Amended 2016 Revolving Credit Facility of ~~$150.3~~$155.6 million (which includes a ~~$1.5~~$5.7 million reserve for the shortfall of the borrowing base that supports the 2020 ABL FILO Term Loans compared to the corresponding aggregate principal amount outstanding of $50 million), less ~~$79.6~~$102.1 million then drawn, and less $20.0 million of availability that is required to be maintained at all times when Products Corporation’s consolidated fixed charge coverage ratio that is in effect is greater than 1.0 to 1.0.drawn.

The Company’s foreign subsidiaries held ~~$77.2~~$97.3 million out of the Company's total ~~$85.6~~$109.8 million in cash and cash equivalents as of ~~March 31,~~June 30, 2021. While the cash held by the Company’s foreign subsidiaries is primarily used to fund their operations, the Company regularly assesses its global cash needs and the available sources of cash to fund these needs, which regularly includes repatriating foreign-held cash to settle historical intercompany loans and other intercompany payables.

8. FAIR VALUE MEASUREMENTS

Assets and liabilities are required to be categorized into three levels of fair value based upon the assumptions used to value the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, generally would require significant management judgment. The three levels for categorizing the fair value measurement of assets and liabilities are as follows:

•Level 1: Fair valuing the asset or liability using observable inputs, such as quoted prices in active markets for identical assets or liabilities;

•Level 2: Fair valuing the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and

•Level 3: Fair valuing the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

As of both ~~March 31,~~June 30, 2021 and December 31, 2020, the Company did 0t have any financial assets and liabilities that were required to be measured at fair value.

As of ~~March 31,~~June 30, 2021, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


		March 31, 2021											June 30, 2021
		Fair Value											Fair Value
		Level 1		Level 2		Level 3		Total		Carrying Value			Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:	Liabilities:											Liabilities:
Long-term debt, including current portion(a)	Long-term debt, including current portion(a)	$	0	$	2,333.4	$	0	$	2,333.4	$	3,374.0	Long-term debt, including current portion(a)	$	0	$	2,649.7	$	0	$	2,649.7	$	3,429.1

2223

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

As of December 31, 2020, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


	December 31, 2020
	Fair Value
	Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:
Long-term debt, including current portion(a)	$	0	$	2,168.9	$	0	$	2,168.9	$	3,322.5

(a) The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on quoted market prices for similar issuances and maturities.

The carrying amounts of the Company's cash and cash equivalents, trade receivables, notes receivable, accounts payable and short-term borrowings approximate their respective fair values.

9. FINANCIAL INSTRUMENTS

Letters of Credit

Products Corporation maintains standby and trade letters of credit for various corporate purposes under which Products Corporation is obligated, of which $8.4 million and $7.8 million (including amounts available under credit agreements in effect at that time) were maintained ~~in each case~~ as of ~~March 31,~~June 30, 2021 and December 31, ~~2020.~~2020, respectively. Included in these amounts are approximately $5.9 million and $5.3 million in standby letters of credit that primarily support Products Corporation’s workers compensation, general liability and automobile insurance programs, in each case as outstanding as of ~~March 31,~~June 30, 2021 and December 31, ~~2020.~~2020, respectively. At ~~March 31,~~June 30, 2021 and December 31, 2020, respectively, all of the outstanding letters of credit were collateralized with a deposit of cash at the issuing financial institution. The estimated liability under such programs is accrued by Products Corporation.

10. PENSION AND POST-RETIREMENT BENEFITS

Net Periodic Benefit Cost

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the three ~~month periods~~months ended ~~March 31,~~June 30, 2021 and 2020, respectively, were as follows:


		Pension Plans				Other Post-Retirement Benefit Plans					Pension Plans				Other Post-Retirement Benefit Plans
		Three Months Ended March 31,									Three Months Ended June 30,
		2021		2020		2021		2020			2021		2020		2021		2020
Net periodic benefit costs:	Net periodic benefit costs:									Net periodic benefit costs:
Service cost	Service cost	$	0.3	$	0.4	$	0	$	0	Service cost	$	0.4	$	0.4	$	0	$	0
Interest cost	Interest cost	2.3		3.7		0		0.1		Interest cost	2.3		3.7		0.1		0.1
Expected return on plan assets	Expected return on plan assets	(4.9)		(5.8)		0		0		Expected return on plan assets	(5.0)		(5.6)		$	0	0
Amortization of actuarial loss	Amortization of actuarial loss	3.4		2.7		0.2		0.1		Amortization of actuarial loss	3.2		2.9		0.1		0.1

Total net periodic benefit costs prior to allocation										Total net periodic benefit costs prior to allocation	$	0.9	$	1.4	$	0.2	$	0.2
Portion allocated to Revlon Holdings										Portion allocated to Revlon Holdings	(0.1)		(0.1)		0		0
Total net periodic benefit costs	Total net periodic benefit costs	$	1.1	$	1.0	$	0.2	$	0.2	Total net periodic benefit costs	$	0.8	$	1.3	$	0.2	$	0.2

In the three months ended ~~March 31,~~June 30, 2021, the Company recognized net periodic benefit cost of ~~$1.3~~$1.0 million, compared to net periodic benefit cost of ~~$1.2~~$1.5 million in the three months ended ~~March 31,~~June 30, 2020, primarily due to lower interest costs partially offset by lower expected return on plan assets and higher amortization of actuarial loss.

2324

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the six months ended June 30, 2021 and 2020, respectively, were as follows:


	Pension Plans				Other Post-Retirement Benefit Plans
	Six Months Ended June 30,
	2021		2020		2021		2020
Net periodic benefit costs:
Service cost	$	0.7	$	0.8	$	0	$	0
Interest cost	4.6		7.4		0.1		0.2
Expected return on plan assets	(9.9)		(11.4)		0		0
Amortization of actuarial loss	6.6		5.6		0.3		0.2

Total net periodic benefit costs prior to allocation	$	2.0	$	2.4	$	0.4	$	0.4
Portion allocated to Revlon Holdings	(0.1)		(0.1)		0		0
Total net periodic benefit costs	$	1.9	$	2.3	$	0.4	$	0.4

In the six months ended June 30, 2021, the Company recognized net periodic benefit cost of $2.3 million, compared to net periodic benefit cost of $2.7 million in the six months ended June 30, 2020, primarily due to lower interest costs partially offset by lower expected return on plan assets and higher amortization of actuarial loss.

Net periodic benefit costs are reflected in the Company's Consolidated Financial Statements as follows for the periods presented:

Three Months Ended March 31,
2021 2020
Net periodic benefit costs:
Selling, general and administrative expense $ 0.4 $ 0.4
Miscellaneous, net 0.9 0.8
Total net periodic benefit costs $ 1.3 $ 1.2


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Net periodic benefit costs:

Selling, general and administrative expense	$	0.3	$	0.4	$	0.7	$	0.8
Miscellaneous, net	0.7		1.1		1.6		1.9
Total net periodic benefit costs	$	1.0	$	1.5	$	2.3	$	2.7

The Company expects that it will have net periodic benefit cost of approximately $5 million for its pension and other post-retirement benefit plans for all of 2021, compared with net periodic benefit cost of $4.0 million in 2020.

Contributions:

The Company’s intent is to fund at least the minimum contributions required to meet applicable federal employee benefit laws and local laws, or to directly pay benefit payments where appropriate. During the three months ended ~~March 31,~~June 30, 2021, ~~$13.5~~$3.3 million and $0.2 million were contributed to the Company’s pension plans and other post-retirement benefit plans, respectively. During the six months ended June 30, 2021, $16.8 million and $0.4 million were contributed to the Company's pension plans and other post-retirement benefit plans, respectively. During 2021, the Company expects to contribute approximately $21 million to $24 million in the aggregate to its pension and other post-retirement benefit plans once given effect to the provision of the American Rescue Plan signed into law by President Biden on March 11, 2021. The American Rescue Plan includes pension funding relief for both single employer and multiemployer plans. The single employer provisions provide for higher interest rates and a longer shortfall amortization period to be used for funding valuation and benefit restriction purposes. By default, the interest rate changes will take effect for the 2020 plan year (for both minimum contribution and benefit restriction purposes) and the change in the shortfall amortization period will take effect for the 2022 plan year. However, plan sponsors can elect to defer the interest rate changes to as late as 2022 or accelerate the change in shortfall amortization period to as early as 2019. As a result, each plan sponsor will need to assess the optimal effective date(s) for the relief and make any appropriate elections.

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

As a result of the CARES Act passed by the U.S. Congress in March 2020 to address the economic environment resulting from COVID-19, and in accordance with the Limited Relief for Pension Funding and Retirement Plan Distributions provision of such act, the Company deferred to 2021 approximately $11.8 million of contributions that were otherwise scheduled to be paid to its 2 qualified pension plans at different earlier dates during 2020. The deferral was in effect only for 2020 and under the CARES relief provisions the Company was required to pay the contributions by no later than January 4, 2021, including interest at the plans’ 2020 effective interest rate ~~("EIR")~~ from the original due date to the actual payment date. The Company paid the contributions by the due date. The first quarterly contributions for the 2 qualified plans were originally due by April 15, 2020. The Company had already made $1.6 million in contributions to its qualified pension plans during the first quarter of 2020, prior to adopting the aforementioned provision of the CARES Act.

11. STOCK COMPENSATION PLAN

Revlon's amended Stock Plan provides for awards of stock options, stock appreciation rights, restricted or unrestricted stock and restricted stock units ("RSUs") to eligible employees and directors of Revlon and its affiliates, including Products Corporation. AnOn June 3, 2021 Revlon’s stockholders approved an amendment to the Stock Plan to reserve an additional 2,000,000 shares and extend the term until August 2030. As a result, an aggregate of ~~6,565,000~~8,565,000 shares were reserved for issuance as Awards under the Stock Plan, of which there remained approximately ~~0.6~~2.6 million shares available for grant as of ~~March 31,~~June 30, 2021.

2019 Transaction Incentive Program

As of ~~March 31,~~June 30, 2021, a total of ~~58,278~~126,275 time-based RSUs under Tier 1 of the Revlon 2019 ~~TIP~~Transaction Incentive Program (the "2019 TIP") had been granted and are ~~outstanding.~~outstanding under the Stock Plan.

The 2019 TIP also provided for the following cash-based awards payable to certain employees, subject to continued employment through the respective vesting dates: (i) Tier 1 - $6.8 million payable in 2 equal installments as of December 31, 2020 and December 31, 2021; and (ii) Tier 2 - $2.5 million payable in 1 installment as of December 31, 2020. Such RSUs and cash-based awards ~~follow the Special Vesting Rules~~are eligible for vesting following a termination without cause or due to death or ~~disability.~~disability or if not assumed upon a change in control (the “Special Vesting Rules”). Since inception and through ~~March 31,~~June 30, 2021, the Company granted ~~$3.6~~$1.5 million cash-based awards, net of forfeitures, under Tier 1, which are being amortized over the period from the grant dates to December 31, 2021. The total amount amortized for this Tier 1 cash-based awards since the program's inception and through ~~March 31,~~June 30, 2021 is approximately ~~$3.7~~$4.1 million, of which

~~Table of Contents~~

~~COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share~~ $0.4 million and ~~per share amounts)~~

~~$0.6~~$1.0 million were recorded during the three and six months ended ~~March 31, 2021.~~June 30, 2021, respectively. The amortization of such awards is recorded within "Acquisition, integration and divestiture costs" in the Company's Consolidated Statements of Operations and Comprehensive Loss.

Long-Term Incentive Program.

During the first quarter of 2021, the Company granted approximately 1.5 million time-based RSU awards under the Stock Plan (the "2021 LTIP RSUs") to certain employees. During the second quarter of 2021, the Company granted approximately 35,000 time-based RSU awards under the 2021 LTIP RSUs. The 2021 LTIP RSUs are 100% time-based and vests as follows: 50% in March 2022; 25% in March 2023; 25% in March 2024.

During the first quarter of 2020, the Company granted approximately 1.3 million time-based and performance-based RSU awards under the Stock Plan (the "2020 LTIP RSUs") to certain employees. During the second quarter of 2020, there were 0 grants of 2020 LTIP RSUs.

~~See~~During the ~~roll-forward table in~~second quarter of 2021, the ~~following sections of this Note 11 for activity related~~Company granted approximately 78,000 TIP awards with both a cash component and RSU component, all pursuant to the ~~three months ended March 31, 2021.~~Stock Plan. These TIP awards are 100% time-based and vests as follows: 50% in June 2022; 50% in June 2023. The awards are subject to continued employment through the respective vesting dates.

Time-Based LTIP and TIP RSUs

The Company recognized ~~$2.3~~$3.3 million and $5.6 million of net compensation expense related to the time-based LTIP and TIP RSUs for the three and six months ended ~~March 31, 2021.~~June 30, 2021, respectively. As of ~~March 31,~~June 30, 2021, the Company had ~~$21.2~~$18.1 million of total deferred compensation expense related to non-vested, time-based LTIP and TIP RSUs. The cost is recognized over the vesting period of the awards, as described above.

Performance-based LTIP RSUs

The Company recognized ~~$0.4~~$0.1 million and $0.5 million of net compensation expense related to the performance-based LTIP RSUs for the three and six months ended ~~March 31, 2021.~~June 30, 2021, respectively. As of ~~March 31,~~June 30, 2021, the Company had ~~$13.4~~$12.1 million of total deferred compensation expense related to non-vested, performance-based LTIP RSUs. The cost is recognized over the service period of the awards, as described above.

~~Acceleration of Vesting~~

Under the aforementioned provisions for acceleration of vesting, as of March 31, 2021 and since the time these provisions became effective in September 2019, 50,593 LTIP RSUs and 41,913 2019 TIP Tier 1 RSUs were vested on an accelerated basis due to involuntary terminations, resulting in accelerated amortization of approximately $1.8 million. In addition as of March 31, 2021 and since the time this provision became effective in September 2019, the Company also recorded approximately $1.6 million of accelerated amortization in connection with the cash portion of the 2019 TIP Tier 1 that were vested on an accelerated basis due to involuntary terminations. See the roll-forward table in the following sections of this Note 11 for activity related to the three months ended March 31, 2021.

2526

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Acceleration of Vesting

Under the aforementioned provisions for acceleration of vesting, as of June 30, 2021 and since the time these provisions became effective in September 2019, 56,876 LTIP RSUs and 47,388 2019 TIP Tier 1 RSUs were vested on an accelerated basis due to involuntary terminations, resulting in accelerated amortization of approximately $2.0 million. In addition, for the six months ended June 30, 2021 and under the same accelerated vesting provisions, the Company also recorded approximately $1.8 million of accelerated amortization in connection with the cash portion of the 2019 TIP Tier 1 and Tier 2 awards that were vested on an accelerated basis due to involuntary terminations. Approximately $0.2 million in accelerated amortization were recorded in connection with the cash portion of the 2019 TIP Tier 1 awards during each of the three and six months ended June 30, 2021. See the roll-forward table in the following sections of this Note 11 for activity related to the six months ended June 30, 2021.

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

During the ~~three~~six months ended ~~March 31,~~June 30, 2021, the activity related to time-based and performance-based RSUs previously granted to eligible employees and the grant date fair value per share related to these RSUs were as follows under the LTIP and 2019 TIP programs, respectively:


		Time-Based LTIP	Performance-Based LTIP			Time-Based LTIP				Performance-Based LTIP
		RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU		RSUs (000's)		Weighted-Average Grant Date Fair Value per RSU			RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU		RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU
Outstanding as of December 31, 2020	Outstanding as of December 31, 2020								Outstanding as of December 31, 2020
2019 TIP RSUs ~~(b)~~(a)	2019 TIP RSUs ~~(b)~~(a)	58.8	$	15.95	n/a		$	—	2019 TIP RSUs ~~(b)~~(a)	58.8	$	15.95	n/a	$	—
LTIP RSUs:	LTIP RSUs:								LTIP RSUs:
2020	2020	496.5	14.96		462.9		14.96		2020	496.5	14.96		462.9	14.96
2019	2019	169.3	22.55		255.3		22.55		2019	169.3	22.55		255.3	22.55
2018	2018	66.4	19.40		215.9		19.42		2018	66.4	19.40		215.9	19.42
Total LTIP RSUs	Total LTIP RSUs	732.2			934.1				Total LTIP RSUs	732.2			934.1
Total LTIP and TIP RSUs Outstanding as of December 31, 2020	Total LTIP and TIP RSUs Outstanding as of December 31, 2020	791.0			934.1				Total LTIP and TIP RSUs Outstanding as of December 31, 2020	791.0			934.1
Granted	Granted								Granted
2019 TIP RSUs Granted	2019 TIP RSUs Granted	2.2	11.40		n/a		—		2019 TIP RSUs Granted	80.1	13.11		n/a	—
LTIP RSUs:	LTIP RSUs:								LTIP RSUs:
2021	2021	1,487.2	10.59		0		0		2021	1,543.9	10.73		0	0
2020	2020	0	0		0		0		2020	0	0		0	0
2019	2019	0	0		0		0		2019	0	0		0	0
2018	2018	0	0		0		0		2018	0	0		0	0
Total LTIP RSUs Granted	Total LTIP RSUs Granted	1,487.2			0				Total LTIP RSUs Granted	1,543.9			0
Vested	Vested								Vested
2020 TIP RSUs Vested (c)		(1.0)	16.44		—		—
2019 TIP RSUs Vested (b)									2019 TIP RSUs Vested (b)	(7.3)	15.75		—	—
LTIP RSUs:	LTIP RSUs:								LTIP RSUs:
2020 ~~(c)~~(b)	2020 ~~(c)~~(b)	(181.4)	14.96		0		0		2020 ~~(c)~~(b)	(182.7)	14.96		0	0
2019 ~~(c)~~(b)	2019 ~~(c)~~(b)	(84.2)	22.55		0		0		2019 ~~(c)~~(b)	(90.5)	22.55		0	0
2018)~~(c)~~(b)	2018)~~(c)~~(b)	(65.9)	19.42		(38.5)		19.44		2018)~~(c)~~(b)	(65.9)	19.42		(38.5)	19.44
Total LTIP RSUs Vested	Total LTIP RSUs Vested	(331.5)			(38.5)				Total LTIP RSUs Vested	(339.1)			(38.5)
Forfeited/Canceled	Forfeited/Canceled								Forfeited/Canceled
2020 TIP RSUs Forfeited/Canceled (b)		(1.7)	16.44		n/a		—
2019 TIP RSUs Forfeited/Canceled (a)									2019 TIP RSUs Forfeited/Canceled (a)	(5.3)	15.67		n/a	—
LTIP RSUs:	LTIP RSUs:								LTIP RSUs:
2021	2021	0	0		0		0		2021	(17.5)	10.59		0	0
2020	2020	(11.4)	14.96		(13.4)		14.96		2020	(38.4)	14.96		(53.8)	14.96
2019	2019	(3.1)	22.55		(7.8)		22.55		2019	(5.7)	22.55		(34.4)	22.55
2018	2018	(0.5)	16.80		(177.4)		19.42		2018	(0.5)	16.80		(177.4)	19.42
Total LTIP RSUs Forfeited/Canceled	Total LTIP RSUs Forfeited/Canceled	(15.0)			(198.6)				Total LTIP RSUs Forfeited/Canceled	(62.1)			(265.6)
Outstanding as of March 31, 2021
2020 TIP RSUs		58.3	15.54		n/a		—
Outstanding as of June 30, 2021									Outstanding as of June 30, 2021
2019 TIP RSUs									2019 TIP RSUs	126.3	14.07		n/a	—
LTIP RSUs:	LTIP RSUs:								LTIP RSUs:
2021	2021	1,487.2	10.59		0		0		2021	1,526.4	10.73		0	0
2020	2020	303.7	14.96		449.5		14.96		2020	275.4	14.96		409.1	14.96
2019	2019	82.0	22.55		247.5		22.55		2019	73.1	22.55		220.9	22.55
2018	2018	0	0		0		0		2018	0	0		0	0
Total LTIP RSUs	Total LTIP RSUs	1,872.9			697.0				Total LTIP RSUs	1,874.9			630.0
Total LTIP and TIP RSUs Outstanding as of March 31, 2021		1,931.2			697.0
Total LTIP and TIP RSUs Outstanding as of June 30, 2021									Total LTIP and TIP RSUs Outstanding as of June 30, 2021	2,001.2			630.0

((a) The 2019 TIP provides for RSU awards that are only time-based.

(b) Includes acceleration of vesting upon involuntary terminations for the three and six months ended ~~March 31,~~June 30, 2021 of ~~951~~6,283 and 7,234 RSUs, respectively, under the 2019 and 2018 LTIPs as well as 5,475 and ~~of 710~~6,185 RSUs, respectively, under the 2019 TIP Tier I awards.

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

12. INCOME TAXES

The Company's provision for income taxes represents federal, foreign, state and local income taxes. The Company's effective tax rate differs from the applicable federal statutory rate due to the effect of state and local income taxes, tax rates and income in foreign jurisdictions. The Company’s tax provision changes quarterly based on various factors including, but not limited to, the geographical level and mix of earnings; enacted tax legislation; foreign, state and local income taxes; tax audit settlements; and the interaction of various global tax strategies.

The Company recorded a provision for income taxes of ~~$11.2~~$7.2 million (Products Corporation - provision for income taxes of ~~$11.1~~$7.3 million) for the three months ended ~~March 31,~~June 30, 2021 and a benefit from income taxes of ~~$37.2~~$9.9 million (Products Corporation - benefit from income taxes ~~of $36.9~~$9.6 million) for the three months ended ~~March 31,~~June 30, 2020, respectively. The ~~$48.4~~$17.1 million increase (Products Corporation ~~- $48.0 million)~~$16.9 million in the provision for income taxes in the three months ended ~~March 31,~~June 30, 2021, compared to the three months ended ~~March 31,~~June 30, 2020, was primarily due to an increase in losses for which no tax benefit can be recognized.

The Company recorded a provision for income taxes of $18.4 million (Products Corporation - provision for income taxes of $18.4 million) for the six months ended June 30, 2021 and a benefit from income taxes of $47.1 million (Products Corporation - benefit from income taxes of $46.5 million) for the six months ended June 30, 2020, respectively. The $65.5 million increase (Products Corporation - $64.9 million) in the provision for income taxes in the six months ended June 30, 2021, compared to the six months ended June 30, 2020, was primarily due to an increase in losses for which no tax benefit can be recognized.

For the three ~~months~~and six month periods ended ~~March 31, 2021, the Company used the annual effective tax rate method to calculate its tax provision. For the three months ended March 31,~~June 30, 2020, the Company concluded that the use of the cut-off tax rate method was more appropriate than the annual effective tax rate method, because the annual effective tax rate method would have not been reliable due to its sensitivity to minimal changes in forecasted annual pre-tax earnings.

The Company's effective tax rate for the three ~~months~~and six month periods ended ~~March 31,~~June 30, 2021 was lower than the federal statutory rate of 21% primarily due to losses for which no tax benefit can be recognized. On March 11, 2021, President Biden signed into law the “American Rescue Plan Act of 2021” (the "ARPA") which expands the Employee Retention Credit and the roster of ‘covered employees’ under §162(m) deduction limits. The ARPA did not have a significant impact on the Company’s financial results.

The Company's effective tax rate for the three ~~months~~and six month periods ended ~~March 31,~~June 30, 2020 was lower than the federal statutory rate of 21% primarily due to the impact of non-deductible impairment charges and the valuation allowance related to the limitation on the deductibility of interest, partially offset by the impact of the "Coronavirus Aid, Relief and Economic Security Act" (the "CARES Act"), signed into law on March 27, 2020 by President Trump, which resulted in a partial release of a valuation allowance on the Company's 2019 federal tax attributes associated with the limitation on the deductibility of interest.

The CARES Act, among other things, includes provisions providing for refundable payroll tax credits, the deferral of employer social security tax payments, acceleration of alternative minimum tax credit refunds and the increase of the net interest deduction limitation from 30% to 50%. The Company ~~has~~ adopted the net interest deduction limitation of 50% for the taxable period ending December 31, 2020 as outlined in the CARES Act.

In assessing the recoverability of its deferred tax assets, the Company continually evaluates all available positive and negative evidence to assess the amount of deferred tax assets for which it is more likely than not to realize a benefit. For any deferred tax asset in excess of the amount for which it is more likely than not that the Company will realize a benefit, the Company establishes a valuation allowance. A valuation allowance is a non-cash charge, and it in no way limits the Company's ability to utilize its deferred tax assets, including its ability to utilize tax loss and credit carryforward amounts.

For further information, see Note 13, "Income Taxes," to the Consolidated Financial Statements in the Company's 2020 Form 10-K and Item 1A. “Risk ~~Factors-~~Factors - Uncertainties in the interpretation and application of the income tax provisions could have a material impact on the Company's financial condition, results of operations and/or cash flows” in the Company's 2020 Form 10-K.

~~13. ACCUMULATED OTHER COMPREHENSIVE LOSS~~

~~A roll-forward of the Company's accumulated other comprehensive loss as of March 31, 2021 is as follows:~~

Foreign Currency Translation Actuarial (Loss) Gain on Post-retirement Benefits Other Accumulated Other Comprehensive Loss
Balance at January 1, 2021 $ (17.1) $ (260.5) $ (0.3) $ (277.9)
Foreign currency translation adjustment, net of tax of NaN million (4.9) — — (4.9)
Amortization of pension related costs, net of tax of NaN million (a)
— 3.5 — 3.5
Other comprehensive (loss) gain $ (4.9) $ 3.5 $ 0 $ (1.4)
Balance at March 31, 2021 $ (22.0) $ (257.0) $ (0.3) $ (279.3)

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

13. ACCUMULATED OTHER COMPREHENSIVE LOSS

A roll-forward of the Company's accumulated other comprehensive loss as of June 30, 2021 is as follows:


	Foreign Currency Translation		Actuarial (Loss) Gain on Post-retirement Benefits		Other		Accumulated Other Comprehensive Loss







Balance at January 1, 2021	$	(17.1)	$	(260.5)	$	(0.3)	$	(277.9)
Foreign currency translation adjustment, net of tax	(5.4)		—		—		(5.4)
Amortization of pension related costs, net of tax (a)	—		7.0		—		7.0




Other comprehensive (loss) gain	$	(5.4)	$	7.0	$	0	$	1.6
Balance at June 30, 2021	$	(22.5)	$	(253.5)	$	(0.3)	$	(276.3)

(a) Amounts represent the change in accumulated other comprehensive loss as a result of the amortization of actuarial losses (gains) arising during each year related to the Company’s pension and other post-retirement plans. See Note 10, "Pension and Post-retirement Benefits," for further information on the Company’s pension and other post-retirement plans.

For the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, the Company did not have any activity related to derivative instruments.

14. SEGMENT DATA AND RELATED INFORMATION

Operating Segments

Operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the Company's "Chief Executive Officer") in deciding how to allocate resources and in assessing the Company's performance. As a result of the similarities in the procurement, manufacturing and distribution processes for the Company’s products, much of the information provided in the Consolidated Financial Statements and provided in the segment table below is similar to, or the same as, that reviewed on a regular basis by the Company's Chief Executive Officer.

The Company operates in 4 brand-centric reporting units that are aligned with its organizational structure based on 4 global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances, which represent the Company's 4 reporting segments.

The Company's management evaluates segment profit for each of the Company's reportable segments. The Company allocates corporate expenses to each reportable segment to arrive at segment profit, and these expenses are included in the internal measure of segment operating performance. The Company defines segment profit as income from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses. Segment profit also excludes the impact of certain items that are not directly attributable to the reportable segments' underlying operating performance. Such items are shown below in the table reconciling segment profit to consolidated income from continuing operations before income taxes. The Company does not have any material inter-segment sales.

The accounting policies for each of the reportable segments are the same as those described in the Company's 2020 Form 10-K, in Note 1, "Description of Business and Summary of Significant Accounting Policies." The Company's assets and liabilities are managed centrally and are reported internally in the same manner as the Consolidated Financial Statements; thus, no additional information regarding assets and liabilities of the Company’s reportable segments is produced for the Company's Chief Executive Officer or included in these Consolidated Financial Statements.

The following table is a comparative summary of the Company’s net sales and segment profit for Revlon and Products Corporation by reportable segment for the periods presented.

2830

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Revlon, Inc.

Three Months Ended March 31,
2021 2020
Segment Net Sales:
Revlon $ 162.0 $ 181.8
Elizabeth Arden 112.2 95.2
Portfolio 96.0 110.0
Fragrances 74.8 66.0
Total $ 445.0 $ 453.0
Segment Profit:
Revlon $ 8.0 $ 15.6
Elizabeth Arden 9.2 4.2
Portfolio 13.1 7.2
Fragrances 7.9 1.4
Total $ 38.2 $ 28.4
Reconciliation:
Total Segment Profit $ 38.2 $ 28.4
Less:
Depreciation and amortization 33.3 36.8
Non-cash stock compensation expense 3.1 2.4
Non-Operating items:
Restructuring and related charges 7.3 34.4
Acquisition, integration and divestiture costs 0.6 2.1
Loss on divested assets 0 0.8
Financial control remediation and sustainability actions and related charges 0.2 2.1
Excessive coupon redemptions 0 4.2
COVID-19 charges 6.2 7.5
Capital structure and related charges 0.2 0
Impairment charges 0 124.3
Operating loss (12.7) (186.2)
Less:
Interest Expense 58.9 48.4
Amortization of debt issuance costs 8.7 4.0
Foreign currency losses, net 3.3 16.6
Miscellaneous, net 1.2 (4.1)
Loss from operations before income taxes $ (84.8) $ (251.1)




	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Segment Net Sales:
Revlon	$	186.8	$	135.0	$	348.8	$	316.8
Elizabeth Arden	124.7		80.9		236.9		176.1
Portfolio	98.7		88.5		194.7		198.5
Fragrances	87.2		43.2		162.0		109.2
Total	$	497.4	$	347.6	$	942.4	$	800.6

Segment Profit:
Revlon	$	21.2	$	12.3	$	29.2	$	27.9
Elizabeth Arden	11.6		10.8		20.8		15.0
Portfolio	11.1		14.5		24.2		21.7
Fragrances	20.0		7.8		27.9		9.2
Total	$	63.9	$	45.4	$	102.1	$	73.8

Reconciliation:
Total Segment Profit	$	63.9	$	45.4	$	102.1	$	73.8
Less:

Depreciation and amortization	32.3		36.4		65.6		73.2
Non-cash stock compensation expense	3.4		1.1		6.5		3.5
Non-Operating items:
Restructuring and related charges	9.9		22.3		17.2		56.7
Acquisition, integration and divestiture costs	0.6		1.2		1.2		3.3
(Gain) loss on divested assets	(1.8)		(0.2)		(1.8)		0.6
Financial control remediation and sustainability actions and related charges	0.2		5.7		0.4		7.8
Excessive coupon redemptions	0		0		0		4.2
COVID-19 charges	0		17.9		6.2		25.4


Capital structure and related charges	4.8		0		5.0		0
Impairment charges	0		19.8		0		144.1



Operating income (loss)	14.5		(58.8)		1.8		(245.0)
Less:
Interest Expense	61.9		60.9		120.8		109.3

Amortization of debt issuance costs	13.3		6.0		22.0		10.0

Gain on early extinguishment of debt	0		(11.9)		0		(11.9)
Foreign currency (gains) losses, net	(1.7)		2.3		1.6		18.9
Miscellaneous, net	1.5		20.6		2.7		16.5
Loss from operations before income taxes	$	(60.5)	$	(136.7)	$	(145.3)	$	(387.8)

2931

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Products Corporation

Three Months Ended March 31,
2021 2020
Segment Net Sales:
Revlon $ 162.0 $ 181.8
Elizabeth Arden 112.2 95.2
Portfolio 96.0 110.0
Fragrances 74.8 66.0
Total $ 445.0 $ 453.0
Segment Profit:
Revlon $ 8.4 $ 16.4
Elizabeth Arden 9.5 4.6
Portfolio 13.2 7.7
Fragrances 8.1 1.7
Total $ 39.2 $ 30.4
Reconciliation:
Total Segment Profit $ 39.2 $ 30.4
Less:
Depreciation and amortization 33.3 36.8
Non-cash stock compensation expense 3.1 2.4
Non-Operating items:
Restructuring and related charges 7.3 34.4
Acquisition, integration and divestiture costs 0.6 2.1
Loss on divested assets 0 0.8
Financial control remediation and sustainability actions and related charges 0.2 2.1
Excessive coupon redemptions 0 4.2
COVID-19 charges 6.2 7.5
Capital structure and related charges 0.2 0
Impairment charge 0 124.3
Operating loss (11.7) (184.2)
Less:
Interest Expense 58.9 48.4
Amortization of debt issuance costs 8.7 4.0
Foreign currency losses, net 3.3 16.6
Miscellaneous, net 1.2 (4.1)
Loss from operations before income taxes $ (83.8) $ (249.1)



	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Segment Net Sales:
Revlon	$	186.8	$	135.0	$	348.8	$	316.8
Elizabeth Arden	124.7		80.9		236.9		176.1
Portfolio	98.7		88.5		194.7		198.5
Fragrances	87.2		43.2		162.0		109.2
Total	$	497.4	$	347.6	$	942.4	$	800.6

Segment Profit:
Revlon	$	21.8	$	13.0	$	30.2	$	29.4
Elizabeth Arden	11.9		11.3		21.4		15.9
Portfolio	11.6		15.0		24.8		22.7
Fragrances	20.3		8.0		28.4		9.7
Total	$	65.6	$	47.3	$	104.8	$	77.7

Reconciliation:
Total Segment Profit	$	65.6	$	47.3	$	104.8	$	77.7
Less:

Depreciation and amortization	32.3		36.4		65.6		73.2
Non-cash stock compensation expense	3.4		1.1		6.5		3.5
Non-Operating items:
Restructuring and related charges	9.9		22.3		17.2		56.7
Acquisition, integration and divestiture costs	0.6		1.2		1.2		3.3
(Gain) loss on divested assets	(1.8)		(0.2)		(1.8)		0.6
Financial control remediation and sustainability actions and related charges	0.2		5.7		0.4		7.8


Excessive coupon redemptions	0		0		0		4.2
COVID-19 charges	0		17.9		6.2		25.4
Capital structure and related charges	4.8		0		5.0		0
Impairment charge	0		19.8		0		144.1

Operating income (loss)	16.2		(56.9)		4.5		(241.1)
Less:
Interest Expense	61.9		60.9		120.8		109.3

Amortization of debt issuance costs	13.3		6.0		22.0		10.0

Gain on early extinguishment of debt	0		(11.9)		0		(11.9)
Foreign currency (gains) losses, net	(1.7)		2.3		1.6		18.9
Miscellaneous, net	1.5		20.6		2.7		16.5
Loss from operations before income taxes	$	(58.8)	$	(134.8)	$	(142.6)	$	(383.9)

As of ~~March 31,~~June 30, 2021, the Company had operations established in approximately 25 countries outside of the U.S. and its products are sold throughout the world. Generally, net sales by geographic area are presented by attributing revenues from external customers on the basis of where the products are sold.

3032

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The following tables present the Company's segment net sales by geography and total net sales by classes of similar products for the periods presented:


		Three Months Ended March 31, 2021					Three Months Ended June 30, 2021										Six Months Ended June 30, 2021
			Revlon		Elizabeth Arden			Portfolio		Fragrances		Total			Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area:	Geographic Area:											Geographic Area:
Net Sales	Net Sales													Net Sales
North America	North America		$	83.0	$	28.4		$	63.5	$	51.3	$	226.2	North America	$	99.5	$	20.2	$	63.2	$	61.0	$	243.9	$	182.5	$	48.6	$	126.7	$	112.3	$	470.1
EMEA*	EMEA*		37.6		26.0			24.9		15.6		104.1		EMEA*	44.0		29.5		27.0		17.9		118.4		81.6		55.5		51.9		33.5		222.5
Asia	Asia		11.0		51.6			0.7		3.0		66.3		Asia	11.6		68.2		1.2		3.9		84.9		22.6		119.8		1.9		6.9		151.2
Latin America*	Latin America*		11.4		1.3			3.1		2.3		18.1		Latin America*	15.1		2.0		4.3		2.2		23.6		26.5		3.3		7.4		4.5		41.7
Pacific*	Pacific*		19.0		4.9			3.8		2.6		30.3		Pacific*	16.6		4.8		3.0		2.2		26.6		35.6		9.7		6.8		4.8		56.9
			$	162.0	$	112.2		$	96.0	$	74.8	$	445.0		$	186.8	$	124.7	$	98.7	$	87.2	$	497.4	$	348.8	$	236.9	$	194.7	$	162.0	$	942.4

Three Months Ended March 31, 2020
Revlon Elizabeth Arden Portfolio Fragrances Total
Geographic Area:
Net Sales
   North America 99.1 21.4 70.8 42.2 $ 233.5
   EMEA* 37.3 25.9 30.6 16.3 110.1
   Asia 14.7 43.1 0.5 3.4 61.7
   Latin America* 14.0 0.8 4.9 0.8 20.5
   Pacific* 16.7 4.0 3.2 3.3 27.2
$ 181.8 $ 95.2 $ 110.0 $ 66.0 $ 453.0


			Three Months Ended June 30, 2020											Six Months Ended June 30, 2020
	Revlon			Elizabeth Arden		Portfolio		Fragrances		Total		Revlon			Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area:
Net Sales
North America	$	80.1		$	15.0	$	52.1	$	29.7	$	176.9	179.2			36.4		122.9		71.9		$	410.4
EMEA*	26.5			13.7		30.2		9.3		79.7		63.8			39.6		60.8		25.6		189.8
Asia	6.8			49.1		0.7		2.0		58.6		21.5			92.2		1.2		5.4		120.3
Latin America*	10.0			0.2		3.4		0.3		13.9		24.0			1.0		8.3		1.1		34.4
Pacific*	11.6			2.9		2.1		1.9		18.5		28.3			6.9		5.3		5.2		45.7
	$	135.0		$	80.9	$	88.5	$	43.2	$	347.6	$	316.8		$	176.1	$	198.5	$	109.2	$	800.6

* The EMEA region includes Europe, the Middle East and Africa; the Latin America region includes Mexico, Central America and South America; and the Pacific region includes Australia and New Zealand.


		Three Months Ended March 31,					Three Months Ended June 30,						Six Months Ended June 30,
			2021	2020							2021		2020			2021			2020
Classes of similar products:	Classes of similar products:											Classes of similar products:
Net sales:	Net sales:											Net sales:
Color cosmetics	Color cosmetics			$	113.4	26%		$	130.0	29%		Color cosmetics	$	130.3	26%	$	70.6	20%	$	243.7	26%	$	200.6	25%
Fragrance	Fragrance			107.4		24%		94.9		21%		Fragrance	127.9		26%	64.0		18%	235.3		25%	158.9		20%
Hair care	Hair care			109.7		25%		116.7		26%		Hair care	117.7		24%	105.4		30%	227.4		24%	222.1		28%
Beauty care	Beauty care			37.8		8%		46.1		10%		Beauty care	41.4		8%	45.4		13%	79.2		8%	91.5		11%
Skin care	Skin care			76.7		17%		65.3		14%		Skin care	80.1		16%	62.2		19%	156.8		17%	127.5		16%
				$	445.0			$	453.0				$	497.4		$	347.6		$	942.4		$	800.6

The following table presents the Company's long-lived assets by geographic area:


		March 31, 2021			December 31, 2020				June 30, 2021			December 31, 2020
Long-lived assets, net:	Long-lived assets, net:							Long-lived assets, net:
United States	United States	$	1,176.3	83%	$	1,194.9	82%	United States	$	1,152.5	83%	$	1,194.9	82%
International	International	246.9		17%	260.7		18%	International	241.3		17%	260.7		18%
		$	1,423.2		$	1,455.6			$	1,393.8		$	1,455.6

3133

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

15. REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE

Following are the components of Revlon's basic and diluted loss per common share for the periods presented:

Three months ended March 31,
2021 2020
Numerator:
Net loss $ (96.0) $ (213.9)
Denominator:
Weighted-average common shares outstanding – Basic 53,653,449 53,167,453
Effect of dilutive restricted stock and RSUs 0 0
Weighted-average common shares outstanding – Diluted 53,653,449 53,167,453
Basic and Diluted (loss) earnings per common share:
Net loss per common share $ (1.79) $ (4.02)
Unvested restricted stock and RSUs under the Stock Plan(a)
376,812 300,787


	Three months ended June 30,				Six months ended June 30,
	2021		2020		2021		2020
Numerator:


Net loss	$	(67.7)	$	(126.8)	$	(163.7)	$	(340.7)
Denominator:
Weighted-average common shares outstanding – Basic	54,015,794		53,471,004		53,835,622		53,319,228
Effect of dilutive restricted stock and RSUs	0		0		0		0
Weighted-average common shares outstanding – Diluted	54,015,794		53,471,004		53,835,622		53,319,228
Basic and Diluted (loss) earnings per common share:


Net loss per common share	$	(1.25)	$	(2.37)	$	(3.04)	$	(6.39)





Unvested restricted stock and RSUs under the Stock Plan(a)	667,978		0		504,499		56,058

(a) These are outstanding common stock equivalents that were not included in the computation of Revlon's diluted earnings per common share because their inclusion would have had an anti-dilutive effect.

16. CONTINGENCIES

Citibank Litigation

In the matter captioned In re Citibank August 11, 2020 Wire Transfers, No. 20-cv-06539-JMF (S.D.N.Y. Feb. 16, 2021) (the “Citi Decision”), the United States District Court for the Southern District of New York held that certain wire transfers mistakenly paid by Citibank, N.A. (“Citi”) from its own funds on August 11, 2020 to holders of term loans issued to Revlon under a Term Credit Agreement dated as of September 7, 2016 (as amended, the “2016 Facility”) were final and complete transactions not subject to revocation. The wire payments at issue were made to all lenders under the 2016 Facility in amounts equaling the principal and interest outstanding on the loans at that time. Certain lenders that received the payments returned the funds soon after the mistaken transfer, but holders of approximately $504 million did not, and as a result of the Citi Decision those lenders are entitled to keep the funds in discharge of their debt.

Citi has appealed the Citi Decision. Citi has also asserted subrogation rights, but, as yet, there has been no determination of those rights (if any) under the 2016 Facility and Revlon has not taken a position on this issue. In these circumstances, it is the current intention of the Company to continue to make the scheduled payments under the 2016 Facility as if the full amount of the 2016 Facility remains outstanding.

The Company is involved in various routine legal proceedings incidental to the ordinary course of its business. The Company believes that the outcome of all pending legal proceedings in the aggregate is not reasonably likely to have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows. However, in light of the uncertainties involved in legal proceedings generally, the ultimate outcome of a particular matter could be material to the Company’s operating results for a particular period depending on, among other things, the size of the loss or the nature of the liability imposed and the level of the Company’s income for that particular period.

17. RELATED PARTY TRANSACTIONS

Transfer and Reimbursement Agreements

Revlon, Products Corporation and MacAndrews & Forbes have entered into reimbursement agreements (the "Reimbursement Agreements") pursuant to which: (i) MacAndrews & Forbes is obligated to provide (directly or through its affiliates) certain professional and administrative services, including, without limitation, employees, to the Company, and to purchase services from third-party providers, such as insurance, legal, accounting and air transportation services, on behalf of the Company, to the extent requested by Products Corporation; and (ii) Products Corporation is obligated to provide certain

3234

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

professional and administrative services, including, without limitation, employees, to MacAndrews & Forbes and to purchase services from third-party providers, such as insurance, legal and accounting services, on behalf of MacAndrews & Forbes, to the extent requested by MacAndrews & Forbes, provided that in each case the performance of such services does not cause an unreasonable burden to MacAndrews & Forbes or Products Corporation, as the case may be.

The Company reimburses MacAndrews & Forbes for the allocable costs of the services that MacAndrews & Forbes purchases for or provides to the Company and for the reasonable out-of-pocket expenses that MacAndrews & Forbes incurs in connection with the provision of such services. MacAndrews & Forbes reimburses Products Corporation for the allocable costs of the services that Products Corporation purchases for or provides to MacAndrews & Forbes and for the reasonable out-of-pocket expenses incurred by Products Corporation in connection with the purchase or provision of such services. Each of the Company, on the one hand, and MacAndrews & Forbes, on the other, has agreed to indemnify the other party for losses arising out of the services provided by it under the Reimbursement Agreements, other than losses resulting from its willful misconduct or gross negligence.

The Reimbursement Agreements may be terminated by either party on 90 days' notice. The Company does not intend to request services under the Reimbursement Agreements unless their costs would be at least as favorable to the Company as could be obtained from unaffiliated third parties.

The Company participates in MacAndrews & Forbes' directors and officers liability insurance program (the "D&O Insurance Program"), as well as its other insurance coverages, such as property damage, business interruption, liability and other coverages, which cover the Company, as well as MacAndrews & Forbes and its subsidiaries. The limits of coverage for certain of the policies are available on an aggregate basis for losses to any or all of the participating companies and their respective directors and officers. The Company reimburses MacAndrews & Forbes from time-to-time for their allocable portion of the premiums for such coverage or the Company pays the insurers directly, which premiums the Company believes are more favorable than the premiums that the Company would pay were it to secure stand-alone coverage. Any amounts paid by the Company directly to MacAndrews & Forbes in respect of premiums are included in the amounts paid under the Reimbursement Agreements. To ensure the availability of directors and officers liability insurance coverage through January 2023, the Company and MacAndrews & Forbes agreed to collectively make payments under MacAndrews & Forbes’ D&O Insurance Program. In furtherance of such arrangement, during 2020, the Company made a payment of approximately $5.3 million to MacAndrews & Forbes under the Reimbursement Agreements. ~~Consequently, as~~The Company expects to make a further payment of ~~March 31,~~approximately $1.4 million in the second half of 2021 ~~the Company has 0 balance outstanding~~ in respect of its participation in the D&O Insurance Program.

The net activity related to services purchased under the Transfer and Reimbursement Agreements during the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020 was approximately $0.1 million and $0.3 million income, respectively. As of ~~March 31,~~both June 30, 2021 and December 31, 2020, a receivable balance of $0.1 million ~~at both dates~~ from MacAndrews & Forbes was included in the Company's Unaudited Consolidated Balance Sheet for transactions subject to the Transfer and Reimbursement Agreements.

Tax Sharing Agreements

As a result of a debt-for-equity exchange transaction completed in March 2004 (the "2004 Revlon Exchange Transactions"), as of March 25, 2004, Revlon, Products Corporation and their U.S. subsidiaries were no longer included in the MacAndrews & Forbes Group for U.S. federal income tax purposes.

Registration Rights Agreement

Prior to the consummation of Revlon's initial public equity offering in February 1996, Revlon and Revlon Worldwide Corporation (which subsequently merged into REV Holdings LLC, a Delaware limited liability company and a wholly-owned subsidiary of MacAndrews & Forbes ("REV Holdings")), the then direct parent of Revlon entered into a registration rights agreement (the "Registration Rights Agreement"). In February 2003, MacAndrews & Forbes executed a joinder agreement to the Registration Rights Agreement, pursuant to which REV Holdings, MacAndrews & Forbes and certain transferees of Revlon's Common Stock held by REV Holdings (the "Holders") have the right to require Revlon to register under the Securities Act all or part of the Class A Common Stock owned by such Holders, including, without limitation, the shares of Class A Common Stock purchased by MacAndrews & Forbes in connection with Revlon's 2003 $50.0 million equity rights offering and the shares of Class A Common Stock which were issued to REV Holdings upon its conversion of all 3,125,000 shares of its Class B Common Stock in October 2013 (a "Demand Registration"). In connection with closing the 2004 Revlon Exchange Transactions and pursuant to the 2004 Investment Agreement, MacAndrews & Forbes executed a joinder agreement that provided that MacAndrews & Forbes would also be a Holder under the Registration Rights Agreement and that all shares acquired by MacAndrews & Forbes pursuant to the 2004 Investment Agreement are deemed to be registrable securities under the Registration Rights Agreement. This included all of the shares of Class A Common Stock acquired by MacAndrews & Forbes in connection with Revlon’s March 2006 $110 million rights offering of shares of its Class A Common Stock and related private placement to MacAndrews & Forbes, and Revlon’s January 2007 $100 million rights offering of shares of its

3335

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Class A Common Stock and related private placement to MacAndrews & Forbes. Pursuant to the Registration Rights Agreement, in 2009 Revlon registered under the Securities Act all 9,336,905 shares of Class A Common Stock issued to MacAndrews & Forbes in the 2009 Exchange Offer, in which, among other things, Revlon issued to MacAndrews & Forbes shares of Class A Common Stock at a ratio of one share of Class A Common Stock for each $5.21 of outstanding principal amount of the then-outstanding Senior Subordinated Term Loan that MacAndrews & Forbes contributed to Revlon

Revlon may postpone giving effect to a Demand Registration for a period of up to 30 days if Revlon believes such registration might have a material adverse effect on any plan or proposal by Revlon with respect to any financing, acquisition, recapitalization, reorganization or other material transaction, or if Revlon is in possession of material non-public information that, if publicly disclosed, could result in a material disruption of a major corporate development or transaction then pending or in progress or could result in other material adverse consequences to Revlon. In addition, the Holders have the right to participate in registrations by Revlon of its Class A Common Stock (a "Piggyback Registration"). The Holders will pay all out-of-pocket expenses incurred in connection with any Demand Registration. Revlon will pay any expenses incurred in connection with a Piggyback Registration, except for underwriting discounts, commissions and expenses attributable to the shares of Class A Common Stock sold by such Holders.

As of ~~March 31,~~June 30, 2021, MacAndrews & Forbes beneficially owned approximately ~~86.4%~~86.2% of Revlon's Class A Common Stock, which at such date was Revlon's only class of capital stock outstanding. As a result, MacAndrews & Forbes is able to elect Revlon’s entire Board of Directors and control the vote on all matters submitted to a vote of Revlon's stockholders. MacAndrews & Forbes is beneficially owned by Ronald O. Perelman. Mr. Perelman is Chairman of Revlon’s and ~~Product~~Products Corporation's Board of Directors.

Other

Certain of Products Corporation’s debt obligations, including the 2016 Credit Agreements and Products Corporation's Senior Notes, have been, and may in the future be, supported by, among other things, guarantees from all of Products Corporation's domestic subsidiaries (subject to certain limited exceptions) and, for the 2016 Credit Agreements, guarantees from Revlon. The obligations under such guarantees are secured by, among other things, all of the capital stock of Products Corporation and, its domestic subsidiaries (subject to certain limited exceptions) and 66% of the capital stock of Products Corporation's and its domestic subsidiaries' first-tier foreign subsidiaries.

During the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, the Company engaged several companies in which MacAndrews & Forbes had a controlling interest to provide the Company with various ordinary course business services. These services included processing approximately ~~$2.5~~$5.6 million and ~~$13.0~~$14.2 million of coupon redemptions for the Company's retail customers for the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, respectively, for which the Company incurred fees of approximately ~~$0.1~~$0.2 million and ~~$0.3~~$0.4 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, respectively, and other similar advertising, coupon redemption and raw material supply services, for which the Company had net payables aggregating to approximately ~~$0.1 million and~~ $0.3 million as of ~~March 31,~~both June 30, 2021 and December 31, ~~2020, respectively.~~2020. As of ~~March 31,~~June 30, 2021 and December 31, 2020, payable balances of ~~less than $0.1~~$0.2 million and approximately $0.6 million, respectively, were included in the Company's Consolidated Balance Sheet for the aforementioned coupon redemption services. The Company believes that its engagement of each of these affiliates was on arm's length terms, taking into account each firm's expertise in its respective field, and that the fees paid or received were at least as favorable as those available from unaffiliated parties.

3436

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

18. PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION

Products Corporation's 6.25% Senior Notes are fully and unconditionally guaranteed on a senior basis by certain of Products Corporation’s direct and indirect wholly-owned domestic subsidiaries (the ~~"6.25% Senior Notes Guarantors"~~"Guarantors Subsidiaries").

The following Condensed Consolidating Financial Statements present the financial information as of ~~March 31,~~June 30, 2021 and December 31, 2020, and for each of the ~~three~~six months ~~March 31,~~June 30, 2021 and 2020 for: (i) Products Corporation on a stand-alone basis; (ii) the Guarantor Subsidiaries on a stand-alone basis; (iii) the subsidiaries of Products Corporation that did not guarantee and do not guarantee Products Corporation's 6.25% Senior Notes (the "Non-Guarantor Subsidiaries") on a stand-alone basis; and; (iv) Products Corporation, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries on a consolidated basis. The Condensed Consolidating Financial Statements are presented on the equity method, under which the investments in subsidiaries are recorded at cost and adjusted to the applicable share of the subsidiary's cumulative results of operations, capital contributions, distributions and other equity changes. The principal elimination entries eliminate investments in subsidiaries and intercompany balances and transactions.

Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of March 31, 2021
Products Corporation Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
ASSETS
Cash and cash equivalents $ 7.6 $ 1.5 $ 76.5 $ 0 $ 85.6
Trade receivables, less allowances for doubtful accounts 74.7 81.1 159.8 0 315.6
Inventories, net 114.4 149.1 177.7 0 441.2
Prepaid expenses and other 222.3 24.6 64.2 0 311.1
Intercompany receivables 3,754.7 3,692.3 746.3 (8,193.3) 0
Investment in subsidiaries 1,698.7 15.9 0 (1,714.6) 0
Property, plant and equipment, net 171.9 69.0 94.7 0 335.6
Deferred income taxes 0 3.4 20.5 0 23.9
Goodwill 48.9 264.0 250.3 0 563.2
Intangible assets, net 9.8 183.4 226.3 0 419.5
Other assets 66.8 8.7 29.4 0 104.9
Total assets $ 6,169.8 $ 4,493.0 $ 1,845.7 $ (9,907.9) $ 2,600.6
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings $ 0 $ 0 $ 0.3 $ 0 $ 0.3
Current portion of long-term debt 107.1 0 0.1 0 107.2
Accounts payable 84.4 41.0 70.2 0 195.6
Accrued expenses and other 120.0 64.1 221.6 0 405.7
Intercompany payables 4,138.8 3,295.4 758.9 (8,193.1) 0
Long-term debt 3,193.9 0 72.9 0 3,266.8
Other long-term liabilities 273.7 112.7 34.8 0 421.2
Total liabilities 7,917.9 3,513.2 1,158.8 (8,193.1) 4,396.8
Stockholder’s (deficiency) equity (1,748.1) 979.8 686.9 (1,714.8) (1,796.2)
Total liabilities and stockholder’s (deficiency) equity $ 6,169.8 $ 4,493.0 $ 1,845.7 $ (9,907.9) $ 2,600.6

~~Table of Contents~~

~~COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of December 31, 2020
Products Corporation Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
ASSETS
Cash and cash equivalents $ 5.5 $ 2.5 $ 89.1 $ 0 $ 97.1
Trade receivables, less allowances for doubtful accounts 86.0 95.7 170.6 0 352.3
Inventories, net 121.3 147.7 193.6 0 462.6
Prepaid expenses and other 220.6 24.6 55.3 0 300.5
Intercompany receivables 3,592.2 3,549.6 614.1 (7,755.9) 0
Investment in subsidiaries 1,653.6 2.3 0 (1,655.9) 0
Property, plant and equipment, net 178.5 72.1 101.4 0 352.0
Deferred income taxes 0 10.6 23.5 0 34.1
Goodwill 48.9 264.0 250.8 0 563.7
Intangible assets, net 10.0 187.8 233.0 0 430.8
Other assets 67.9 9.3 31.9 0 109.1
Total assets $ 5,984.5 $ 4,366.2 $ 1,763.3 $ (9,411.8) $ 2,702.2
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings $ 0 $ 0 $ 2.5 $ 0 $ 2.5
Current portion of long-term debt 159.2 0 58.3 0 217.5
Accounts payable 72.5 48.0 82.8 0 203.3
Accrued expenses and other 144.1 61.7 217.4 0 423.2
Intercompany payables 3,897.1 3,162.0 696.6 (7,755.7) 0
Long-term debt 3,104.7 0 0.3 0 3,105.0
Other long-term liabilities 377.3 33.8 42.6 0 453.7
Total liabilities 7,754.9 3,305.5 1,100.5 (7,755.7) 4,405.2
Stockholder’s (deficiency) equity (1,770.4) 1,060.7 662.8 (1,656.1) (1,703.0)
Total liabilities and stockholder’s (deficiency) equity $ 5,984.5 $ 4,366.2 $ 1,763.3 $ (9,411.8) $ 2,702.2

~~Table of Contents~~

~~COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended March 31, 2021
Products Corporation Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
Net Sales $ 96.1 $ 118.2 $ 230.7 $ 0 $ 445.0
Cost of sales 47.6 56.0 87.6 0 191.2
Gross profit 48.5 62.2 143.1 0 253.8
Selling, general and administrative expenses 98.2 52.4 108.9 0 259.5
Acquisition, integration and divestiture costs 0.5 0 0.1 0 0.6
Restructuring charges and other, net 1.2 1.5 2.7 0 5.4
Operating (loss) income (51.4) 8.3 31.4 0 (11.7)
Other (income) expense:
Intercompany interest, net (0.3) 0.6 (0.3) 0 0
Interest expense 57.8 0 1.1 0 58.9
Amortization of debt issuance costs 8.7 0 0 0 8.7
Foreign currency losses, net (0.6) (1.7) 5.6 0 3.3
Miscellaneous, net 14.5 2.7 (16.0) 0 1.2
Other expense (income), net 80.1 1.6 (9.6) 0 72.1
(Loss) income from operations before income taxes (131.5) 6.7 41.0 0 (83.8)
Provision for (benefit from) for income taxes 0.7 (0.1) 10.5 0 11.1
(Loss) income from operations, net of taxes (132.2) 6.8 30.5 0 (94.9)
Equity in income (loss) of subsidiaries 43.3 6.0 0 (49.3) 0
Net (loss) income $ (88.9) $ 12.8 $ 30.5 $ (49.3) $ (94.9)
Other comprehensive (loss) income (1.2) 7.1 2.8 (10.1) (1.4)
Total comprehensive (loss) income $ (90.1) $ 19.9 $ 33.3 $ (59.4) $ (96.3)


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of June 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	12.0	$	2.4	$	95.4	$	0	$	109.8
Trade receivables, less allowances for doubtful accounts	77.0		86.6		150.7		0		314.3
Inventories, net	109.5		154.7		177.7		0		441.9
Prepaid expenses and other	212.7		27.2		66.3		0		306.2
Intercompany receivables	3,782.7		3,842.6		691.6		(8,316.9)		0
Investment in subsidiaries	1,765.0		16.6		0		(1,781.6)		0
Property, plant and equipment, net	165.8		65.7		90.1		0		321.6
Deferred income taxes	0		12.3		20.3		0		32.6
Goodwill	48.9		264.0		250.4		0		563.3
Intangible assets, net	9.5		178.9		223.5		0		411.9
Other assets	59.7		8.4		28.9		0		97.0
Total assets	$	6,242.8	$	4,659.4	$	1,794.9	$	(10,098.5)	$	2,598.6
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	0	$	0	$	0.8	$	0	$	0.8
Current portion of long-term debt	129.6		0		0.1		0		129.7
Accounts payable	76.2		41.6		79.2		0		197.0
Accrued expenses and other	117.9		76.1		221.7		0		415.7
Intercompany payables	4,231.6		3,422.6		662.5		(8,316.7)		0
Long-term debt	3,226.5		0		72.9		0		3,299.4
Other long-term liabilities	314.4		101.6		(4.1)		0		411.9
Total liabilities	8,096.2		3,641.9		1,033.1		(8,316.7)		4,454.5
Stockholder’s (deficiency) equity	(1,853.4)		1,017.5		761.8		(1,781.8)		(1,855.9)
Total liabilities and stockholder’s (deficiency) equity	$	6,242.8	$	4,659.4	$	1,794.9	$	(10,098.5)	$	2,598.6

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended March 31, 2020
Products Corporation Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
Net Sales $ 116.4 $ 112.4 $ 224.2 $ 0 $ 453.0
Cost of sales 58.4 54.4 85.0 0 197.8
Gross profit 58.0 58.0 139.2 0 255.2
Selling, general and administrative expenses 104.4 71.0 112.0 0 287.4
Acquisition, integration and divestiture costs 1.1 0.5 0.5 0 2.1
Restructuring charges and other, net 23.6 1.3 (0.1) 0 24.8
Impairment charges 124.3 0 0 0 124.3
Loss on divested assets 0.8 0 0 0 0.8
Operating (loss) income (196.2) (14.8) 26.8 0 (184.2)
Other (income) expenses:
Intercompany interest, net (2.8) 0.6 2.2 0 0
Interest expense 46.5 0 1.9 0 48.4
Amortization of debt issuance costs 4.0 0 0 0 4.0
Foreign currency losses, net (5.5) 1.9 20.2 0 16.6
Miscellaneous, net (23.9) (9.2) 29.0 0 (4.1)
Other expense (income), net 18.3 (6.7) 53.3 0 64.9
Loss from operations before income taxes (214.5) (8.1) (26.5) 0 (249.1)
Benefit from income taxes (16.3) (20.2) (0.4) 0 (36.9)
(Loss) income from operations, net of taxes (198.2) 12.1 (26.1) 0 (212.2)
Equity in (loss) income of subsidiaries (34.1) (20.0) 0 54.1 0
Net (loss) income $ (232.3) $ (7.9) $ (26.1) $ 54.1 $ (212.2)
Other comprehensive (loss) income (2.7) 6.5 (8.8) 2.3 (2.7)
Total comprehensive (loss) income $ (235.0) $ (1.4) $ (34.9) $ 56.4 $ (214.9)


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of December 31, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	5.5	$	2.5	$	89.1	$	0	$	97.1
Trade receivables, less allowances for doubtful accounts	86.0		95.7		170.6		0		352.3
Inventories, net	121.3		147.7		193.6		0		462.6
Prepaid expenses and other	220.6		24.6		55.3		0		300.5
Intercompany receivables	3,592.2		3,549.6		614.1		(7,755.9)		0
Investment in subsidiaries	1,653.6		2.3		0		(1,655.9)		0
Property, plant and equipment, net	178.5		72.1		101.4		0		352.0
Deferred income taxes	0		10.6		23.5		0		34.1
Goodwill	48.9		264.0		250.8		0		563.7
Intangible assets, net	10.0		187.8		233.0		0		430.8
Other assets	67.9		9.3		31.9		0		109.1
Total assets	$	5,984.5	$	4,366.2	$	1,763.3	$	(9,411.8)	$	2,702.2
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	0	$	0	$	2.5	$	0	$	2.5
Current portion of long-term debt	159.2		0		58.3		0		217.5
Accounts payable	72.5		48.0		82.8		0		203.3
Accrued expenses and other	144.1		61.7		217.4		0		423.2
Intercompany payables	3,897.1		3,162.0		696.6		(7,755.7)		0
Long-term debt	3,104.7		0		0.3		0		3,105.0
Other long-term liabilities	377.3		33.8		42.6		0		453.7
Total liabilities	7,754.9		3,305.5		1,100.5		(7,755.7)		4,405.2
Stockholder’s (deficiency) equity	(1,770.4)		1,060.7		662.8		(1,656.1)		(1,703.0)
Total liabilities and stockholder’s (deficiency) equity	$	5,984.5	$	4,366.2	$	1,763.3	$	(9,411.8)	$	2,702.2

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Three Months Ended March 31, 2021
Products Corporation Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash provided by (used in) operating activities $ 5.4 $ (41.6) $ 7.8 $ 0 $ (28.4)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities (1.9) 0.4 0.8 0 (0.7)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft (3.5) (4.9) (2.2) 0 (10.6)
Borrowings under the SISO Term Loan Facility 100.0 0 0 0 100.0
Net repayments under the Amended 2016 Revolving Credit Facility (59.3) 0 0 0 (59.3)
Borrowings under the 2021 Foreign Asset-Based Term Facility 75.0 0 0 0 75.0
Repayments of the 2018 Foreign Asset-Based Term Facility (58.9) 0 0 0 (58.9)
Repayments under the 2016 Term Loan Facility (2.3) 0 0 0 (2.3)
Payment of financing costs (11.8) 0 0 0 (11.8)
Tax withholdings related to net share settlements of restricted stock and RSUs (2.4) 0 0 0 (2.4)
Other financing activities (0.1) 0 0 0 (0.1)
Net cash provided by (used in) financing activities 36.7 (4.9) (2.2) 0 29.6
Effect of exchange rate changes on cash, cash equivalents and restricted cash (21.9) 47.7 (27.1) 0 (1.3)
Net increase (decrease) in cash, cash equivalents and restricted cash 18.3 1.6 (20.7) 0 (0.8)
Cash, cash equivalents and restricted cash at beginning of period $ 6.5 $ 7.8 $ 88.2 $ 0 $ 102.5
Cash, cash equivalents and restricted cash at end of period $ 24.8 $ 9.4 $ 67.5 $ 0 $ 101.7



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	112.4	$	131.2	$	253.8	$	0	$	497.4
Cost of sales	51.1		54.4		90.8		0		196.3
Gross profit	61.3		76.8		163.0		0		301.1
Selling, general and administrative expenses	90.6		60.6		126.5		0		277.7
Acquisition and integration costs	0.6		0		0		0		0.6
Restructuring charges and other, net	5.6		0.7		2.1		0		8.4
Impairment charges	0		0		0		0		0
Gain on divested assets	(1.8)		0		0		0		(1.8)
Operating (loss) income	(33.7)		15.5		34.4		0		16.2
Other (income) expense:
Intercompany interest, net	(0.5)		0.6		(0.1)		0		0
Interest expense	61.9		0		0		0		61.9
Amortization of debt issuance costs	13.3		0		0		0		13.3
Gain on early extinguishment of debt	0		0		0		0		0
Foreign currency losses (gains), net	0.4		0.8		(2.9)		0		(1.7)
Miscellaneous, net	22.2		(14.5)		(6.2)		0		1.5
Other expense (income), net	97.3		(13.1)		(9.2)		0		75.0
(Loss) income from continuing operations before income taxes	(131.0)		28.6		43.6		0		(58.8)
(Benefit from) provision for income taxes	(0.7)		1.5		6.5		0		7.3
(Loss) income from continuing operations, net of taxes	(130.3)		27.1		37.1		0		(66.1)

Equity in income (loss) of subsidiaries	66.7		3.7		0		(70.4)		0
Net (loss) income	$	(63.6)	$	30.8	$	37.1	$	(70.4)	$	(66.1)
Other comprehensive income (loss)	2.8		(2.9)		(0.3)		3.4		3.0
Total comprehensive (loss) income	$	(60.8)	$	27.9	$	36.8	$	(67.0)	$	(63.1)

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Three Months Ended March 31, 2020
Products Corporation Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities $ (57.7) $ 3.1 $ (23.0) $ 0 $ (77.6)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities (1.8) (0.1) 0.1 0 (1.8)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net (decrease) increase in short-term borrowings and overdraft (2.1) (4.8) 0.5 0 (6.4)
Net borrowings under the Amended 2016 Revolving Credit Facility 69.1 0 0 0 69.1
Repayments under the 2016 Term Loan Facility (4.5) 0 0 0 (4.5)
Payments of financing costs (0.3) 0 0 0 (0.3)
Tax withholdings related to net share settlements of restricted stock and RSUs (0.4) 0 0 0 (0.4)
Other financing activities (0.1) 0 0 0 (0.1)
Net cash provided by (used in) financing activities 61.7 (4.8) 0.5 0 57.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 (2.1) (1.2) 0 (3.3)
Net increase (decrease) in cash, cash equivalents and restricted cash 2.2 (3.9) (23.6) 0 (25.3)
Cash, cash equivalents and restricted cash at beginning of period $ 1.0 $ 6.4 97.2 $ 0 104.5
Cash, cash equivalents and restricted cash at end of period $ 3.2 $ 2.5 $ 73.6 $ 0 $ 79.2



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	93.8	$	78.2	$	175.6	$	0	$	347.6
Cost of sales	54.4		43.5		70.7		0		168.6
Gross profit	39.4		34.7		104.9		0		179.0
Selling, general and administrative expenses	58.8		45.2		90.4		0		194.4
Acquisition and integration costs	2.0		(0.5)		(0.3)		0		1.2
Restructuring charges and other, net	17.1		3.0		0.6		0		20.7
Impairment charges	19.8		0		0		0		19.8
Gain on divested assets	(0.2)		0		0		0		(0.2)
Operating (loss) income	(58.1)		(13.0)		14.2		0		(56.9)
Other (income) expense:
Intercompany interest, net	(0.3)		0.6		(0.3)		0		0
Interest expense	59.2		0		1.7		0		60.9
Amortization of debt issuance costs	6.0		0		0		0		6.0
Gain on early extinguishment of debt, net	(11.9)		0		0		0		(11.9)
Foreign currency losses (gains), net	6.2		0.5		(4.4)		0		2.3
Miscellaneous, net	24.9		(6.9)		2.6		0		20.6
Other expense (income), net	84.1		(5.8)		(0.4)		0		77.9
(Loss) income from continuing operations before income taxes	(142.2)		(7.2)		14.6		0		(134.8)
(Benefit from) provision for income taxes	(35.8)		21.6		4.6		0		(9.6)
Loss (income) from continuing operations, net of taxes	(106.4)		(28.8)		10.0		0		(125.2)

Equity in income (loss) of subsidiaries	4.7		(6.9)		0		2.2		0
Net (loss) income	$	(101.7)	$	(35.7)	$	10.0	$	2.2	$	(125.2)
Other comprehensive income (loss)	14.3		7.9		11.2		(19.1)		14.3
Total comprehensive (loss) income	$	(87.4)	$	(27.8)	$	21.2	$	(16.9)	$	(110.9)

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

~~19. SUBSEQUENT EVENTS~~



Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	208.5	$	249.4	$	484.5	$	0	$	942.4
Cost of sales	98.7		110.4		178.4		0		387.5
Gross profit	109.8		139.0		306.1		0		554.9
Selling, general and administrative expenses	188.8		113.0		235.4		0		537.2
Acquisition, integration and divestiture costs	1.1		0		0.1		0		1.2
Restructuring charges and other, net	6.8		2.2		4.8		0		13.8

(Gain) loss on divested assets	(1.8)		0		0		0		(1.8)
Operating (loss) income	(85.1)		23.8		65.8		0		4.5
Other (income) expense:
Intercompany interest, net	(0.8)		1.2		(0.4)		0		0
Interest expense	119.7		0		1.1		0		120.8
Amortization of debt issuance costs	22.0		0		0		0		22.0

Foreign currency losses, net	(0.2)		(0.9)		2.7		0		1.6
Miscellaneous, net	36.7		(11.8)		(22.2)		0		2.7
Other expense (income), net	177.4		(11.5)		(18.8)		0		147.1
(Loss) income from operations before income taxes	(262.5)		35.3		84.6		0		(142.6)
Provision for (benefit from) for income taxes	0		1.4		17.0		0		18.4
(Loss) income from operations, net of taxes	(262.5)		33.9		67.6		0		(161.0)

Equity in income (loss) of subsidiaries	110.0		9.7		0		(119.7)		0
Net (loss) income	$	(152.5)	$	43.6	$	67.6	$	(119.7)	$	(161.0)
Other comprehensive (loss) income	1.6		4.2		2.5		(6.7)		1.6
Total comprehensive (loss) income	$	(150.9)	$	47.8	$	70.1	$	(126.4)	$	(159.4)

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

~~Revlon Global Growth Accelerator Program~~


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	$	210.2	$	190.7	$	399.8	$	(0.1)	$	800.6
Cost of sales	112.9		97.9		155.7		(0.1)		366.4
Gross profit	97.3		92.8		244.1		0		434.2
Selling, general and administrative expenses	163.2		116.1		202.5		0		481.8
Acquisition, integration and divestiture costs	3.2		0		0.1		0		3.3
Restructuring charges and other, net	40.7		4.3		0.5		0		45.5
Impairment charges	144.1		0		0		0		144.1
Loss on divested assets	0.6		0		0		0		0.6
Operating (loss) income	(254.5)		(27.6)		41.0		0		(241.1)
Other (income) expenses:
Intercompany interest, net	(3.0)		1.1		1.9		0		0
Interest expense	105.7		0		3.6		0		109.3
Amortization of debt issuance costs	10.0		0		0		0		10.0
Loss on early extinguishment of debt, net	(11.9)		0		0		0		(11.9)
Foreign currency losses, net	0.6		2.4		15.9		0		18.9
Miscellaneous, net	0.9		(16.1)		31.7		0		16.5
Other expense (income), net	102.3		(12.6)		53.1		0		142.8
Loss from operations before income taxes	(356.8)		(15.0)		(12.1)		0		(383.9)
Benefit from income taxes	(52.1)		1.4		4.2		0		(46.5)
(Loss) income from operations, net of taxes	(304.7)		(16.4)		(16.3)		0		(337.4)

Equity in (loss) income of subsidiaries	(29.3)		(26.9)		0		56.2		0
Net (loss) income	$	(334.0)	$	(43.3)	$	(16.3)	$	56.2	$	(337.4)
Other comprehensive (loss) income	11.6		14.4		2.4		(16.8)		11.6
Total comprehensive (loss) income	$	(322.4)	$	(28.9)	$	(13.9)	$	39.4	$	(325.8)

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

On May 10, 2021, the Company announced that it is expanding the existing Revlon 2020 Restructuring Program through 2023. The Company will rename the revised program the Revlon Global Growth Accelerator (“RGGA”). The expanded program includes a reinvestment strategy to strengthen our brands


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash provided by (used in) operating activities	$	(38.3)	$	(41.2)	$	40.2	$	0	$	(39.3)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(0.6)		0.2		(0.4)		0		(0.8)



CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	(0.2)		(4.6)		(1.9)		0		(6.7)
Borrowings on term loans	305.0		0		0		0		305.0

Repayments on term loans	(176.1)		0		0		0		(176.1)
Net (repayments) borrowings under the revolving credit facilities	(36.8)		0		0		0		(36.8)


Payment of financing costs	(15.8)		0		0		0		(15.8)
Tax withholdings related to net share settlements of restricted stock and RSUs	(2.4)		0		0		0		(2.4)
Other financing activities	(0.2)		0		0		0		(0.2)
Net cash provided by (used in) financing activities	73.5		(4.6)		(1.9)		0		67.0
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(18.0)		47.7		(30.7)		0		(1.0)
Net increase (decrease) in cash, cash equivalents and restricted cash	16.6		2.1		7.2		0		25.9
Cash, cash equivalents and restricted cash at beginning of period	$	6.5	$	7.8	$	88.2	$	0	$	102.5
Cash, cash equivalents and restricted cash at end of period	$	23.1	$	9.9	$	95.4	$	0	$	128.4

Table of Contents

COMBINED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and ~~drive long-term profitable margin and revenue growth through realized incremental productivity initiatives and enhanced capabilities.~~per share amounts)

~~The major initiatives underlying the Revlon Global Growth Accelerator program include:~~


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2020
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	$	(148.3)	$	14.6	$	(30.5)	$	0	$	(164.2)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities	(2.7)		0		0		0		(2.7)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net (decrease) increase in short-term borrowings and overdraft	(1.3)		(6.2)		0.5		0		(7.0)
Net borrowings under the Amended 2016 Revolving Credit Facility	(22.9)		0		0		0		(22.9)
Borrowings under the 2020 BrandCo Facilities	880.0		0		0		0		880.0
Repurchases of the 5.75% Senior Notes	(99.6)		0		0		0		(99.6)
Repayment of the 2019 Term Loan Facility	(200.0)		0		0		0		(200.0)
Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)		0		0		0		(31.4)
Repayments under the 2016 Term Loan Facility	(6.9)		0		0		0		(6.9)
Payments of financing costs	(101.2)		0		0		0		(101.2)
Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		0		0		0		(1.6)
Other financing activities	(1.0)		0		0		0		(1.0)
Net cash provided by (used in) financing activities	414.1		(6.2)		0.5		0		408.4
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0		(9.0)		6.9		0		(2.1)
Net increase (decrease) in cash, cash equivalents and restricted cash	263.1		(0.6)		(23.1)		0		239.4
Cash, cash equivalents and restricted cash at beginning of period	$	1.0	$	6.4	97.2		$	0	104.5
Cash, cash equivalents and restricted cash at end of period	$	264.1	$	5.8	$	74.1	$	0	$	343.9

•~~Strategic Growth: Boost organic sales growth behind our strategic pillars – brands, markets, and channels -- to deliver an approximate mid-single digit compound average annual growth rate through 2023;~~

•~~Operating Efficiencies: Drive additional operational efficiencies and cost savings to fuel investments in revenue growth; and~~

•~~Build Capabilities: Enhance capabilities and up-skill employees in order to evolve our culture to promote agility and deliver transformational change.~~

Under RGGA, the Company expects to deliver an updated range of annualized cost reductions of approximately $275 million to $325 million from 2020 through the end of 2023. The Company achieved $155 million of cost reductions program to date through the first quarter of 2021 and expects to achieve approximately $60 million to $80 million for the full year 2021 (inclusive of the first quarter of 2021 cost reductions), with the balance to be realized during 2022 and 2023.

In connection with implementing RGGA, the Company expects to recognize an updated cost range of approximately $185 million and $205 million of total pre-tax restructuring and related charges, consisting of employee-related costs, such as severance, pension and other termination costs, as well as related third party expenses. The Company also expects to incur approximately $15 million of additional capital expenditures. The Company recorded pre-tax restructuring and related charges of ~~$76.1 million~~ program to date through the first quarter of 2021 in connection with the Revlon 2020 Restructuring Program. Under the expanded program, the Company expects to incur pre-tax restructuring and related charges of approximately $65 million to $75 million during 2021 (inclusive of the first quarter of 2021 charges) and the remainder during 2022 and 2023. The Company expects that substantially all of these restructuring and related charges will be paid in cash, with approximately $50 million to $55 million of the total charges expected to be paid in 2021, with the remainder to be paid during 2022 and 2023.

~~Amendment No. 8 to the Amended 2016 Revolving Credit Agreement: Tranche A Revolving Credit Facility and SISO Term Loan Facility~~

On May 7, 2021, Products Corporation entered into Amendment No. 8 to the Amended 2016 Revolving Credit Agreement (“Amendment No. 8”). Amendment No. 8, among other things, made certain amendments pursuant to which (i) the maturity date applicable to the “Tranche A” revolving loans and the SISO Facility under the Amended 2016 Revolving Credit Agreement is extended from June 8, 2023 to May 7, 2024, subject to a springing maturity to the earlier of (x) 91 days prior to the maturity of the Company’s term loan facility due September 7, 2023, to the extent such term loans are then outstanding, and (y) to the extent the Company’s first-in, last-out term loans (the “2020 ABL FILO Term Loans”) are then outstanding, the earliest stated maturity of the 2020 ABL FILO Term Loans, (ii) the commitments under the “Tranche A” revolving facility are reduced from $300 million to $270 million and under the SISO Facility are upsized from $100 million to $130 million, (iii) the financial covenant is changed from (A)(x) a minimum excess availability requirement of $20 million when the fixed charge coverage ratio is greater than 1.00x or (y) a minimum excess availability requirement of $30 million when the fixed charge coverage ratio is less than 1.00x to (B) a springing minimum fixed charge coverage ratio of 1.00x when excess availability is less than $27.5 million, (iv) certain advance rates in respect of the borrowing base under the credit agreement are increased and (v) the perpetual cash dominion requirement is replaced with a springing cash dominion requirement triggered only when excess availability is less than $45 million. In addition, Amendment No. 8 increases the interest rate margin applicable to the “Tranche A” revolving loans to 3.75% from a range of 2.50-3.00% and decreases the LIBOR “floor” applicable thereto from 1.75% to 0.50%.

On May 7, 2021, the Company also entered into a successor agent appointment and agency transfer agreement pursuant to which MidCap Funding IV Trust succeeded Citibank, N.A. as the collateral agent and administrative agent for the Amended 2016 Revolving Credit Agreement. Products Corporation has paid certain customary fees to MidCap Funding IV Trust and the lenders under the Amended 2016 Revolving Credit Facility in connection with Amendment No. 8.

4144

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Item 2. Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the information contained in the Unaudited Consolidated Financial Statements and related notes included elsewhere in this document, and in the Company's other public filings with the Securities and Exchange Commission (“SEC”), including our ~~Annual Report on~~2020 Form ~~10-K for the fiscal year ended December 31, 2020.~~10-K. As discussed in more detail in the Section entitled “Forward-Looking Statements,” this discussion contains forward-looking statements, which involve risks and uncertainties.

For more details on the newly announced Revlon Global Growth Accelerator program and Amendment No. 8 to the Amended 2016 Revolving Credit Agreement, see Note 19, "Subsequent Events" to the Company's Unaudited Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

COVID-19 Pandemic

While the Company continues to execute its business strategy, the ongoing COVID-19 pandemic has adversely impacted net sales in all major commercial regions around the globe that are important to the Company's business. The COVID-19 pandemic’s adverse impact on the global economy has contributed to significant and extended quarantines, stay-at-home orders and other social distancing measures; closures and bankruptcies of retailers, beauty salons, spas, offices and manufacturing facilities; increased levels of unemployment; travel and transportation restrictions leading to declines in consumer traffic in key shopping and tourist areas around the globe; and import and export restrictions. These adverse conditions have resulted in the general slowdown of the global economy, in turn contributing to declines in net sales within some of the Company’s reporting segments and regions. However, as COVID-19 restrictions are lifted, the Company is seeing a resumption in consumer spending and consumption. The Company continues to closely monitor the associated impacts and take appropriate actions in an effort to mitigate the COVID-19 pandemic’s negative effects on the Company’s operations and financial results.

Overview

Overview of the Business

Revlon, Inc. ("Revlon" and together with its subsidiaries, the "Company") conducts its business exclusively through its direct wholly-owned operating subsidiary, Revlon Consumer Products Corporation ("Products Corporation"), and its subsidiaries. Revlon is an indirect majority-owned subsidiary of MacAndrews & Forbes Incorporated (together with certain of its affiliates other than the Company, "MacAndrews & Forbes"), a corporation beneficially owned by Ronald O. Perelman.

The Company operates in four brand-centric reporting segments that are aligned with its organizational structure based on four global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances. The Company manufactures, markets and sells an extensive array of beauty and personal care products worldwide, including color cosmetics; fragrances; skin care; hair color, hair care and hair treatments; beauty tools; men's grooming products; anti-perspirant deodorants; and other beauty care products.

Business Strategy

The Company remains focused on its 3 key strategic pillars to drive its future success and growth. First, strengthening its iconic brands through innovation and relevant product portfolios; second, building its capabilities to better communicate and connect with its consumers through media channels where they spend the most time; and third, ensuring availability of its products where consumers shop, both in-store and increasingly online. The Company has continued to deliver against the objectives of the Revlon ~~2020 Restructuring Program,~~Global Growth Accelerator (“RGGA”) program, which includes rightsizing our organization with the objectives of driving improved profitability, cash flow and liquidity. The Company is also managing the business to conserve cash and liquidity, as well as focusing on stabilizing the business, growing e-commerce and preparing the foundation for achieving future growth.

Strategic Review

In August 2019, it was disclosed that MacAndrews & Forbes and the Company determined to explore strategic transactions involving the Company and third parties. This review is ongoing and remains focused on exploring potential options for the Company's portfolio and regional brands (the “Strategic Review”).

For additional information regarding the Company's business, see Part 1, Item 1 "Business" in the Company's 2020 Form 10-K.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~For additional information regarding the Company's business, see "Part 1, Item 1 - Business" in the Company's 2020 Form 10-K.~~

Overview of Net Sales and Earnings Results

Consolidated net sales in the ~~three months ended March 31,~~second quarter of 2021 were ~~$445.0~~$497.4 million, a ~~$8.0~~$149.8 million ~~decrease,~~increase, or ~~1.8%~~43.1%, compared to ~~$453.0~~$347.6 million in the ~~three months ended March 31,~~second quarter of 2020. Excluding the ~~$14.5~~$22.4 million favorable FX impact, consolidated net sales ~~decreased~~increased by ~~$22.5~~$127.4 million, or ~~5.0%~~36.7%, during the ~~three months ended March 31, 2021. The ongoing COVID-19 pandemic negatively impacted consolidated net sales for the three months ended March 31, 2021 by~~ ~~an estimated $44 million ($43.3 million XFX).~~ ~~The~~second quarter of 2021.The XFX net sales ~~decrease~~increase of ~~$22.5~~$127.4 million in the ~~three months ended March 31,~~second quarter of 2021 was due to: a ~~$25.2~~$43.4 million, or ~~13.9%, decrease~~32.1% increase in Revlon segment net sales, ~~and~~ a ~~$16.1~~$41.5 million, ~~or14.6%~~or 96.1%, ~~decrease~~increase in ~~Portfolio~~Fragrances segment net sales, ~~partially offset by~~ a ~~$11.4~~$35.5 million, or ~~12.0%~~43.9%, increase in Elizabeth Arden segment net sales and a ~~$7.4~~$7.0 million or ~~11.2%~~7.9%, increase in Portfolio segment net sales.

Consolidated net sales in the six months ended June 30, 2021 were $942.4 million, a $141.8 million increase, or 17.7%, compared to $800.6 million in the six months ended June 30, 2020. Excluding the $36.9 million favorable FX impact, consolidated net sales increased by $104.9 million, or 13.1%, during the six months ended June 30, 2021. The XFX net sales increase of $104.9 million in the six months ended June 30, 2021 was due to: a $48.9 million, or 44.8%, increase in Fragrances segment net sales, a $46.9 million, or 26.6%, increase in Elizabeth Arden segment net sales, a $18.2 million, or 5.7%, increase in Revlon segment net sales, partially offset by a $9.1 million, or 4.6%, decrease in Portfolio segment net sales.

Consolidated loss from continuing operations, net of taxes, in the ~~three months ended March 31,~~second quarter of 2021 was ~~$96.0~~$67.7 million, compared to ~~consolidated loss from continuing operations, net of taxes, of $213.9~~$126.8 million in the ~~three months ended March 31,~~second quarter of 2020. The ~~$117.9~~$59.1 million decrease in consolidated loss from continuing operations, net of taxes, in the second quarter of 2021 was primarily due to:

•$122.1 million of higher gross profit, primarily due to higher net sales in the second quarter of 2021, primarily as a ~~$124.3~~result of the effects of COVID-19 on net sales during the second quarter of 2020;

•a $19.8 million decrease in non-cash impairment charges attributable to the non-cash impairment charges of ~~$99.8~~$11.2 million and of ~~$24.5~~$8.6 million recorded on the Company's goodwill and on certain of the Company's indefinite-lived intangible assets, respectively, following the Company's interim impairment assessments during the ~~first~~second quarter of 2020, compared to having no impairment charges in ~~2021;~~

•~~$28.9 million~~the second quarter of ~~lower SG&A expenses in the three months ended March 31, 2021, compared to the prior year period, primarily driven by cost reductions achieved primarily through the Revlon 2020 Restructuring Program;~~2021;

•a ~~$19.4~~$19.1 million net decrease in other miscellaneous expenses, net, in the second quarter of 2021 compared to the second quarter of 2020, primarily due to financing fees expensed in 2020 in connection with the 2020 BrandCo Refinancing Transactions;

•a $12.3 million decrease in restructuring charges, primarily related to lower expenditures under ~~the Revlon 2020 Restructuring Program~~RGGA in the ~~three months ended March 31,~~second quarter of 2021, compared to the expenditures incurred primarily under the ~~same~~2020 Revlon Restructuring program induring the ~~three months ended March 31,~~second quarter of 2020;

•$~~13.3~~4.0 millionof favorable variance in foreign currency, resulting from ~~$3.3~~$1.7 million in foreign currency gains during the second quarter of 2021, compared to $2.3 million in foreign currency losses during the ~~three months ended March 31, 2021, compared to $16.6 million in foreign currency losses during the three months ended March 31, 2020~~second quarter of 2020; and

•a ~~$1.5~~$1.6 million ~~decrease~~increase in acquisition, integration and divestiture costs in the three months ended March 31, 2021, compared to the prior year period, primarily driven by higher amortization of the cash-based awards under Tier 1 and Tier 2 of the Revlon 2019 TIP in the prior year period; and

•~~$0.8 million of lower loss~~gain on divested assets, primarily related to the ~~loss of $0.8 million recorded in 2020 on the~~ sale of certain assets ~~compared to having no losses~~ in the ~~three months ended March 31, 2021;~~second quarter of 2020, consisting of the Company's Gatineau brand;

with the foregoing partially offset by:

•$83.1 million of higher SG&A expenses in the second quarter of 2021 compared to the second quarter of 2020, primarily driven by the increased level of activity compared to the prior year quarter, as the Company starts to show signs of rebound from the negative effects of the ongoing COVID-19 pandemic;

•a ~~$48.4~~$17.1 million increase in the provision for income taxes in the ~~three months ended March 31,~~second quarter of 2021 compared to the ~~prior year period,~~second quarter of 2020, primarily due to an increase in losses for which no tax benefit can be ~~recognized;~~recognized;

•a ~~$10.5~~$11.9 million ~~increase~~decrease in ~~interest expense~~net gain on the early extinguishment of debt in the ~~three months ended March 31,~~second quarter of 2021, attributable to the net gain of approximately $11.9 million recorded upon the repurchase and cancellation of approximately $112.8 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes during the second quarter of 2020, compared to having no gain in the ~~prior year period, primarily due to higher weighted average borrowings and higher weighted average interest rates driven primarily by the 2020 BrandCo Term Loan Facility;~~second quarter of 2021;

•a $5.3 million increase in other miscellaneous expenses, net, in the three months ended March 31, 2021, compared to the prior year period, primarily due to higher net periodic benefit costs in connection with the Company's pension plans;

•~~a $4.7~~$7.3 million increase in amortization of debt issuance costs in the ~~three months ended March 31,~~second quarter of 2021, compared to the ~~prior year period,~~second quarter of 2020, primarily due to the additional debt issuance costs recorded and amortized in connection with the 2021 and 2020 Refinancing Transactions; and

•~~$1.4~~a $1.0 million~~of lower gross profit~~ increase in interest expense in the ~~three months ended March 31,~~second quarter of 2021, compared to the second quarter of 2020, primarily due to higher weighted average borrowings and higher weighted average interest rates driven primarily by the ~~lower net sales.~~2020 BrandCo Term Loan Facility.

4346

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Consolidated loss from continuing operations, net of taxes, in the six months ended June 30, 2021 was $163.7 million, compared to consolidated loss from continuing operations, net of taxes, of $340.7 million in the six months ended June 30, 2020. The $177.0 million decrease in consolidated loss from continuing operations, net of taxes was primarily due to:

•a $144.1 million decrease in impairment charges attributable to the non-cash impairment charges of $111.0 million and of $33.1 million recorded on the Company's goodwill and on certain of the Company's indefinite-lived intangible assets, respectively, following the Company's interim impairment assessments during the six months ended June 30, 2020, all of which are primarily attributable to the effects of COVID-19, compared to having no impairment charges in 2021;

•$120.7 millionof higher gross profit in the six months ended June 30, 2021, primarily due to higher net sales in the six months ended June 30, 2021, primarily as a result of the effects of COVID-19 on net sales during the prior year period;

•a $31.7 million decrease in restructuring charges, primarily related to lower expenditures under RGGA in the six months ended June 30, 2021, compared to the expenditures incurred primarily under the 2020 Revlon Restructuring Program in the six months ended June 30, 2020;

•$17.3 million of favorable variance in foreign currency, resulting from $1.6 million in foreign currency losses during the six months ended June 30, 2021, compared to $18.9 million in foreign currency losses during the six months endedJune 30, 2020;

•a $13.8 million decrease in other miscellaneous expenses, net, in the six months ended June 30, 2021, compared to the prior year period, primarily due to financing fees expensed in 2020 in connection with the 2020 BrandCo Refinancing Transactions;

•$2.4 million of lower loss on divested assets primarily related to the loss of $0.6 million recorded during the six months ended June 30, 2020 on the sale of certain assets, compared to having $1.8 million in gains in the six months ended June 30, 2021, primarily related to the sale of certain assets in the second quarter of 2020, consisting of the Company's Gatineau brand; and

•a $2.1 million decrease in acquisition, integration and divestiture costs in the six months ended June 30, 2021, compared to the prior year period, primarily driven by higher amortization of the cash-based awards under Tier 1 and Tier 2 of the Revlon 2019 TIP in the prior year period;

with the foregoing partially offset by:

•a $65.5 million increase in the provision for income taxes in the six months ended June 30, 2021, compared to the prior year period, primarily due to an increase in losses for which no tax benefit can be recognized;

•$54.2 million of higher SG&A expenses in the six months ended June 30, 2021, compared to the prior year period, primarily driven by the increased level of activity compared to the prior year period, as the Company starts to show signs of rebound from the negative effects of the ongoing COVID-19 pandemic;

•a $12.0 million increase in amortization of debt issuance costs in the six months ended June 30, 2021, compared to the prior year period, primarily due to the additional debt issuance costs recorded and amortized in connection with the 2021 and 2020 Refinancing Transactions;

•a $11.9 million decrease in net gain on the early extinguishment of debt in the second quarter of 2021, attributable to the net gain of approximately $11.9 million recorded upon the repurchase and cancellation of approximately $112.8 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes during the second quarter of 2020, compared to having no gain in the second quarter of 2021; and

•a $11.5 million increase in interest expense in the six months ended June 30, 2021, compared to the prior year period, primarily due to higher weighted average interest rates driven primarily by the 2020 BrandCo Term Loan Facility.

Operating Segments

The Company operates in four reporting segments: Revlon, Elizabeth Arden, Portfolio and Fragrances.

For additional information regarding the Company's Operating Segments, see Note 14, "Segment Data" to the Company's Unaudited Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Results of Operations — Revlon, Inc.

Segment Results:

The Company's management evaluates segment profit for each of the Company's reportable segments. The Company allocates corporate expenses to each reportable segment to arrive at segment profit, as these expenses are included in the internal measure of segment operating performance. The Company defines segment profit as income from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses. Segment profit also excludes the impact of certain items that are not directly attributable to the segments' underlying operating performance. The Company does not have any material inter-segment sales. For a reconciliation of segment profit to loss from continuing operations before income taxes, see Note 14, "Segment Data and Related Information," to the Company's Unaudited Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

The following ~~table~~tables provide a comparative summary of the Company's segment results for the periods presented.

Net Sales Segment Profit
Three Months Ended March 31, Change
XFX Change (a)
Three Months Ended March 31, Change
XFX Change (a)
2021 2020 $ % $ % 2021 2020 $ % $ %
Revlon $ 162.0 $ 181.8 $ (19.8) (10.9) % $ (25.2) (13.9) % $ 8.0 $ 15.6 $ (7.6) (48.7) % $ (8.6) (55.1) %
Elizabeth Arden 112.2 95.2 17.0 17.9 % 11.4 12.0 % 9.2 4.2 5.0 119.0 % 3.6 85.7 %
Portfolio 96.0 110.0 (14.0) (12.7) % (16.1) (14.6) % 13.1 7.2 5.9 81.9 % 5.4 75.0 %
Fragrances 74.8 66.0 8.8 13.3 % 7.4 11.2 % 7.9 1.4 6.5 N.M. 6.3 N.M.
Total $ 445.0 $ 453.0 $ (8.0) (1.8) % $ (22.5) (5.0) % $ 38.2 $ 28.4 $ 9.8 34.5 % $ 6.7 23.6 %



	Net Sales												Segment Profit
	Three Months Ended June 30,				Change				XFX Change (a)				Three Months Ended June 30,				Change				XFX Change (a)
	2021		2020		$		%		$		%		2021		2020		$		%		$		%
Revlon	$	186.8	$	135.0	$	51.8	38.4	%	$	43.4	32.1	%	$	21.2	$	12.3	$	8.9	72.4	%	$	7.1	57.7	%
Elizabeth Arden	124.7		80.9		43.8		54.1	%	35.5		43.9	%	11.6		10.8		0.8		7.4	%	(0.5)		(4.6)	%
Portfolio	98.7		88.5		10.2		11.5	%	7.0		7.9	%	11.1		14.5		(3.4)		(23.4)	%	(4.0)		(27.6)	%
Fragrances	87.2		43.2		44.0		101.9	%	41.5		96.1	%	20.0		7.8		12.2		156.4	%	11.8		151.3	%
Total	$	497.4	$	347.6	$	149.8	43.1	%	$	127.4	36.7	%	$	63.9	$	45.4	$	18.5	40.7	%	$	14.4	31.7	%


	Net Sales												Segment Profit
	Six Months Ended June 30,				Change				XFX Change (a)				Six Months Ended June 30,				Change				XFX Change (a)
	2021		2020		$		%		$		%		2021		2020		$		%		$		%
Revlon	$	348.8	$	316.8	$	32.0	10.1	%	$	18.2	5.7	%	$	29.2	$	27.9	$	1.3	4.7	%	$	(1.5)	(5.4)	%
Elizabeth Arden	236.9		176.1		60.8		34.5	%	46.9		26.6	%	20.8		15.0		5.8		38.7	%	3.1		20.7	%
Portfolio	194.7		198.5		(3.8)		(1.9)	%	(9.1)		(4.6)	%	24.2		21.7		2.5		11.5	%	1.4		6.5	%
Fragrances	162.0		109.2		52.8		48.4	%	48.9		44.8	%	27.9		9.2		18.7		203.3	%	18.1		196.7	%
Total	$	942.4	$	800.6	$	141.8	17.7	%	$	104.9	13.1	%	$	102.1	$	73.8	$	28.3	38.3	%	$	21.1	28.6	%

(a) XFX excludes the impact of foreign currency fluctuations.

(N.M. - Not meaningful)

Revlon Segment

Second quarter results:

Revlon segment net sales in the three months ended ~~March 31,~~June 30, 2021 were ~~$162.0~~$186.8 million, a ~~$19.8~~$51.8 million, or ~~10.9%~~38.4%, ~~decrease,~~increase, compared to ~~$181.8~~$135.0 million in the three months ended ~~March 31,~~June 30, 2020. Excluding the ~~$5.4~~$8.4 million favorable FX impact, total Revlon segment net sales in the three months ended ~~March 31,~~June 30, 2021 ~~decreased~~increased by ~~$25.2~~$43.4 million, or ~~13.9%~~32.1%, compared to the three months ended ~~March 31,~~June 30, 2020. ~~The ongoing COVID-19 pandemic negatively impacted the Revlon's segment net sales for the three months ended March 31, 2021 by~~ ~~an estimated~~ ~~$22.8 million ($22.4 million XFX).~~The Revlon ~~segment's~~segment XFX ~~decrease~~increase in net sales of ~~$25.2~~$43.4 million in the three months ended~~March 31,~~ June 30, 2021 was driven by ~~lower~~higher net sales of Revlon color cosmetics, both in ~~International regions~~North America and in ~~North America,~~International regions, and, to a lower extent, ~~by lower net sales of~~ ~~RevlonColorSilk~~ ~~hair color products and~~ ~~Revlon~~-branded hair-care products in North America. This decrease was due, primarily, to the continuing effects of the COVID-19 pandemic on the mass retail channels, and the related global supply chain constraints, partially offset by ~~increased~~higher net sales of Revlon-branded ~~beauty tools primarily in North America, as customers are using more products at home, and Revlon-branded~~ professional ~~hair-care~~hair care products in International ~~regions,~~regions. This increase was due, primarily, to retail channels starting to show signs of improvement from the effects of the ongoing COVID-19 pandemic, as well as salons' increased activity ~~in some international markets resumed~~ in connection with ~~temporary lift of restrictions related to the COVID-19 pandemic~~progressive and/or.

Revlon segment profit in the three months ended March 31, 2021 was $8.0 million, a $7.6 million, or 48.7%, decrease, compared to $15.6 million in the three months ended March 31, 2020. Excluding the $1.0 million favorable FX impact, Revlon segment profit in the three months ended March 31, 2021 decreased by $8.6 million, or 55.1%, compared to the three months

4448

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

temporary lifting of restrictions related to the ongoing COVID-19 pandemic, partially offset by decreased net sales in North America of Revlon ColorSilk hair color products, Revlon-branded hair-care products and Revlon-branded beauty tools.

Revlon segment profit in the three months ended ~~March 31,~~June 30, 2021 was $21.2 million, a $8.9 million, or 72.4%, increase, compared to $12.3 million in the three months ended June 30, 2020. Excluding the $1.8 million favorable FX impact, Revlon segment profit in the three months ended June 30, 2021 increased by $7.1 million, or 57.7%, compared to the three months ended June 30, 2020. This increase was driven primarily by the Revlon segment's higher net sales, as described above, as well as higher gross profit margin, partially offset by higher brand support and other SG&A expenses, primarily driven by the increase in sales' activity.

Year-to-date results:

Revlon segment net sales in the six months ended June 30, 2021 were $348.8 million, a $32.0 million, or 10.1%, increase, compared to $316.8 million in the six months ended June 30, 2020. Excluding the $13.8 million favorable FX impact, total Revlon segment net sales in the six months ended June 30, 2021 increased by $18.2 million, or 5.7%, compared to the six months ended June 30, 2020. The Revlon segment's XFX increase in net sales of $18.2 million in the six months endedJune 30, 2021 was driven by higher net sales of Revlon color cosmetics in North America and higher net sales of Revlon-brandedprofessionalhair care products in International regions. This increase was due, primarily, to the mass retail channel starting to show signs of improvement from the effects of the ongoing COVID-19 pandemic, as well as salons' increased activity in connection with progressive and/or temporary lifting of restrictions related to the ongoing COVID-19 pandemic, partially offset by decreased net sales in North America of Revlon ColorSilk hair color products and Revlon-branded hair-care products.

Revlon segment profit in the six months ended June 30, 2021 was $29.2 million, a $1.3 million, or 4.7%, increase, compared to $27.9 million in the six months ended June 30, 2020. Excluding the $2.8 million favorable FX impact, Revlon segment profit in the six months ended June 30, 2021 decreased by $1.5 million, or 5.4%, compared to the six months ended June 30, 2020. This decrease was driven primarily by the Revlon segment's ~~lower~~higher brand support expenses to support the increase in sales' activity, partially offset primarily by higher net sales, as described above, as well as slightly ~~lower~~higher gross profit margin, ~~partially offset by the segment's lower SG&A expenses, primarily~~ ~~driven by cost reductions achieved primarily through the Revlon 2020 Restructuring Program.~~

Elizabeth Arden Segment

Second quarter results:

Elizabeth Arden segment net sales in the three months ended ~~March 31,~~June 30, 2021 were ~~$112.2~~$124.7 million, a ~~$17.0~~$43.8 million, or ~~17.9%~~54.1%, increase, compared to ~~$95.2~~$80.9 million in the three months ended ~~March 31,~~June 30, 2020. Excluding the ~~$5.6~~$8.3 million favorable FX impact, Elizabeth Arden segment net sales in the three months ended ~~March 31,~~June 30, 2021 increased by ~~$11.4~~$35.5 million, or ~~12.0%~~43.9%, compared to the three months ended ~~March 31,~~June 30, 2020. ~~The ongoing COVID-19 pandemic negatively impacted the Elizabeth Arden's segment net sales for the three months ended March 31, 2021 by an estimated~~ ~~$3.3 million ($3.0 million XFX).~~ The Elizabeth Arden segment XFX increase in net sales of ~~$11.4~~$35.5 million in the three months ended ~~March 31,~~June 30, 2021 was driven primarily by higher net sales of Ceramide skin care products, Green Tea and White Tea fragrances, as well as certain other Elizabeth Arden-branded fragrances and skin care products, primarily in International regions. This increase was due, primarily, to growth in e-commerce net sales, as well as an increase in the travel retail business, while there are also signs of improvements from the effects of the ongoing COVID-19 pandemic on foot traffic at department stores and other retail outlets, primarily internationally.

Elizabeth Arden segment profit in the three months ended June 30, 2021 was $11.6 million, a $0.8 million increase, compared to $10.8 million in the three months ended June 30, 2020. Excluding the $1.3 million favorable FX impact, Elizabeth Arden segment profit in the three months ended June 30, 2021 decreased by $0.5 million, compared to the three months ended June 30, 2020. This decrease was driven primarily by the Elizabeth Arden segment's higher brand support and other SG&A expenses to support the increase in sales activity, as well as moderately lower gross profit margin, partially offset by higher net sales, as described above.

Year-to-date results:

Elizabeth Arden segment net sales in the six months ended June 30, 2021 were $236.9 million, a $60.8 million, or 34.5%, increase, compared to $176.1 million in the six months ended June 30, 2020. Excluding the $13.9 million favorable FX impact, Elizabeth Arden segment net sales in the six months ended June 30, 2021 increased by $46.9 million, or 26.6%, compared to

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

the six months ended June 30, 2020. The Elizabeth Arden segment XFX increase in net sales of $46.9 million in the six months ended June 30, 2021 was driven primarily by higher net sales of Ceramide skin care products, both in ~~North America~~International regions and in ~~International regions,~~North America, and, to a lower extent, higher net sales of Green Tea and White Tea fragrances, as well as other Elizabeth Arden-branded fragrances and skin care products, primarily in International ~~regions and mainly in connection with~~regions. This increase was due, primarily, to growth in e-commerce net sales, as well as an increase in the travel retail ~~business.~~business, while there are also signs of improvements from the effects of the ongoing COVID-19 pandemic ~~This increase~~on foot traffic at department stores and other retail outlets, and it was partially offset by lower net sales of Prevage, primarily in ~~International regions, in~~ connection with the delayed launches on certain new ~~products, and lower net sales of certain other~~ ~~Elizabeth Arden-branded skin care products, due, primarily, to the continuing effects of the COVID-19 pandemic on foot traffic at department stores and other retail outlets.~~products.

Elizabeth Arden segment profit in the ~~three~~six months ended ~~March 31,~~June 30, 2021 was ~~$9.2~~$20.8 million, a ~~$5.0~~$5.8 million, or ~~119.0%~~38.7%, increase, compared to ~~$4.2~~$15.0 million in the ~~three~~six months ended ~~March 31,~~June 30, 2020. Excluding the ~~$1.4~~$2.7 million favorable FX impact, Elizabeth Arden segment profit in the ~~three~~six months ended ~~March 31,~~June 30, 2021 increased by ~~$3.6~~$3.1 million, or ~~85.7%~~20.7%, compared to the ~~three~~six months ended ~~March 31,~~June 30, 2020. This increase was driven primarily by the Elizabeth Arden segment's higher net sales as described above, partially offset ~~primarily~~ by higher brand support and other SG&A expenses to support the increase ~~level of~~in sales activity, as well as moderately lower gross profit ~~margin,~~margin.

Portfolio Segment

Second quarter results:

Portfolio segment net sales in the three months ended ~~March 31,~~June 30, 2021 were ~~$96.0~~$98.7 million, a ~~$14.0~~$10.2 million, or ~~12.7%~~11.5%, ~~decrease,~~increase, compared to ~~$110.0~~$88.5 million in the three months ended ~~March 31,~~June 30, 2020. Excluding the ~~$2.1~~$3.2 million favorable FX impact, total Portfolio segment net sales in the three months ended ~~March 31,~~June 30, 2021 ~~decreased~~increased by ~~$16.1~~$7.0 million, or ~~14.6%~~7.9%, compared to the three months ended ~~March 31,~~June 30, 2020. The ~~ongoing COVID-19 pandemic negatively impacted the Portfolio's~~Portfolio segment XFX increase in net sales ~~for~~of $7.0 million in the three months ended ~~March 31,~~June 30, 2021 was driven primarily by ~~an estimated~~higher net sales of ~~$13.6~~Mitchum anti-perspirant deodorants and American Crew men's grooming products, and also by higher net sales in North America of Almay color cosmetics and CND nail products, primarily in connection with the mass retail channel starting to show signs of improvement from the effects of the ongoing COVID-19 pandemic. This increase was partially offset, primarily, by lower net sales of previously sold brands and of certain local and regional skin care products brands in International regions.

Portfolio segment profit in the three months ended June 30, 2021 was $11.1 million, ~~($13.2~~a $3.4 million, ~~XFX).~~or 23.4%, decrease, compared to $14.5 million in the three months ended June 30, 2020. Excluding the $0.6 million favorable FX impact, Portfolio segment profit in the three months ended June 30, 2021 decreased by $4.0 million, or 27.6%, compared to the three months ended June 30, 2020. This decrease was driven primarily by the Portfolio segment's higher brand support and other SG&A expenses to support the increase in sales activity, partially offset by higher net sales, as described above, as well as higher gross profit margin.

Year-to-date results:

Portfolio segment net sales in the six months ended June 30, 2021 were $194.7 million, a $3.8 million, or 1.9%, decrease, compared to $198.5 million in the six months ended June 30, 2020. Excluding the $5.3 million favorable FX impact, total Portfolio segment net sales in the six months ended June 30, 2021 decreased by $9.1 million, or 4.6%, compared to the six months ended June 30, 2020. The Portfolio segment XFX decrease in net sales of ~~$16.1~~$9.1 million in the ~~three~~six months ended ~~March 31,~~June 30, 2021 was driven primarily by lower net sales of previously sold brands and of certain local and regional skin care products brands, both in International regions and in North ~~America, as well as lower~~America. This decrease was partially offset by higher net sales of ~~Mitchum~~American Crew ~~anti-perspirant deodorants, primarily~~men's grooming products, and also by higher net sales in North America of CND nail products and of Almay color cosmetics, ~~driven,~~ primarily byin connection with retail channels recently starting to show signs of improvement from the ~~continuing~~ effects of the ongoing COVID-19 ~~pandemic on the mass retail channel and the related global supply chain constraints.~~

pandemic.

Portfolio segment profit in the ~~three~~six months ended ~~March 31,~~June 30, 2021 was ~~$13.1~~$24.2 million, a ~~$5.9~~$2.5 million, or ~~81.9%~~11.5%, increase compared to ~~$7.2~~$21.7 million in the ~~three~~six months ended ~~March 31,~~June 30, 2020. Excluding the ~~$0.5~~$1.1 million favorable FX impact, Portfolio segment profit in the ~~three~~six months ended ~~March 31,~~June 30, 2021 increased by ~~$5.4~~$1.4 million, or ~~75.0%~~6.5%, compared to the ~~three~~six months ended ~~March 31,~~June 30, 2020. This increase was driven primarily by the Portfolio segment's higher gross profit margin, as well as lower SG&A, achieved primarily through ~~the Revlon 2020 Restructuring Program,~~RGGA, partially offset by higher ~~and~~ brand support expenses ~~as well as higher gross profit margin,~~ ~~partially offset by the segment's~~ and lower net sales as described above.

~~Fragrances Segment~~

Fragrances segment net sales in the three months ended March 31, 2021 were $74.8 million, a $8.8 million, or 13.3%, increase, compared to $66.0 million in the three months ended March 31, 2020. Excluding the $1.4 million favorable FX impact, total Fragrances segment net sales in the three months ended March 31, 2021 increased by $7.4 million, or 11.2%, compared to the three months ended March 31, 2020. The ongoing COVID-19 pandemic negatively impacted the Fragrances' segment net sales for the three months ended March 31, 2021 by an estimated ~~$4.7 million ($4.6 million XFX).~~ ~~The Fragrances segment XFX increase in net sales of $7.4 million in the three months ended March 31, 2021 was driven primarily by increases in sales of~~ ~~Juicy Couture~~, ~~Curve~~ ~~and~~ ~~John Varvatos~~ ~~fragrances in North America, primarily due to a recovery from the~~

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

ongoing COVID-19 pandemic, as retailers are restocking their inventory levels, partially offset primarily by decreases in other distributed fragrances, primarily linked to the lingering effect of the ongoing COVID-19 pandemic.

Fragrances segment profit in the three months ended March 31, 2021 was $7.9 million, a $6.5 million, increase, compared to $1.4 million in the three months ended March 31, 2020. Excluding the $0.2 million favorable FX impact, Fragrances segment profit in the three months ended March 31, 2021 increased by $6.3 million, compared to the three months ended March 31, 2020. This increase was driven primarily by the Fragrances segment's higher net sales, as described above, ~~as well as lower brand support expenses, partially offset by the segment's slightly lower gross profit margin.~~

~~Geographic Results:~~

~~The following tables provide a comparative summary of the Company's North America and International net sales for the periods presented:~~

Three Months Ended March 31, Change
XFX Change (a)
2021 2020 $ % $ %
Revlon
North America $ 83.0 $ 99.1 $ (16.1) (16.2) % $ (16.3) (16.4) %
International 79.0 82.7 (3.7) (4.5) % (8.9) (10.8) %
Elizabeth Arden
North America $ 28.4 $ 21.4 $ 7.0 32.7 % $ 6.2 29.0 %
International 83.8 73.8 10.0 13.6 % 5.2 7.0 %
Portfolio
North America $ 63.5 $ 70.8 $ (7.3) (10.3) % $ (7.8) (11.0) %
International 32.5 39.2 (6.7) (17.1) % (8.3) (21.2) %
Fragrances
North America $ 51.3 $ 42.2 $ 9.1 21.6 % $ 8.8 20.9 %
International 23.5 23.8 (0.3) (1.3) % (1.4) (5.9) %
Total Net Sales $ 445.0 $ 453.0 $ (8.0) (1.8) % $ (22.5) (5.0) %

~~(a)~~ ~~XFX excludes the impact of foreign currency fluctuations.~~

~~Revlon Segment~~

~~North America~~

In North America, Revlon segment net sales in the three months ended March 31, 2021 decreased by $16.1 million, or 16.2%, to $83.0 million, compared to $99.1 million in the three months ended March 31, 2020. Excluding the $0.2 million favorable FX impact, Revlon segment net sales in North America in the three months ended March 31, 2021 decreased by $16.3 million, or 16.4%, compared to the three months ended March 31, 2020. The ongoing COVID-19 pandemic negatively impacted the Revlon's segment net sales in North America for the three months ended March 31, 2021 by an estimated $14.5 million ($14.5 million XFX). ~~The Revlon segment's $16.3 million XFX decrease in North America net sales in the three months ended March 31, 2021 was primarily due to the Revlon segment's lower net sales of~~ ~~Revlon~~ ~~color cosmetics, as well as~~ ~~Revlon ColorSilk~~ ~~hair color products and~~ ~~Revlon~~-branded hair-care products due, primarily, to the continuing effects of the COVID-19 pandemic on the mass retail channel, and the related global supply chain constraints, partially offset by higher net sales of ~~Revlon-branded beauty tools.~~

~~International~~

Internationally, Revlon segment net sales in the three months ended March 31, 2021 decreased by $3.7 million, or 4.5%, to $79.0 million, compared to $82.7 million in the three months ended March 31, 2020. Excluding the $5.2 million favorable FX impact, Revlon segment International net sales in the three months ended March 31, 2021 decreased by $8.9 million, or 10.8%, compared to the three months ended March 31, 2020. The ongoing COVID-19 pandemic negatively impacted the Revlon's segment International net sales for the three months ended March 31, 2021 by an estimated $8.3 million ($7.9 million XFX).

4650

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Fragrances Segment

Second quarter results:

Fragrances segment net sales in the three months ended June 30, 2021 were $87.2 million, a $44.0 million, or 101.9%, increase, compared to $43.2 million in the three months ended June 30, 2020. Excluding the $2.5 million favorable FX impact, total Fragrances segment net sales in the three months ended June 30, 2021 increased by $41.5 million, or 96.1%, compared to the three months ended June 30, 2020. The Fragrances segment XFX increase in net sales of $41.5 million in the three months ended June 30, 2021 was driven primarily by higher net sales of Juicy Couture, John Varvatos, Britney Spears and Curve fragrances, as well as other branded and distributed fragrances, primarily in North America and, to a lower extent, also in International regions, primarily due to a recovery from the ongoing COVID-19 pandemic, as retailers are restocking their inventory levels.

Fragrances segment profit in the three months ended June 30, 2021 was $20.0 million, a $12.2 million, or 156.4%, increase, compared to $7.8 million in the three months ended June 30, 2020. Excluding the $0.4 million favorable FX impact, Fragrances segment profit in the three months ended June 30, 2021 increased by $11.8 million, or 151.3%, compared to the three months ended June 30, 2020. This increase was driven primarily by the Fragrances segment's higher net sales, as described above, partially offset by higher SG&A including brand support expense to support the increase in sales activity.

Year-to-date results:

Fragrances segment net sales in the six months ended June 30, 2021 were $162.0 million, a $52.8 million, or 48.4%, increase, compared to $109.2 million in the six months ended June 30, 2020. Excluding the $3.9 million favorable FX impact, total Fragrances segment net sales in the six months ended June 30, 2021 increased by $48.9 million, or 44.8%, compared to the six months ended June 30, 2020. The Fragrances segment XFX increase in net sales of $48.9 million in the six months ended June 30, 2021 was driven primarily by higher net sales of Juicy Couture, John Varvatos, Curve and Britney Spears fragrances, as well as other brand and distributed fragrances, primarily in North America and, to a lower extent, also in International regions, primarily due to a recovery from the ongoing COVID-19 pandemic, as retailers are restocking their inventory levels.

Fragrances segment profit in the six months ended June 30, 2021 was $27.9 million, a $18.7 million, increase, compared to $9.2 million in the six months ended June 30, 2020. Excluding the $0.6 million favorable FX impact, Fragrances segment profit in the six months ended June 30, 2021 increased by $18.1 million, compared to the six months ended June 30, 2020. This increase was driven primarily by the Fragrances segment's higher net sales, as described above, partially offset by the segment's higher other SG&A expenses primarily due to the increase in sales activity.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Geographic Results:

The following tables provide a comparative summary of the Company's North America and International net sales for the periods presented:


	Three Months Ended June 30,				Change				XFX Change (a)
	2021		2020		$		%		$		%
Revlon
North America	$	99.5	$	80.1	$	19.4	24.2	%	$	18.4	23.0	%
International	87.3		54.9		32.4		59.0	%	25.0		45.5	%
Elizabeth Arden
North America	$	20.2	$	15.0	$	5.2	34.7	%	$	4.6	30.7	%
International	104.5		65.9		38.6		58.6	%	30.9		46.9	%
Portfolio
North America	$	63.2	$	52.1	$	11.1	21.3	%	$	10.9	20.9	%
International	35.5		36.4		(0.9)		(2.5)	%	(3.9)		(10.7)	%
Fragrance
North America	$	61.0	$	29.7	$	31.3	105.4	%	$	31.3	105.4	%
International	26.2		13.5		12.7		94.1	%	10.2		75.6	%
Total Net Sales	$	497.4	$	347.6	$	149.8	43.1	%	$	127.4	36.7	%



















	Six Months Ended June 30,				Change				XFX Change (a)
	2021		2020		$		%		$		%
Revlon
North America	$	182.5	$	179.2	$	3.3	1.8	%	$	2.1	1.2	%
International	166.3		137.6		28.7		20.9	%	16.1		11.7	%
Elizabeth Arden
North America	$	48.6	$	36.4	$	12.2	33.5	%	$	10.8	29.7	%
International	188.3		139.7		48.6		34.8	%	36.1		25.8	%
Portfolio
North America	$	126.7	$	122.9	$	3.8	3.1	%	$	3.1	2.5	%
International	68.0		75.6		(7.6)		(10.1)	%	(12.2)		(16.1)	%
Fragrances
North America	$	112.3	$	71.9	$	40.4	56.2	%	$	40.1	55.8	%
International	49.7		37.3		12.4		33.2	%	8.8		23.6	%
Total Net Sales	$	942.4	$	800.6	$	141.8	17.7	%	$	104.9	13.1	%

(a) XFX excludes the impact of foreign currency fluctuations.

Revlon Segment

Second quarter results:

North America

In North America, Revlon segment net sales in the three months ended June 30, 2021 increased by $19.4 million, or 24.2%, to $99.5 million, compared to $80.1 million in the three months ended June 30, 2020. Excluding the $1.0 million favorable FX impact, Revlon segment net sales in North America in the three months ended June 30, 2021 increased by $18.4 million, or 23.0%, compared to the three months ended June 30, 2020. The Revlon segment's ~~$8.9~~$18.4 million XFX ~~decrease~~increase in North America net sales in the three months ended June 30, 2021 was due to higher net sales of Revlon color cosmetics due, primarily, to retail channels starting to show signs of improvement from the effects of the ongoing COVID-19 pandemic,

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

partially offset by lower net sales of RevlonColorSilk hair color products, Revlon-branded hair-care products and Revlon-branded beauty tools.

International

Internationally, Revlon segment net sales in the three months ended June 30, 2021 increased by $32.4 million, or 59.0%, to $87.3 million, compared to $54.9 million in the three months ended June 30, 2020. Excluding the $7.4 million favorable FX impact, Revlon segment International net sales in the three months ended June 30, 2021 increased by $25.0 million, or 45.5%, compared to the three months ended June 30, 2020. The Revlon segment's $25.0 million XFX increase in International net sales in the three months ended ~~March 31,~~June 30, 2021 was driven primarily by ~~the Revlon segment's lower~~higher net sales of Revlon-brandedprofessionalhair care products, Revlon color cosmetics, and, to a lower extent, Revlon ColorSilk hair color products across all of the Company's International regions, due, primarily, to salons' increased activity in connection with progressive and/or temporary lifting of restrictions related to the ~~continuing~~ongoing COVID-19 pandemic and to retail channels starting to show signs of improvement from the effects of the ongoing COVID-19 ~~pandemic on~~pandemic.

Year-to-date results:

North America

In North America, Revlon segment net sales in the ~~mass retail channel,~~six months ended June 30, 2021 increased by $3.3 million, or 1.8%, to $182.5 million, compared to $179.2 million in the six months ended June 30, 2020. Excluding the $1.2 million favorable FX impact, Revlon segment net sales in North America in the six months ended June 30, 2021 increased by $2.1 million, or 1.2%, compared to the six months ended June 30, 2020.The Revlon segment's $2.1 million XFX increase in North America net sales in the six months ended June 30, 2021 was primarily due to higher net sales of Revlon color cosmetics, which year-to-date positive performance was driven by the increase in sales experienced in the three months ended June 30, 2021, as disclosed elsewhere above, partially offset by ~~higher~~lower net sales of Revlon ColorSilk hair color products and Revlon-branded hair-care products.

International

Internationally, Revlon segment net sales in the six months ended June 30, 2021 increased by $28.7 million, or 20.9%, to $166.3 million, compared to $137.6 million in the six months ended June 30, 2020. Excluding the $12.6 million favorable FX impact, Revlon segment International net sales in the six months ended June 30, 2021 increased by $16.1 million, or 11.7%, compared to the six months ended June 30, 2020. The Revlon segment's $16.1 million XFX increase in International net sales in the six months ended June 30, 2021 was driven primarily by higher net sales of Revlon-branded professional hair-care products and of Revlon ColorSilk hair color products, primarily in the EMEA region. This increase was partially offset primarily by lower net sales of Revlon color cosmetics attributable to the negative year-to-date effects of the COVID-19 pandemic on this items in this region, which only started to show improvements during the three months ended June 30, 2021.

Elizabeth Arden Segment

Second quarter results:

North America

In North America, Elizabeth Arden segment net sales in the three months ended ~~March 31,~~June 30, 2021 increased by ~~$7.0~~$5.2 million, or ~~32.7%~~34.7%, to ~~$28.4~~$20.2 million, compared to ~~$21.4~~$15.0 million in the three months ended ~~March 31,~~June 30, 2020. Excluding the ~~$0.8~~$0.6 million favorable FX impact, Elizabeth Arden ~~segment~~ net sales in North America in the three months ended ~~March 31,~~June 30, 2021 increased by ~~$6.2~~$4.6 million, or ~~29.0%~~30.7%, compared to the three months ended ~~March 31,~~June 30, 2020.The Elizabeth Arden segment's ~~$6.2~~$4.6 million XFX increase in North America net sales in the three months ended ~~March 31, 2021 was driven primarily by the Elizabeth Arden segment's higher net sales of~~ ~~Ceramide~~ ~~skin care products,~~ ~~as well as growth in e-commerce net sales, partially offset by lower net sales of~~ ~~certain other~~ ~~Elizabeth Arden~~-branded skin care products, due, primarily, to the continuing effects of the COVID-19 pandemic on foot traffic at department stores and other retail outlets. The ongoing COVID-19 pandemic negatively impacted the Elizabeth Arden's segment net sales in North America for the three months ended March 31, 2021 by an estimated $0.8 million ($0.8 million XFX).

~~International~~

Internationally, Elizabeth Arden segment net sales in the three months ended March 31, 2021 increased by $10.0 million, or 13.6%, to $83.8 million, compared to $73.8 million in the three months ended March 31, 2020. Excluding the $4.8 million favorable FX impact, Elizabeth Arden segment International net sales in the three months ended March 31, 2021 increased by $5.2 million, or 7.0%, compared to the three months ended March 31, 2020.~~The ongoing COVID-19 pandemic negatively impacted the Elizabeth Arden's segment International net sales for the three months ended March 31, 2021 by an estimated $2.4 million ($2.3 million XFX).The Elizabeth Arden segment's $5.2 million XFX increase in International net sales in the three months ended March 31,~~June 30, 2021 was driven primarily by higher net sales of ~~Ceramide~~ ~~skin care productsand, to a lower extent, higher net sales of~~ ~~Green Tea~~ ~~and~~ ~~White Tea~~ ~~fragrances, as well as other~~certain Elizabeth Arden-branded fragrances and other skin care products ~~primarily in connection with~~ ~~growth in e-commerce net sales, as well as~~ ~~an increase in the travel retail business~~, ~~primarily in the Asia region. This increase was~~ ~~partially offset by lower net sales of~~ ~~Prevage skin care products within the Asia region, primarily~~ ~~in connection with the delayed launches on certain new products.~~

~~Portfolio Segment~~

~~North America~~

In North America, Portfolio segment net sales in the three months ended March 31, 2021 decreased by $7.3 million, or 10.3%, to $63.5 million, as compared to $70.8 million in the three months ended March 31, 2020. Excluding the $0.5 million favorable FX impact, Portfolio segment net sales in North America in the three months ended March 31, 2021 decreased by $7.8 million, or 11.0%, compared to the three months ended March 31, 2020. The ongoing COVID-19 pandemic negatively impacted the Portfolio's segment net sales in North America for the three months ended March 31, 2021 by an estimated $8.0 million ($7.9 million XFX). ~~The Portfolio segment's $7.8 million XFX decrease in North America net sales in the three months ended March 31, 2021 was driven primarily by the Portfolio segment's lower net sales of~~ ~~certain local and regional products brands, lower net sales of~~ ~~Mitchum~~ ~~anti-perspirant deodorants, as well as, to a lower extent, lower net sales of~~ ~~Almay~~ ~~color cosmetics,~~ due, primarily, to signs of improvements from the ~~continuing~~ effects of ~~the COVID-19 pandemic on the mass retail channel and the related global supply chain constraints~~.

~~International~~

Internationally, Portfolio segment net sales in the three months ended March 31, 2021 decreased by $6.7 million, or 17.1%, to $32.5 million, compared to $39.2 million in the three months ended March 31, 2020. Excluding the $1.6 million favorable FX impact, Portfolio segment International net sales decreased by $8.3 million, or 21.2%, in the three months ended March 31, 2021, compared to the three months ended March 31, 2020.~~The ongoing COVID-19 pandemic negatively impacted the Portfolio's segment International net sales for the three months ended March 31, 2021 by an estimated $5.7 million ($5.3 million XFX)~~. ~~The Portfolio segment's $8.3 million XFX decrease in International net sales in the three months ended~~

4753

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~March 31,~~the ongoing COVID-19 pandemic on foot traffic at department stores and other retail outlets. This increase was partially offset by lower net sales of Ceramide skin care products.

International

Internationally, Elizabeth Arden segment net sales in the three months ended June 30, 2021 increased by $38.6 million, or 58.6%, to $104.5 million, compared to $65.9 million in the three months ended June 30, 2020. Excluding the $7.7 million favorable FX impact, Elizabeth Arden segment International net sales in the three months ended June 30, 2021 increased by $30.9 million, or 46.9%, compared to the three months ended June 30, 2020. The Elizabeth Arden segment's $30.9 million XFX increase in International net sales in the three months ended June 30, 2021 was driven primarily by ~~the Portfolio segment's lower net sales of certain local and regional skin care products brands, as well as, to a lower extent, lower~~higher net sales of ~~Almay~~Ceramide ~~color cosmetics~~skin care products, Green Tea and White Tea fragrances, as well as certain other Elizabeth Arden-branded fragrances and skin care products. This increase was due, primarily, to growth in e-commerce net sales, as well as an increase in the ~~continuing~~travel retail business, while there are also signs of improvements from the effects of the ongoing COVID-19 pandemic on ~~the mass~~foot traffic at department stores and other retail ~~channel and the related global supply chain constraints~~outlets.

~~Fragrances Segment~~Year-to-date results:

North America

In North America, ~~Fragrances~~Elizabeth Arden segment net sales in the six months ended June 30, 2021 increased by $12.2 million, or 33.5%, to $48.6 million, compared to $36.4 million in the six months ended June 30, 2020. Excluding the $1.4 million favorable FX impact, Elizabeth Arden segment net sales in North America in the six months ended June 30, 2021 increased by $10.8 million, or 29.7%, compared to the six months ended June 30, 2020.The Elizabeth Arden segment's $10.8 million XFX increase in North America net sales in the six months ended June 30, 2021 was driven primarily by higher net sales of Ceramide skin care products, as well as certain other Elizabeth Arden-branded fragrances and skin care products. This increase was due, primarily, to signs of improvements from the effects of the ongoing COVID-19 pandemic on foot traffic at department stores and other retail outlets, and it was partially offset by lower net sales of Prevage, primarily in connection with the delayed launches on certain new products.

International

Internationally, Elizabeth Arden segment net sales in the six months ended June 30, 2021 increased by $48.6 million, or 34.8%, to $188.3 million, compared to $139.7 million in the six months ended June 30, 2020. Excluding the $12.5 million favorable FX impact, Elizabeth Arden segment International net sales in the six months ended June 30, 2021 increased by $36.1 million, or 25.8%, compared to the six months ended June 30, 2020.The Elizabeth Arden segment's $36.1 million XFX increase in International net sales in the six months ended June 30, 2021 was driven primarily by higher net sales of Ceramide skin care products and, to a lower extent, higher net sales of Green Tea and White Tea fragrances, as well as other Elizabeth Arden-branded fragrances and skin care products. This increase was due, primarily, to growth in e-commerce net sales, as well as an increase in the travel retail business, while there are also signs of improvements from the effects of the ongoing COVID-19 pandemic on foot traffic at department stores and other retail outlets, and it was partially offset by lower net sales of Prevage, primarily in connection with the delayed launches on certain new products.

Portfolio Segment

Second quarter results:

North America

In North America, Portfolio segment net sales in the three months ended ~~March 31,~~June 30, 2021 increased by ~~$9.1~~$11.1 million, or ~~21.6%~~21.3%, to ~~$51.3~~$63.2 million, as compared to ~~$42.2~~$52.1 million in the three months ended ~~March 31,~~June 30, 2020. Excluding the ~~$0.3~~$0.2 million favorable FX impact, ~~Fragrances~~Portfolio segment ~~net sales in~~ North America ~~increased by $8.8 million, or 20.9%,~~net sales in the three months ended ~~March 31,~~June 30, 2021 increased by $10.9 million, or 20.9%, compared to the three months ended ~~March 31,~~June 30, 2020. The ~~Fragrances~~Portfolio segment's ~~$8.8~~$10.9 million XFX increase in North America net sales in the three months ended ~~March 31,~~June 30, 2021 was driven primarily by ~~increases in~~higher net sales of ~~Juicy Couture~~Almay ,color cosmetics, ~~Curve and John Varvatos~~CND ~~fragrances primarily due~~nail products, American Crew men's grooming products, Mitchum anti-perspirant deodorants, and also, to a recovery from the ongoing COVID-19 pandemic, as retailers are restocking their inventory levels, partially offset primarily by decreases in other distributed fragrances. The ongoing COVID-19 pandemic negatively impacted the Fragrances' segmentlower extent, higher net sales of certain local and regional skin care products, primarily in ~~North America for the three months ended March 31, 2021 by an estimated $3.4 million ($3.4 million XFX).~~

~~International~~

~~Internationally, Fragrances segment net sales in the three months ended March 31, 2021 decreased by $0.3 million, or 1.3%,~~connection with retail channels starting to $23.5 million, compared to $23.8 million in the three months ended March 31, 2020. Excluding the $1.1 million favorable FX impact, Fragrances segment International net sales decreased by $1.4 million, or 5.9%, in the three months ended March 31, 2021, compared to the three months ended March 31, 2020.~~The ongoing COVID-19 pandemic negatively impacted the Fragrances' segment International net sales for the three months ended March 31, 2021 by an estimated $1.3 million ($1.2 million XFX)~~. The Fragrances segment's $1.4 million XFX decrease in International net sales in the three months ended March 31, 2021 was driven primarily by lower net sales in the Company's EMEA and Pacific regions due to the continuing impactsshow signs of improvement from ~~the COVID-19 pandemic, resulting in decreased foot traffic and temporary~~ ~~door closures~~ ~~and the related global supply chain constraints.~~

~~Gross profit:~~

~~The table below shows the Company's gross profit and gross margin for the periods presented:~~

Three Months Ended March 31,
2021 2020 Change
Gross profit $ 253.8 $ 255.2 $ (1.4)
Percentage of net sales 57.0 % 56.3 % 0.7 %

Gross profit decreased by $1.4 million in the three months ended March 31, 2021, as compared to the three months ended of 2020. Gross profit as a percentage of net sales (i.e., gross margin) in the three months ended March 31,2021 increased by 0.7% percentage points, as compared to the three months ended March 31, 2020. The increase in gross margin in the three months ended March 31, 2021, as compared to the prior year period, was impacted by lower sales allowances, favorable foreign currency impacts and cost reductions achieved through the Revlon 2020 Restructuring Program, partially offset by the negative effect of product mix and higher manufacturing costs, primarily attributable to the effects of the ongoing COVID-19 pandemic.

4854

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~SG&A expenses:~~

~~The table below shows the Company's SG&A expenses for the periods presented:~~

Three Months Ended March 31,
2021 2020 Change
SG&A expenses $ 260.5 $ 289.4 $ (28.9)
International

~~SG&A expenses~~Internationally, Portfolio segment net sales in the three months ended June 30, 2021 decreased by ~~$28.9~~$0.9 million, or 2.5%, to $35.5 million, compared to $36.4 million in the three months ended ~~March 31,~~June 30, 2020. Excluding the $3.0 million favorable FX impact, Portfolio segment International net sales decreased by $3.9 million, or 10.7%, in the three months ended June 30, 2021, compared to the three months ended ~~March 31, 2020,~~June 30, 2020. The Portfolio segment's $3.9 million XFX decrease in International net sales in the three months ended June 30, 2021 was driven primarily ~~by:~~

•~~lower general and administrative expenses of approximately $27.2 million,~~ ~~primarily driven~~ by~~cost reductions achieved through the Revlon 2020 Restructuring Program~~;

•~~a net decrease of approximately $5.3 million in brand support expenses, resulting from cost reduction initiatives and decreased media spend to align with the~~ lower net sales ~~primarily~~ of previously sold brands and of certain ~~the EMEA region, within the Fragrances~~local and ~~Portfolio segments,~~regional skin care products brands. This decrease was partially offset by ~~an increase~~higher net sales of Mitchum anti-perspirant deodorants and American Crew men's grooming products, primarily in ~~brand support~~connection with retail channels starting to ~~drive sales growth in Asia and in e-commerce;~~

•~~lower distribution expenses~~show signs of ~~approximately $2.3 million, driven primarily by~~improvement from the ~~net decline in sales;~~

~~with~~effects of the ~~foregoing partially offset by:~~

•~~unfavorable FX impact of approximately $7.0 million.~~ongoing COVID-19 pandemic.

~~Restructuring charges and other, net:~~Year-to-date results:

~~The table below shows the Company's restructuring charges and other, net for the periods presented:~~

Three Months Ended March 31,
2021 2020 Change
Restructuring charges and other, net $ 5.4 $ 24.8 $ (19.4)
North America

~~Restructuring charges~~In North America, Portfolio segment net sales in the six months ended June 30, 2021 increased by $3.8 million, or 3.1%, to $126.7 million, as compared to $122.9 million in the six months ended June 30, 2020. Excluding the $0.7 million favorable FX impact, Portfolio segment net sales in North America in the six months ended June 30, 2021 increased by $3.1 million, or 2.5%, compared to the six months ended June 30, 2020. The Portfolio segment's $3.1 million XFX increase in North America net sales in the six months ended June 30, 2021 was driven primarily by higher net sales of CND nail products, American Crew men's grooming products and ~~other,~~Almay color cosmetics, primarily in connection with retail channels recently starting to show signs of improvement from the effects of the ongoing COVID-19 pandemic. This increase was partially offset by lower net sales of certain local and regional skin care products brands and, to a lower extent, of Mitchum anti-perspirant deodorants.

International

Internationally, Portfolio segment net sales in the six months ended June 30, 2021 decreased ~~$19.4~~by $7.6 million, ~~during~~or 10.1%, to $68.0 million, compared to $75.6 million in the six months ended June 30, 2020. Excluding the $4.6 million favorable FX impact, Portfolio segment International net sales decreased by $12.2 million, or 16.1%, in the six months ended June 30, 2021, compared to the six months ended June 30, 2020.The Portfolio segment's $12.2 million XFX decrease in International net sales in the six months ended June 30, 2021 was driven primarily by lower net sales of previously sold brands and of certain local and regional skin care products brands. This decrease was partially offset primarily by higher net sales of Mitchum anti-perspirant deodorants and American Crew men's grooming products, primarily in connection with retail channels starting to show signs of improvement from the effects of the ongoing COVID-19 pandemic.

Fragrances Segment

Second quarter results:

North America

In North America, Fragrances segment net sales in the three months ended ~~March 31,~~June 30, 2021 increased by $31.3 million, or 105.4%, to $61.0 million, as compared to $29.7 million in the three months ended June 30, 2020. The segment's $31.3 million XFX increase in North America net sales in the three months ended June 30, 2021 was driven primarily by increases in net sales of Juicy Couture, John Varvatos and Curve fragrancesas well as in other brand and distributed fragrances, primarily due to a recovery from the ongoing COVID-19 pandemic, as retailers are restocking their inventory levels.

International

Internationally, Fragrances segment net sales in the three months ended June 30, 2021 increased by $12.7 million, or 94.1%, to $26.2 million, compared to $13.5 million in the three months ended June 30, 2020. Excluding the $2.5 million favorable FX impact, Fragrances segment International net sales increased by $10.2 million, or 75.6%, in the three months ended June 30, 2021, compared to the three months ended ~~March 31, 2020, primarily related to lower expenditures under the Revlon 2020 Restructuring Program~~June 30, 2020. The Fragrances segment's $10.2 million XFX increase in International net sales during the three months ended ~~March 31,~~June 30, 2021 ~~compared~~was driven primarily by higher net sales of Juicy Couture, Britney Spears and John Varvatos fragrances,as well as, to a lower extent, of other brand and distributed fragrances, primarily due to a recovery from the ~~expenditures incurred primarily under the same program in the three months ended March 31, 2020.~~ongoing COVID-19 pandemic, as retailers are restocking their inventory levels.

~~Revlon 2020 Restructuring Program~~

The Revlon 2020 Restructuring Program is designed to reduce the Company’s SG&A expenses, as well as cost of goods sold, improve the Company’s gross profit and Adjusted EBITDA and maximize productivity, cash flow and liquidity.

As a result of the Revlon 2020 Restructuring Program, the Company expects to eliminate approximately 975 positions worldwide, including approximately 625 current employees and approximately 350 open positions, of which approximately ~~935~~ ~~were eliminated by March 31, 2021~~

In connection with implementing the Revlon 2020 Restructuring Program, the Company recognized, since the inception of the program and through March 31, 2021, $76.1 million of total pre-tax restructuring and related charges consisting primarily of i) ~~$55.9 million~~ ~~of employee severance, other personnel benefits and other costs; and (ii)~~ ~~$20.2 million~~ ~~of lease and other restructuring-related charges that were~~ ~~recorded~~ ~~within SG&A.~~

In addition, the Company expects restructuring charges in the range of $75 million to $85 million to be charged and paid during 2021 and 2022. The Company expects that substantially all of these restructuring and related charges will be paid in cash, with $51.5 million of the total charges paid in 2020, $10.9 million paid during the first three months of 2021, approximately $30 million to $35 million expected to be paid during the remainder of 2021, and with any residual balance expected to be paid in 2022.

~~As a result of the Revlon 2020~~ ~~Restructuring Program~~, the Company expects to deliver in the range of $200 million to $230 million of annualized cost reductions from 2020 through the end of 2022, with approximately 50% of these annualized cost reductions realized from the headcount reductions that occurred in 2020. The Company achieved $28 million of cost

4955

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~reductions during~~Year-to-date results:

North America

In North America, Fragrances segment net sales in the six months ended June 30, 2021 increased by $40.4 million, or 56.2%, to $112.3 million, as compared to $71.9 million in the six months ended June 30, 2020. Excluding the $0.3 million favorable FX impact, Fragrances segment net sales in North America increased by $40.1 million, or 55.8%, in the six months ended June 30, 2021, compared to the six months ended June 30, 2020. The Fragrances segment's $40.1 million XFX increase in North America net sales in the six months ended June 30, 2021 was driven primarily by higher net sales of Juicy Couture, Curve, John Varvatos and Britney Spears fragrances, as well as other brand and distributed fragrances, primarily due to a recovery from the ongoing COVID-19 pandemic, as retailers are restocking their inventory levels.

International

Internationally, Fragrances segment net sales in the six months ended June 30, 2021 increased by $12.4 million, or 33.2%, to $49.7 million, compared to $37.3 million in the six months ended June 30, 2020. Excluding the $3.6 million favorable FX impact, Fragrances segment International net sales increased by $8.8 million, or 23.6%, in the six months ended June 30, 2021, compared to the six months ended June 30, 2020.The Fragrances segment's $8.8 million XFX increase in International net sales in the six months ended June 30, 2021 was driven primarily by higher net sales of Britney Spears, John Varvatos and Juicy Couture fragrances,as well as, to a lower extent, of other brand and distributed fragrances, primarily due to a recovery from the ongoing COVID-19 pandemic, as retailers are restocking their inventory levels.

Gross profit:

The table below shows the Company's gross profit and gross margin for the periods presented:


	Three Months Ended June 30,									Six Months Ended June 30,
	2021			2020			Change			2021			2020			Change
Gross profit	$	301.1		$	179.0		$	122.1		$	554.9		$	434.2		$	120.7
Percentage of net sales	60.5		%	51.5		%	9.0		%	58.9		%	54.2		%	4.7		%

Second quarter results:

Gross profit increased by $122.1 million in three months ended June 30, 2021, as compared to three months ended June 30, 2020. Gross profit as a percentage of net sales (i.e., gross margin) in the three months ended ~~March 31,~~June 30, 2021 ~~bringing~~increased by 9.0% compared to the ~~total cost reductions realized since~~three months ended June 30, 2020. The increase in gross margin in the ~~inception~~three months ended June 30, 2021, as compared to the prior year quarter, was impacted primarily by lower manufacturing costs attributable to the effects of the ~~program~~ongoing COVID-19 pandemic compared to ~~approximately $155 million.~~the prior year's quarter, favorable foreign currency impacts and lower sales returns.

For further information on the Revlon 2020 Restructuring Program and on the Company's other restructuring initiatives, see Note 2, "Restructuring Charges," to the Consolidated Financial Statements in the ~~Company's~~ ~~2020 Form 10-K.~~Year-to-date results:

~~Impairment Charges:~~Gross profit increased by $120.7 million in the six months ended June 30, 2021, as compared to the six months ended June 30, 2020. Gross profit as a percentage of net sales (i.e., gross margin) in the six months ended June 30, 2021 increased by 4.7% percentage points, as compared to the six months ended June 30, 2020. The increase in gross margin in the six months ended June 30, 2021, as compared to the prior year period, was impacted primarily by favorable foreign currency impacts and lower sales returns, partially offset by lower favorable inventory adjustment in the six months ended June 30, 2021.

SG&A expenses:

The table below shows the Company's ~~impairment charges~~SG&A expenses for the periods presented:

Three Months Ended March 31,
2021 2020 Change
Impairment charges $ — $ 124.3 $ (124.3)

~~In the first quarter of 2021, the Company assessed whether indicators of impairment existed that might result in additional impairment charges. Based upon such assessment,~~ no ~~additional impairment changes were recognized as of March 31, 2021.~~

During the first quarter of 2020, as a result of the COVID-19 pandemic’s impact on the Company’s operations, the Company determined that indicators of potential impairment existed requiring the Company to perform an interim impairment analysis. These indicators included a deterioration in the general economic conditions, developments in equity and credit markets, deterioration in some of the economic channels in which the Company's operates (especially in the mass retail channel), the recent trading values of the Company's capital stock and the corresponding decline in the Company’s market capitalization and the revision of the Company's expected future cash flows as a result of the COVID-19 pandemic. Based on the first quarter of 2020 interim impairment analysis, the Company recorded $99.8 million and $24.5 million of total non-cash impairment charges on its goodwill and indefinite-lived intangible assets, respectively.

~~Interest expense:~~

~~The table below shows the Company's interest expense for the periods presented:~~

Three Months Ended March 31,
2021 2020 Change
Interest expense $ 58.9 $ 48.4 $ 10.5

~~The $10.5 million increase in interest expense during th~~e ~~three months endedMarch 31, 2021, as compared to the~~ ~~three months endedMarch 31, 2020, was primarily due to higher weighted average borrowings and higher weighted average interest rates driven primarily by the 2020 BrandCo Term Loan Facility.~~

~~Provision for income taxes:~~

~~The table below shows the Company's provision for income taxes for the periods presented:~~

Three Months Ended March 31,
2021 2020 Change
Provision for (benefit from) income taxes $ 11.2 $ (37.2) $ 48.4


	Three Months Ended June 30,						Six Months Ended June 30,
	2021		2020		Change		2021		2020		Change
SG&A expenses	$	279.4	$	196.3	$	83.1	$	539.9	$	485.7	$	54.2

5056

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Second quarter results:

SG&A expenses increased by $83.1 million in the three months ended June 30, 2021, compared to the three months ended June 30, 2020, driven primarily by:

•higher brand support expenses of approximately $40.9 million, resulting from the resumption of activities to sustain the higher level of net sales across all segments, compared to the three months ended June 30, 2020, when brand support expense had been reduced in response to the early periods of the COVID-19 pandemic;

•higher general and administrative expenses of approximately $23.1 million, primarily driven by the lifting of the temporary cost reduction measures taken in response to COVID-19 that benefited the three months ended June 30, 2020;

•unfavorable FX impact of approximately $11.2 million; and

•higher distribution expenses of approximately $5.5 million, driven primarily by the increase in net sales.

Year-to-date results:

SG&A expenses increased by $54.2 million in the six months ended June 30, 2021, compared to the six months ended June 30, 2020, driven primarily by:

•higher brand support expenses of approximately $35.6 million, resulting from the resumption of activities to sustain the higher level of net sales across all segments, compared to the six months ended June 30, 2020, when brand support expense had been reduced in response to the early periods of the COVID-19 pandemic; and

•unfavorable FX impact of approximately $18.2 million; and

•higher distribution expenses of approximately $3.2 million, driven primarily by the increase in net sales

with the foregoing partially offset by:

•lower general and administrative expenses of approximately $3.6 million, primarily driven by cost reductions achieved during the six months ended June 30, 2021 through the Revlon 2020 Restructuring Program (subsequently renamed during 2021 the Revlon Global Growth Accelerator, “RGGA”, as further defined below).

Restructuring charges and other, net:

The table below shows the Company's restructuring charges and other, net for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
	2021		2020		Change		2021		2020		Change
Restructuring charges and other, net	$	8.4	$	20.7	$	(12.3)	$	13.8	$	45.5	$	(31.7)

Second quarter results:

Restructuring charges and other, net, decreased $12.3 million during the three months ended June 30, 2021, compared to the three months ended June 30, 2020, primarily related to lower expenditures under RGGA (as further defined below) in the three months ended June 30, 2021, compared to the expenditures incurred primarily under the 2020 Revlon Restructuring program in the three months ended June 30, 2020.

Year-to-date results:

Restructuring charges and other, net, decreased $31.7 million during the six months ended June 30, 2021, compared to the six months ended June 30, 2020, primarily related to lower expenditures under RGGA in the six months ended June 30, 2021, compared to the expenditures incurred primarily under the 2020 Revlon Restructuring Program in the six months ended June 30, 2020.

Revlon Global Growth Accelerator Program

On May 10, 2021, the Company announced that it is expanding the existing Revlon 2020 Restructuring Program through 2023. The Company renamed the revised program the Revlon Global Growth Accelerator (“RGGA”). RGGA includes a reinvestment strategy to strengthen our brands and drive long-term profitable margin and revenue growth through realized incremental productivity initiatives and enhanced capabilities.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

The major initiatives underlying the RGGA program include:

•Strategic Growth: Boost organic sales growth behind our strategic pillars – brands, markets, and channels -- to deliver an approximate mid-single digit compound average annual growth rate through 2023;

•Operating Efficiencies: Drive additional operational efficiencies and cost savings to fuel investments in revenue growth; and

•Build Capabilities: Enhance capabilities and up-skill employees in order to evolve our culture to promote agility and deliver transformational change.

Under RGGA, the Company expects to deliver an updated range of annualized cost reductions of approximately $275 million to $325 million from 2020 through the end of 2023. Approximately 50% of these annualized cost reductions were realized from the headcount reductions that occurred in 2020. The remaining cost reductions will be realized through reductions in SG&A expenses and cost of goods sold. The Company achieved $7 million and $35 million of cost reductions during the three and six months ended June 30, 2021, bringing the total cost reductions realized since the inception of the program to approximately $162 million and expects to achieve approximately $60 million to $80 million for the full year 2021 (inclusive of the first and second quarters of 2021 cost reductions), with the balance to be realized during 2022 and 2023.

In connection with implementing RGGA, the Company expects to recognize an updated cost range of approximately $185 million and $205 million of total pre-tax restructuring and related charges, consisting of employee-related costs, such as severance, pension and other termination costs, as well as related third party expenses. The Company also expects to incur approximately $15 million of additional capital expenditures. Under the RGGA program, the Company expects to incur pre-tax restructuring and related charges of approximately $65 million to $75 million during 2021 (inclusive of the first and second quarters of 2021 charges) and the remainder during 2022 and 2023. The Company expects that substantially all of these restructuring and related charges will be paid in cash, with $21.8 million of the total charges paid as of June 30, 2021, approximately $50 million to $55 million of the total charges expected to be paid during the second half of 2021, with the remainder to be paid during 2022 and 2023.

In connection with RGGA, during the three months ended June 30, 2021, the Company recorded $9.9 million of total pre-tax restructuring and related charges consisting primarily of i) $8.4 million of employee severance, other personnel benefits and other costs; and (ii) $1.5 million of lease and other restructuring-related charges that were recorded within SG&A and cost of sales. During the six months ended June 30, 2021, the Company recorded $17.2 million of total pre-tax restructuring and related charges consisting primarily of i) $13.8 million of employee severance, other personnel benefits and other costs; and (ii) $3.4 million of lease and other restructuring-related charges that were recorded within SG&A and cost of sales. Since its inception and through June 30, 2021, the Company recorded $86.0 million of total pre-tax restructuring and related charges consisting primarily of i) $64.3 million of employee severance, other personnel benefits and other costs; and (ii) $21.7 million of lease and other restructuring-related charges that were recorded within SG&A and cost of sales.

Since its inception in March 2020 and through June 30, 2021, approximately 950 positions have been eliminated worldwide under RGGA.

For further information on RGGA, see Note 2, "Restructuring Charges," to the Company's Unaudited Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

Impairment Charges:

The table below shows the Company's impairment charges for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
	2021		2020		Change		2021		2020		Change
Impairment charges	$	—	$	19.8	$	(19.8)	$	—	$	144.1	$	(144.1)

Second quarter results:

In the second quarter of 2021, the Company assessed whether indicators of impairment existed that might result in additional impairment charges. Based upon such assessment, no additional impairment changes were recognized for the three months ended June 30, 2021.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

During the second quarter of 2020, primarily as a result of COVID-19 affecting multiple countries around the world, the Company considered whether indicators of impairment existed that would warrant an interim assessment of goodwill for impairment purposes. Based on the second quarter of 2020 interim impairment analysis, the Company recorded $11.2 million and $8.6 million of total non-cash impairment charges on its goodwill and indefinite-lived intangible assets, respectively.

Year-to-date results:

During the six months ended June 30, 2021, the Company assessed whether indicators of impairment existed that might result in additional impairment charges. Based upon such assessment, no additional impairment changes were recognized for the six months ended June 30, 2021.

During the six months ended June 30, 2020, as a result of the COVID-19 pandemic’s impact on the Company’s operations, the Company determined that indicators of potential impairment existed requiring the performance of interim impairment analyses. Based on interim impairment analyses during the six months ended June 30, 2020, the Company recorded $111.0 million and $33.1 million of total non-cash impairment charges on its goodwill and indefinite-lived intangible assets, respectively.

Interest expense:

The table below shows the Company's interest expense for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
	2021		2020		Change		2021		2020		Change
Interest expense	$	61.9	$	60.9	$	1.0	$	120.8	$	109.3	$	11.5

Second quarter results:

The $1.0 million increase in interest expense in the three months ended June 30, 2021, as compared to the three months ended June 30, 2020, was primarily due to higher weighted average interest rates driven primarily by the 2020 BrandCo Term Loan Facility.

Year-to-date results:

The $11.5 million increase in interest expense during the six months endedJune 30, 2021, as compared to the six months endedJune 30, 2020, was primarily due to higher weighted average interest rates driven primarily by the 2020 BrandCo Term Loan Facility.

Gain on early extinguishment of debt:


	Three Months Ended June 30,					Six Months Ended June 30,
	2021	2020		Change		2021		2020		Change
Gain on early extinguishment of debt	—	$	(11.9)	$	11.9	$	—	$	(11.9)	$	11.9

Gain on early extinguishment of debt for the three and six months ended June 30, 2020 includes net debt extinguishment gains of $11.9 million recorded during the second quarter of 2020 upon the repurchase and subsequent cancellation of approximately $112.8 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes occurring in the second quarter of 2020.

For information on the terms and conditions of these debt instruments, see Note 8, "Debt," in the Audited Consolidated Financial Statements in the Company's 2020 Form 10-K.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Provision for (benefit from) income taxes:

The table below shows the Company's provision for income taxes for the periods presented:


	Three Months Ended June 30,						Six Months Ended June 30,
	2021		2020		Change		2021		2020		Change
Provision for (benefit from) income taxes	$	7.2	$	(9.9)	$	17.1	$	18.4	$	(47.1)	$	65.5

Second quarter results:

The Company recorded a provision for income taxes of ~~$11.2~~$7.2 million for the three months ended ~~March 31,~~June 30, 2021, compared to a benefit ~~for~~from income taxes of ~~$37.2~~$9.9 million for the three months ended ~~March 31,~~June 30, 2020. The ~~$48.4~~$17.1 million increase in the provision for income taxes for the three months ended ~~March 31,~~June 30, 2021, compared to the three months ended June 30, 2020, was primarily due to an increase in losses for which no tax benefit can be recognized.

Year-to-date results:

The Company recorded a provision for income taxes of $18.4 million for the six months ended June 30, 2021, compared to a benefit for income taxes of $47.1 million for the six months ended June 30, 2020. The $65.5 million increase in the provision for income taxes for the six months ended June 30, 2021, compared to same period in 2020, was primarily due to an increase in losses for which no tax benefit can be recognized.

For the three and six months ended ~~March 31,~~June 30, 2021, the Company used the annual effective tax rate method to calculate its tax provision.

For the three ~~months~~and six month periods ended ~~March 31,~~June 30, 2020, the Company concluded that the use of the cut-off tax rate method was more appropriate than the annual effective tax rate method, because the annual effective tax rate method would have not been reliable due to its sensitivity to minimal changes in forecasted annual pre-tax earnings.

For further information, see Note 12, "Income Taxes," to the Company's Unaudited Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

~~Results of Operations — Products Corporation~~

Products Corporation's Consolidated Statements of Operations and Comprehensive Loss are essentially identical to Revlon, Inc.'s Consolidated Statements of Operations and Comprehensive Loss, except for the following:

Three Months Ended March 31,
2021 2020
Net loss - Revlon, Inc. $ (96.0) $ (213.9)
Selling, general and administrative expenses - public company costs 1.0 2.0
Provision for income taxes 0.1 (0.3)
Net loss - Products Corporation $ (94.9) $ (212.2)

~~Refer to Revlon’s “Management Discussion and Analysis of Financial Condition and Results of Operations” herein.~~

5160

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Results of Operations — Products Corporation


	Three Months Ended June 30,				Six Months Ended June 30,
	2021		2020		2021		2020
Net loss - Revlon, Inc.	$	(67.7)	$	(126.8)	$	(163.7)	$	(340.7)
Selling, general and administrative expenses - public company costs	1.7		1.9		2.7		3.9
Provision for income taxes	(0.1)		(0.3)		—		(0.6)
Net loss - Products Corporation	$	(66.1)	$	(125.2)	$	(161.0)	$	(337.4)

Refer to Revlon’s “Management Discussion and Analysis of Financial Condition and Results of Operations” herein.

Financial Condition, Liquidity and Capital Resources

At ~~March 31,~~June 30, 2021, the Company had a liquidity position of ~~$129.6~~$153.1 million, consisting of: (i) ~~$85.6~~$109.8 million of unrestricted cash and cash equivalents (with approximately ~~$77.2~~$97.3 million held outside the U.S.); (ii) ~~$50.7~~$53.5 million in available borrowing capacity under the Amendment ~~No.7~~No.8 to the Amended 2016 Revolving Credit Facility (which had ~~$229.6~~$282.1 million drawn at such ~~date and an availability reserve of $20 million required to be maintained at all times when Products Corporation’s consolidated fixed charge ratio in effect exceeds 1.0 to 1.0 );~~date); and less (iii) approximately ~~$6.7~~$10.2 million of outstanding checks.

Liquidity and Ability to Continue as a Going Concern

Each reporting period, the Company assesses its ability to continue as a going concern for one year from the date the financial statements are issued. ~~At March 31, 2021, the Company had a liquidity position of $129.6 million, consisting of: (i) $85.6 million of unrestricted cash and cash equivalents (with approximately $77.2 million~~ ~~held outside the U.S.)~~; (ii) $50.7 million in available borrowing capacity under the Amendment No.7 to the Amended 2016 Revolving Credit Facility (which had $229.6 million drawn at such date and an availability reserve of $20 million required to be maintained at all times when Products Corporation’s consolidated fixed charge ratio in effect exceeds 1.0 to 1.0 ); and less (iii) approximately $6.7 million of outstanding checks.

The Company continues to focus on cost reduction and risk mitigation actions to address the ongoing impact from the COVID-19 pandemic as well as other risks in the business environment. It expects to generate additional liquidity through continued cost control initiatives as well as funds provided by selling certain assets or other strategic transactions in connection with the Company's ongoing Strategic Review. If sales continue to decline, the Company’s cost control initiatives may include reductions in discretionary spend and reductions in investments in capital and permanent displays. Management believes that the debt transactions completed in the first ~~quarter~~half of 2021, along with existing cash and cash equivalents and cost control initiatives provides the Company with sufficient liquidity to meet its obligations and maintain business operations for the next twelve months.

Second Quarter of 2021 Financing Transactions

earliest stated maturity of the 2020 ABL FILO Term Loans; (ii) the commitments under the “Tranche A” revolving facility are reduced from $300 million to $270 million and under the SISO Facility are upsized from $100 million to $130 million, (iii) the financial covenant is changed from (A)(x) a minimum excess availability requirement of $20 million when the fixed charge coverage ratio is greater than 1.00x or (y) a minimum excess availability requirement of $30 million when the fixed charge coverage ratio is less than 1.00x to (B) a springing minimum fixed charge coverage ratio of 1.00x when excess availability is less than $27.5 million, (iv) certain advance rates in respect of the borrowing base under the credit agreement are increased, and (v) the perpetual cash dominion requirement is replaced with a springing cash dominion requirement triggered only when excess availability is less than $45 million. In addition, Amendment No. 8 increased the interest rate margin applicable to the “Tranche A” revolving loans to 3.75% from a range of 2.50-3.00% and decreased the LIBOR “floor” applicable thereto from 1.75% to 0.50%.

Amendment No. 8 included an extinguishment, as defined by ASC 470, Debt, with the prior lenders under the Company's Tranche A Revolving Credit facility and the substitution of such lenders under the revolving credit facility with a new lender, MidCap, with which the Company had no prior loans outstanding. In connection with this transaction:

First Quarter of 2021 Financing Transactions

Tranche A - Revolving Credit Facility and SISO Term Loan Facility

June 8, 2023 (the “SISO Facility”) has been established and Products Corporation ~~has~~ borrowed $100 million of term loans thereunder. Except as to pricing, maturity, enforcement priority and certain voting rights, the terms of the SISO Facility ~~are~~were substantially consistent with the first-in, last-out “Tranche B” term loan facility under the Amended 2016 Revolving Credit Agreement, including as to guarantees and collateral.

The above-mentioned Amendment No. 7 represented an exchange of an existing revolving credit agreement with a new revolving credit agreement with the same lenders as defined by ASC 470, Debt, under the revolving credit facility. All pre-existing unamortized deferred financing costs associated with the old revolving credit agreement of approximately $0.8 million were added to the newly incurred deferred financing costs of approximately $4.2 million and their total of approximately $5.1 million will be amortized in accordance with the straight-line method over the term of Tranche A through June 8, 2023. Additionally, approximately $4.3 million of new deferred financing costs were incurred in connection with the SISO Facility with the new lenders, which are amortized in accordance with the effective interest method over the term of the facility.

2021 Foreign Asset-Based Term Facility

than the Other Guarantors), the inventory and accounts receivable of the ABTL Borrowing Base Guarantors, the material bank accounts of each Loan Party, the material intercompany indebtedness owing to any Loan Party (including any intercompany loans made with the proceeds of the 2021 Foreign Asset-Based Term Facility) and certain other material assets of the ABTL Borrowing Base Guarantors, subject to customary exceptions and exclusions. The 2021 Foreign Asset-Based Term Facility includes a cash dominion feature customary for transactions of this type.

including a fee payable to Blue Torch Finance LLC for its services as Agent. Loans under the 2021 Foreign Asset-Based Term Facility may be prepaid without premium or penalty, subject to a prepayment premium equal to 3.0% of the aggregate principal amount of loans prepaid or repaid during the first year after the 2021 ABTL Closing Date, 2.0% of the aggregate principal amount of loans prepaid or repaid during the second year after the 2021 ABTL Closing Date and 1.0% of the aggregate principal amount of loans prepaid or repaid thereafter.

Affirmative and Negative Covenants: The 2021 Foreign Asset-Based Term Agreement contains certain affirmative and negative covenants that, among other things, limit the ABTL Loan Parties’ ability to, subject to various exceptions and qualifications: (i) incur additional debt; (ii) incur liens; (iii) sell, transfer or dispose of assets; (iv) make investments; (v) make dividends and distributions on, or repurchases of, equity; (vi) make prepayments of contractually subordinated or junior lien debt; (vii) enter into certain transactions with their affiliates, including amending certain material intercompany agreements or trade terms; (viii) enter into sale-leaseback transactions; (ix) change their lines of business; (x) restrict dividends from their subsidiaries or restrict liens; (xi) change their fiscal year; and (xii) modify the terms of certain debt. The ABTL Parent Guarantors are subject to certain customary holding company covenants. The ability of the Loan Parties to make certain intercompany asset sales, investments, restricted payments and prepayments of intercompany debt is contingent on certain "cash movement conditions" or "payment conditions" being met, which among other things, require a certain level of liquidity for the applicable Loan Party to effect such type of transactions. The 2021 Foreign Asset-Based Term Agreement also contains a financial covenant requiring the ABTL Loan Parties to maintain a minimum average balance of cash and cash equivalents of $3.5 million, tested monthly, based on the last 10 business days of each month, subject to certain cure rights. The 2021 Foreign Asset-Based Term Agreement also contains certain customary representations, warranties and events of default.

The proceeds from the 2021 Foreign Asset-Based Term Facility were used to extinguish the entire amount outstanding under the 2018 Foreign Asset-Based Term Facility as of the closing date, which was due on July 9, 2021. In connection with such extinguishment, approximately nil and $1.0 million of pre-existing unamortized deferred financing costs were expensed within "Amortization of Debt Issuance Costs" on the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three ~~months~~and six month periods ended ~~March 31,~~June 30, 2021. In accordance with the terms of the 2021 ~~ABTL credit agreement,~~Foreign Asset-Based Term Agreement, approximately $13.8 million of the proceeds from the transaction are held in escrow and are recorded within "Prepaid expenses and ~~Other Assets"~~other assets" on the Company's Unaudited Consolidated Balance Sheet as of ~~March 31,~~June 30, 2021.

Changes in Cash Flows

As of ~~March 31,~~June 30, 2021, the Company had cash, cash equivalents and restricted cash of ~~$101.7~~$128.4 million, compared with $104.5 million at December 31, 2020. The following table summarizes the Company’s cash flows from operating, investing and financing activities for the periods presented:

Three Months Ended March 31,
2021 2020
Net cash used in operating activities $ (28.4) $ (77.6)
Net cash used in investing activities (0.7) (1.8)
Net cash provided by financing activities 29.6 57.4
Effect of exchange rate changes on cash and cash equivalents (1.3) (3.3)
Net decrease in cash, cash equivalents and restricted cash (0.8) (25.3)
Cash, cash equivalents and restricted cash at beginning of period 102.5 104.5
Cash, cash equivalents and restricted cash at end of period $ 101.7 $ 79.2


	Six Months Ended June 30,
	2021		2020
Net cash used in operating activities	$	(39.3)	$	(164.2)
Net cash used in investing activities	(0.8)		(2.7)
Net cash provided by financing activities	67.0		408.4
Effect of exchange rate changes on cash and cash equivalents	(1.0)		(2.1)
Net decrease in cash, cash equivalents and restricted cash	25.9		239.4
Cash, cash equivalents and restricted cash at beginning of period	102.5		104.5
Cash, cash equivalents and restricted cash at end of period	$	128.4	$	343.9

Operating Activities

Net cash used in operating activities was ~~$28.4~~$39.3 million and ~~$77.6~~$164.2 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, respectively. The decrease in cash used in operating activities for the ~~three~~six months ended ~~March 31,~~June 30, 2021, compared to the ~~three~~six months ended ~~March 31,~~June 30, 2020, was primarily driven by a lower loss and favorable working capital changes.

Investing Activities

Net cash used in investing activities was ~~$0.7~~$0.8 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021, compared to ~~$1.8~~$2.7 million of net cash used in investing activities for the ~~three~~six months ended ~~March 31,~~June 30, 2020.

Financing Activities

Net cash provided by financing activities was ~~$29.6~~$67.0 million and ~~$57.4~~$408.4 million for the ~~three~~six months ended ~~March 31,~~June 30, 2021 and 2020, respectively.

Net cash provided by financing activities for the ~~three~~six months ended ~~March 31,~~June 30, 2021 primarily included:

•$~~100.0~~230.0 of borrowings under the SISO Term Loan Facility; and

•$75.0 million of borrowings under the 2021 Foreign Asset-Based Term Facility;

with the foregoing partially offset by:

•$~~59.3~~100.0 million of net repayments under the ~~Amended 2016 Revolving Credit Agreement;~~SISO Term Loan Facility;

•$58.9 million used to fully repay the 2018 Foreign Asset-Based Term Facility;

•$~~11.8~~36.8 million of net repayments under the Amended 2016 Revolving Credit Agreement;

•$15.8 million of payment of financing costs incurred in connection with the first ~~quarter~~and second quarters of 2021 refinancing transactions, comprised of: (i) approximately ~~$4.3~~$5.6 million of payments of financing costs incurred in connection with the SISO Term Loan Facility; (ii) approximately ~~$4.2~~$7.0 million of financing costs incurred in connection with the Tranche A revolving credit facility; and (iii) approximately $3.2 million of payments of financing costs incurred in connection with the 2021 Foreign Asset-Based Term Facility;

•$~~10.6~~7.9 million of interest payments in connection with the troubled debt restructuring accounting treatment of the 2020 Exchange Offer, which were deemed as return of principal to the participating lenders;

•$6.7 million of decreases in short-term borrowings and overdraft;

•$4.7 million of repayments under the 2020 BrandCo Facility; and

•$~~2.3~~4.6 million of repayments under the 2016 Term Loan ~~Facility~~Facility.

Net cash provided by financing activities for the ~~three~~six months ended ~~March 31,~~June 30, 2020 primarily included:

•$~~69.1 million~~880.0 of borrowings under the ~~Amended 2016 Revolving Credit~~2020 BrandCo Term Loan Facility;

with the foregoing partially offset by:

•$~~6.4~~200.0 million ~~of decreases in short-term borrowings and overdraft;~~used to fully repay the 2019 Term Loan Facility;

•$~~4.5~~101.2 million used to pay financing costs incurred in connection with the 2020 BrandCo Refinancing Transactions;

•$99.6 million used to repurchase approximately $112.8 million in aggregate principal face amount of ~~repayments under~~Products Corporation's 5.75% Senior Notes;

•$31.4 million used to partially repay the 2018 Foreign Asset-Based Term Loan;

•$22.9 million used to partially repay the Amended 2016 Revolving Credit Agreement;

•$6.9 million used to partially repay the 2016 Term Loan Facility; and

•$~~0.3~~7.0 million of ~~payments of financing costs incurred~~decreases in ~~connection with the Jefferies 2020 Refinancing Transactions.~~short-term borrowings and overdraft.

Long-Term Debt Instruments

For additional information on the terms and conditions of Products Corporation’s various pre-existing debt instruments and financing transactions, including, without limitation, 5.75% Senior Notes Exchange Offer, the 2020 BrandCo Facilities, 2016 Term Loan Facility, Amended 2016 Revolving Credit Facility, 2019 Term Loan Facility (which was fully repaid as part of consummating the 2020 BrandCo Refinancing Transactions), 2018 Foreign Asset-Based Term Facility (which was refinanced by the 2021 Foreign Asset-Based Term Facility), 2020 Restated Line of Credit Facility and 6.25% Senior Notes Indenture, reference should be made to the ~~Company's~~ 2020 Form 10-K.

Covenants


		Commitment		Borrowing Base		Aggregate principal amount outstanding at March 31, 2021		Availability at March 31, 2021 (a)			Commitment		Borrowing Base		Aggregate principal amount outstanding at June 30, 2021		Availability at June 30, 2021 (a)
Tranche A Revolving Credit Facility	Tranche A Revolving Credit Facility	$	300.0	$	150.3	$	79.6	$	50.7	Tranche A Revolving Credit Facility	$	270.0	$	155.6	$	102.1	$	53.5
SISO Term Loan Facility	SISO Term Loan Facility	100.0		100.0		100.0		—		SISO Term Loan Facility	130.0		130.0		130.0		—

2020 ABL FILO Term Loans	2020 ABL FILO Term Loans	50.0		48.5		50.0		—		2020 ABL FILO Term Loans	50.0		44.3		50.0		—

(a) Availability as of ~~March 31,~~June 30, 2021 is based upon the Tranche A Revolving borrowing base then in effect under Amendment ~~No.7~~No.8 to the Amended 2016 Revolving Credit Facility of ~~$150.3~~$155.6 million which includes a ~~$1.5~~$5.7 million reserve for the shortfall of the borrowing base that supports the 2020 ABL FILO Term Loans compared to the corresponding aggregate principal amount outstanding of $50 million), less ~~$79.6~~$102.1 million then drawn, and less $20.0 million of availability that is required to be maintained at all times when Products Corporation’s consolidated fixed charge coverage ratio that is in effect is greater than 1.0 to 1.0.drawn.

Sources and Uses

The Company’s principal sources of funds are expected to be operating revenues, cash on hand and funds that may be available from time to time for borrowing under the Amended 2016 Revolving Credit Facility and other permissible borrowings. The 2016 Credit Agreements, the 2020 BrandCo Credit Agreement, the 6.25% Senior Notes ~~Indentures~~Indenture and the 2021 Foreign Asset-Based Term Facility contain certain provisions that by their terms limit Products Corporation's and its subsidiaries’ ability to, among other things, incur additional debt, subject to certain exceptions.

The Company’s principal uses of funds are expected to be the payment of operating expenses, including payments in connection with the purchase of permanent wall displays; capital expenditure requirements; debt service payments and costs; cash tax payments; pension and other post-retirement benefit plan contributions; payments in connection with the Company’s restructuring programs, such as the ~~Revlon 2020 Restructuring Program;~~RGGA program; severance not otherwise included in the Company’s restructuring programs; business and/or brand acquisitions (including, without limitation, through licensing transactions), if any; additional debt and/or equity repurchases, if any; costs related to litigation; and payments in connection with discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade. For information regarding certain risks related to the Company’s indebtedness and cash flows, see Item 1A. ~~Risk~~"Risk Factors - "AA substantial portion of Products Corporation's indebtedness is subject to floating interest rates and the potential discontinuation or replacement of LIBOR could result in an increase to our interest expense."

The Company’s cash contributions to its pension and post-retirement benefit plans in the ~~three~~six months ended ~~March 31,~~June 30, 2021 were ~~$13.7~~$17.2 million. The Company expects that cash contributions to its pension and post-retirement benefit plans will be approximately $21 million to $24 million in the aggregate for 2021, once given effect to the provision of the American Rescue Plan signed into law by President Biden on March 11, 2021. The ~~Company��s~~Company’s net cash taxes ~~refunded~~paid in the ~~three~~six months ended ~~March 31,~~June 30, 2021 were ~~$1.0~~$6.6 million. The Company expects to pay net cash taxes totaling approximately $0 million to $10 million in the aggregate during 2021.

The Company’s purchases of permanent wall displays and capital expenditures in the ~~three~~six months ended ~~March 31,~~June 30, 2021 were ~~$5.8~~$8.9 million and ~~$0.7~~$2.9 million, respectively. The Company expects that purchases of permanent wall displays will total approximately $45 million to $50 million in the aggregate during 2021 and expects that capital expenditures will total approximately $20 million to $25 million in the aggregate during 2021.

The Company has undertaken, and continues to assess, refine and implement, a number of programs to efficiently manage its working capital, including, among other things, initiatives intended to optimize inventory levels over time; centralized procurement to secure discounts and efficiencies; prudent management of trade receivables and accounts payable; and controls on general and administrative spending. In the ordinary course of business, the Company’s source or use of cash from operating activities may vary on a quarterly basis as a result of a number of factors, including the timing of working capital flows.

Continuing to execute the Company’s business initiatives could include taking advantage of additional opportunities to reposition, repackage or reformulate one or more brands or product lines, launching additional new products, acquiring businesses or brands (including, without limitation, through licensing transactions), divesting or discontinuing non-core business lines (which may include exiting certain territories), further refining the Company’s approach to retail merchandising and/or taking further actions to optimize its manufacturing, sourcing and organizational size and structure. Any of these actions, the intended purpose of which would be to create value through improving the Company's financial performance, could result in the Company making investments and/or recognizing charges related to executing against such opportunities. Any such activities may be funded with operating revenues, cash on hand, funds that may be available from time to time under the Amended 2016 Revolving Credit Facility, other permissible borrowings and/or other permitted additional sources of capital, which actions could increase the Company’s total debt.

The Company may also, from time-to-time, seek to retire or purchase its outstanding debt obligations and/or equity in open market purchases, block trades, privately negotiated purchase transactions or otherwise and may seek to refinance some or all of its indebtedness based upon market conditions. Any such retirement or purchase of debt and/or equity may be funded with operating cash flows of the business or other sources and will depend upon prevailing market conditions, liquidity requirements, contractual restrictions and other factors, and the amounts involved may be material.

The Company expects that operating revenues, cash on hand and funds that may be available from time-to-time for borrowing under the Amended 2016 Revolving Credit Facility and other permissible borrowings will be sufficient to enable the Company to pay its operating expenses for 2020, including payments in connection with the purchase of permanent wall displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company’s restructuring programs, such as, currently, primarily the ~~Revlon 2020 Restructuring Program,~~RGGA program, severance not otherwise included in the Company’s restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade. The Company also expects to generate additional liquidity from cost reductions resulting from the implementation of, currently, primarily the ~~Revlon 2020 Restructuring Program,~~RGGA program, and cost reductions generated from other cost control initiatives, as well as funds provided by selling certain assets in connection with the Company's ongoing Strategic Review.

There can be no assurance that available funds will be sufficient to meet the Company’s cash requirements on a consolidated basis, as, among other things, the Company’s liquidity can be impacted by a number of factors, including its level of sales, costs and expenditures, as well as accounts receivable and inventory, which serve as the principal variables impacting the amount of liquidity available under the Amended 2016 Revolving Credit Facility and the 2021 Foreign Asset-Based Term Facility. For example, subject to certain exceptions, revolving loans under the Amended 2016 Revolving Credit Facility and term loans under the 2021 Foreign Asset-Based Term Facility must be prepaid to the extent that outstanding loans exceed the applicable borrowing base, consisting of certain accounts receivable, inventory and real estate. For information regarding certain risks related to the Company’s indebtedness and cash flows, see Item 1A. “Risk Factors” in the Company's 2020 Form 10-K.

If the Company’s anticipated level of revenues is not achieved because of, among other things, decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments, whether attributable to the COVID-19 pandemic or otherwise; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company’s products as a result of increased competitive activities by the Company’s competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise; changes in consumer purchasing habits, including with respect to retailer preferences and/or sales channels, such as due to any further consumption declines that the Company has experienced; inventory management by the Company's customers; space reconfigurations or reductions in display

space by the Company's customers; retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; or less than anticipated results from the Company’s existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company’s expenses, including, without limitation, for the purchase of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company’s restructuring programs (such as the ~~Revlon 2020 Restructuring Program)~~RGGA program), severance not otherwise included in the Company’s restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, additional debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the anticipated level of expenses, the Company’s current sources of funds may be insufficient to meet the Company’s cash requirements.

Any such developments, if significant, could reduce the Company’s revenues and operating income and could adversely affect Products Corporation’s ability to comply with certain financial and/or other covenants under the 2020 BrandCo Credit Agreement, 2016 Credit Agreements, the 6.25% Senior Notes Indenture and/or the 2021 Foreign Asset-Based Term Facility and in such event the Company could be required to take measures, including, among other things, reducing discretionary spending. For further discussion of certain risks associated with the Company's business and indebtedness, see Item 1A. "Risk Factors" in the ~~Company's~~ 2020 Form 10-K.

Off-Balance Sheet Transactions

The Company does not maintain any off-balance sheet transactions, arrangements, obligations or other relationships with unconsolidated entities or others that are reasonably likely to have a material current or future effect on the Company's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Discussion of Critical Accounting Policies

For a discussion of the Company's critical accounting policies, see the Company's 2020 Form 10-K.

Recently Evaluated and/or Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements

See Note 1., "Description of Business and Summary of Significant Accounting Policies," to the Company's Unaudited Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

5261

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable as a smaller reporting company.

5362

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company's reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management, including the Company's Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company's disclosure controls and procedures as of the end of the fiscal period covered by this Form 10-Q. Based upon such evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective as of ~~March 31,~~June 30, 2021.

(b) Changes in Internal Control Over Financial Reporting ("ICFR"). There have not been any changes in the Company’s internal control over financial reporting during the quarter ended ~~March 31,~~June 30, 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. As described in Item ~~9A(a)~~4(a) above, the ~~Revlon 2020 Restructuring Program~~RGGA program and the COVID-19 Organizational Actions did not materially affect the Company's ICFR for the quarter ended ~~March 31,~~June 30, 2021.

5463

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Forward-Looking Statements

This Quarterly Report on Form 10-Q for the period ended ~~March 31,~~June 30, 2021, as well as the Company's other public documents and statements, may contain forward-looking statements that involve risks and uncertainties, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the beliefs, expectations, estimates, projections, assumptions, forecasts, plans, anticipations, targets, outlooks, initiatives, visions, objectives, strategies, opportunities, drivers, focus and intents of the Company's management. While the Company believes that its estimates and assumptions are reasonable, the Company cautions that it is very difficult to predict the impact of known and unknown factors, and, of course, it is impossible for the Company to anticipate all factors that could affect its results. The Company's actual results may differ materially from those discussed in such forward-looking statements. Such statements include, without limitation, the Company's expectations, plans and estimates (whether qualitative or quantitative) as to:

(i)the Company's future financial performance and/or sales growth;

(ii)the effect on sales of decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments, whether due to COVID-19 or otherwise; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company's competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise, changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to the continuing consumption declines in core beauty categories in the mass retail channel in North America; inventory management by the Company's customers; inventory de-stocking by certain retail customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; less than anticipated results from the Company's existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company's expenses, including, without limitation, for the purchase of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company's restructuring programs, severance not otherwise included in the Company's restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, additional debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the anticipated level of expenses;

(iii)the Company's belief that continuing to execute its business initiatives could include taking advantage of additional opportunities to reposition, repackage or reformulate one or more brands or product lines, launching additional new products, acquiring businesses or brands (including through licensing transactions, if any), divesting or discontinuing non-core business lines (which may include exiting certain territories), further refining its approach to retail merchandising and/or taking further actions to optimize its manufacturing, sourcing and organizational size and structure, any of which, the intended purpose would be to create value through improving the Company's financial performance, could result in the Company making investments and/or recognizing charges related to executing against such opportunities, which activities may be funded with operating revenues, cash on hand, funds available under the Amended 2016 Revolving Credit Facility, other permissible borrowings and/or other permitted additional sources of capital, which actions could increase the Company's total debt;

(iv)the Company's plans to remain focused on its 3 key strategic pillars to drive its future success and growth, including (1) strengthening its iconic brands through innovation and relevant product portfolios; (2) building its capabilities to better communicate and connect with its consumers through media channels where they spend the most time; and (3) ensuring availability of its products where consumers shop, both in-store and increasingly online;

(v)the effect of restructuring activities, restructuring costs and charges, the timing of restructuring payments and the benefits from such activities;

(vi)the Company's expectation that operating revenues, cash on hand and funds that may be available from time to time for borrowing under the Amended 2016 Revolving Credit Facility, and other permissible borrowings will be sufficient to enable the Company to cover its operating expenses for 2021, including the cash requirements referred to in item (viii) below, and the Company's belief that (a) it has and will have sufficient liquidity to meet its cash needs for at least the next 12 months based upon the cash generated by its operations, cash on hand,

availability under the Amended 2016 Revolving Credit Facility, and other permissible borrowings, along with the

option to further settle intercompany loans and payables with certain foreign subsidiaries, and that such cash resources will be further enhanced as the Company implements cost reductions from its cost control initiatives, as well as funds provided by selling certain assets in connection with the Company's ongoing Strategic Review, and (b) restrictions and/or taxes on repatriation of foreign earnings will not have a material effect on the Company's liquidity during such period;

(vii)the Company's expected principal sources of funds, including operating revenues, cash on hand and funds available for borrowing under the Amended 2016 Revolving Credit Facility, and other permissible borrowings, as well as the availability of funds from the Company taking certain measures, including, among other things, reducing discretionary spending and the Company's expectation to generate additional liquidity from cost reductions resulting from its cost reduction initiatives, as well as funds provided by selling certain assets in connection with the Company's ongoing Strategic Review;

(viii)the Company's expected principal uses of funds, including amounts required for payment of operating expenses including in connection with the purchase of permanent wall displays; capital expenditure requirements; debt service payments and costs; cash tax payments; pension and other post-retirement benefit plan contributions; payments in connection with the Company's restructuring programs; severance not otherwise included in the Company's restructuring programs; business and/or brand acquisitions (including, without limitation, through licensing transactions), if any; debt and/or equity repurchases, if any; costs related to litigation; and payments in connection with discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade (including, without limitation, that the Company may also, from time-to-time, seek to retire or purchase its outstanding debt obligations and/or equity in open market purchases, block trades, privately negotiated purchase transactions or otherwise and may seek to refinance some or all of its indebtedness based upon market conditions and that any such retirement or purchase of debt and/or equity may be funded with operating cash flows of the business or other sources and will depend upon prevailing market conditions, liquidity requirements, contractual restrictions and other factors, and the amounts involved may be material); and its estimates of the amount and timing of such operating and other expenses;

(ix)matters concerning the impact on the Company from changes in interest rates and foreign exchange rates;

(x)the Company's expectation to efficiently manage its working capital, including, among other things, initiatives intended to optimize inventory levels over time; centralized procurement to secure discounts and efficiencies; prudent management of trade receivables, accounts payable and controls on general and administrative spending; and the Company's belief that in the ordinary course of business, its source or use of cash from operating activities may vary on a quarterly basis as a result of a number of factors, including the timing of working capital flows;

(xi)the Company's expectations regarding its future net periodic benefit cost for its U.S. and international defined benefit plans;

(xii)the Company's expectation that its tax provision and effective tax rate in any individual quarter and year-to-date period will vary and may not be indicative of the Company's tax provision and effective tax rate for the full year and the Company's expectations regarding whether it will be required to establish additional valuation allowances on its deferred tax assets;

(xiii)the Company's belief that the outcome of all pending legal proceedings in the aggregate is not reasonably likely to have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows, but that in light of the uncertainties involved in legal proceedings generally, the ultimate outcome of a particular matter could be material to the Company's operating results for a particular period depending on, among other things, the size of the loss or the nature of the liability imposed and the level of the Company's income for that particular period; and

(xiv)the Company's plans to explore certain strategic transactions pursuant to the Strategic Review.

Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language such as "estimates," "objectives," "visions," "projects," "forecasts," "focus," "drive towards," "plans," "targets," "strategies," "opportunities," "assumptions," "drivers," "believes," "intends," "outlooks," "initiatives," "expects," "scheduled to," "anticipates," "seeks," "may," "will" or "should" or the negative of those terms, or other variations of those terms or comparable language, or by discussions of strategies, targets, long-range plans, models or intentions. Forward-looking statements speak only as of the date they are made, and except for the Company's ongoing obligations under the U.S. federal securities laws, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Investors are advised, however, to consult any additional disclosures the Company made or may make in the Company's 2020 Form 10-K and in its Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in each case filed with the SEC

(which, among other places, can be found on the SEC's website at http://www.sec.gov, as well as on the Company's corporate website at www.revloninc.com). Except as expressly set forth in this Quarterly Report on Form 10-Q, the information available from time-to-time on such websites shall not be deemed incorporated by reference into this Quarterly Report on Form 10-Q. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. (See also Item 1A. "Risk Factors" in ~~this Quarterly Report on~~the Company's 2020 Form ~~10-Q~~10-K for further discussion of risks associated with the Company's business). In addition to factors that may be described in the Company's filings with the SEC, including this filing, the following factors, among others, could cause the Company's actual results to differ materially from those expressed in any forward-looking statements made by the Company:

(i)unanticipated circumstances or results affecting the Company's financial performance and or sales growth, including: greater than anticipated levels of consumers choosing to purchase their beauty products through e-commerce and other social media channels and/or greater than anticipated declines in the brick-and-mortar retail channel, or either of those conditions occurring at a rate faster than anticipated; the Company's inability to address the pace and impact of the new commercial landscape, such as its inability to enhance its e-commerce and social media capabilities and/or increase its penetration of e-commerce and social media channels; the Company's inability to drive a successful long-term omni-channel strategy and significantly increase its e-commerce penetration; difficulties, delays and/or the Company's inability to (in whole or in part) develop and implement effective content to enhance its online retail position, improve its consumer engagement across social media platforms and/or transform its technology and data to support efficient management of its digital infrastructure; the Company incurring greater than anticipated levels of expenses and/or debt to facilitate the foregoing objectives, which could result in, among other things, less than anticipated revenues and/or profitability; decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments, whether attributable to COVID-19 or otherwise; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company's competitors; decreased performance by third-party suppliers, whether due to COVID-19, shortages of raw materials or otherwise; and/or supply disruptions at the Company's manufacturing facilities, whether attributable to COVID-19 or otherwise; changes in consumer preferences, such as reduced consumer demand for the Company's color cosmetics and other current products, including new product launches; changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to the continuing consumption declines in core beauty categories in the mass retail channel in North America, whether attributable to COVID-19 or otherwise; lower than expected customer acceptance or consumer acceptance of, or less than anticipated results from, the Company's existing or new products, whether attributable to COVID-19 or otherwise; higher than expected retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels, whether attributable to COVID-19 or otherwise; higher than expected purchases of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company's restructuring programs, severance not otherwise included in the Company's restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise or lower than expected results from the Company's advertising, promotional, pricing and/or marketing plans, whether attributable to COVID-19 or otherwise; decreased sales of the Company’s existing or new products, whether attributable to COVID-19 or otherwise; actions by the Company's customers, such as greater than expected inventory management and/or de-stocking, and greater than anticipated space reconfigurations or reductions in display space and/or product discontinuances or a greater than expected impact from pricing, marketing, advertising and/or promotional strategies by the Company's customers, whether attributable to COVID-19 or otherwise; and changes in the competitive environment and actions by the Company's competitors, including, among other things, business combinations, technological breakthroughs, implementation of new pricing strategies, new product offerings, increased advertising, promotional and marketing spending and advertising, promotional and/or marketing successes by competitors;

(ii)in addition to the items discussed in (i) above, the effects of and changes in economic conditions (such as volatility in the financial markets, whether attributable to COVID-19 or otherwise, inflation, increasing interest rates, monetary conditions and foreign currency fluctuations, tariffs, foreign currency controls and/or government-mandated pricing controls, as well as in trade, monetary, fiscal and tax policies in international markets), political conditions (such as military actions and terrorist activities) and natural ~~disasters, such as the devastating fires in Australia and the earthquakes in Puerto Rico;~~disasters;

(iii)unanticipated costs or difficulties or delays in completing projects associated with continuing to execute the Company's business initiatives or lower than expected revenues or the inability to create value through improving the Company's financial performance as a result of such initiatives, including lower than expected sales, or higher than expected costs, including as may arise from any additional repositioning, repackaging or reformulating of one or more brands or product lines, launching of new product lines, including higher than expected expenses, including for sales returns, for launching its new products, acquiring businesses or brands (including through licensing transactions, if any), divesting or discontinuing non-core business lines (which may include exiting certain territories or converting the Company's go-to-trade structure in certain countries to other business models), further refining its approach to retail merchandising and/or difficulties, delays or increased costs in connection with taking further actions to optimize the Company's manufacturing, sourcing, supply chain or organizational size and structure (including difficulties or delays in and/or the Company's inability to optimally implement its restructuring programs and/or less than expected benefits from such programs and/or more than expected costs in implementing such programs, which could cause the Company not to realize the projected cost reductions), as well as the unavailability of cash generated by operations, cash on hand and/or funds under the Amended 2016 Revolving Credit Facility, and/or other permissible borrowings and/or from other permissible additional sources of capital to fund such potential activities, as well as the unavailability of funds due to potential mandatory repayment obligations under the 2021 Foreign Asset-Based Term Facility;

(iv)difficulties, delays in or less than expected results from the Company's efforts to execute on its 3 key strategic pillars to drive its future success and growth, including, without limitation: (1) less than effective new product development and innovation, less than expected acceptance of its new products and innovations by the Company's consumers and/or customers in one or more of its segments and/or less than expected levels of execution vis-à-vis its new product launches with its customers in one or more of its segments or regions, in each case whether attributable to COVID-19 or otherwise; (2) less than expected levels of advertising, promotional and/or marketing activities for its new product launches, less than expected acceptance of its advertising, promotional, pricing and/or marketing plans and/or brand communication by consumers and/or customers in one or more of its segments, less than expected investment in advertising, promotional and/or marketing activities or greater than expected competitive investment, in each case whether attributable to COVID-19 or otherwise; and/or (3) difficulties or disruptions impacting the Company's ability to ensure availability of its products where consumers shop, both in-store and increasingly online, including, without limitation, difficulties with, delays in or the inability to achieve the Company’s expected results, such as due to, among other things, the Company’s business experiencing greater than anticipated disruptions due to COVID-19 related uncertainty or other related factors making it more difficult to maintain relationships with employees, business partners or governmental entities and/or other unanticipated circumstances, trends or events affecting the Company’s financial performance, including decreased consumer spending in response to the COVID-19 pandemic and related conditions and restrictions, weaker than expected economic conditions due to the COVID-19 pandemic and its related restrictions and conditions continuing for periods longer than currently estimated, or other weakness in the consumption of beauty-related products, lower than expected acceptance of the Company’s new products, adverse changes in foreign currency exchange rates, decreased sales of the Company’s products as a result of increased competitive activities by the Company’s competitors, the unavailability of one or more forms of additional credit in the current capital markets and/or decreased performance by third party suppliers;

(v)difficulties, delays or unanticipated costs or charges or less than expected cost reductions and other benefits resulting from the Company's restructuring activities, higher than anticipated restructuring charges and/or payments and/or changes in the expected timing of such charges and/or payments; and/or less than expected additional sources of liquidity from such initiatives;

(vi)lower than expected operating revenues, cash on hand and/or funds available under the Amended 2016 Revolving Credit Facility, and/or other permissible borrowings or generated from cost reductions resulting from the implementation of cost control initiatives, and/or from selling certain assets in connection with the Company's ongoing Strategic Review; higher than anticipated operating expenses, such as referred to in clause (viii) below; and/or less than anticipated cash generated by the Company's operations or unanticipated restrictions or taxes on repatriation of foreign earnings;

(vii)the unavailability of funds under the Amended 2016 Revolving Credit Facility, and/or other permissible borrowings; the unavailability of funds under the 2021 Foreign Asset-Based Term Facility, such as due to reductions in the applicable borrowing base that could require certain mandatory prepayments; the unavailability of funds from difficulties, delays in or the Company's inability to take other measures, such as reducing discretionary spending and/or less than expected liquidity from cost reductions resulting from the implementation of its restructuring programs and from other cost reduction initiatives, and/or from selling certain assets in connection with the Company's ongoing Strategic Review;

(viii)higher than expected operating expenses, such as higher than expected purchases of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company's restructuring programs, severance not otherwise included in the Company's restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, additional debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise;

(ix)unexpected significant impacts on the Company from changes in interest rates or foreign exchange rates;

(x)difficulties, delays or the inability of the Company to efficiently manage its cash and working capital;

(xi)lower than expected returns on pension plan assets and/or lower discount rates, which could result in higher than expected cash contributions, higher net periodic benefit costs and/or less than expected net periodic benefit income;

(xii)unexpected significant variances in the Company's tax provision, effective tax rate and/or unrecognized tax benefits, whether due to the enactment of the Tax Act or otherwise, such as due to the issuance of unfavorable guidance, interpretations, technical clarifications and/or technical corrections legislation by the U.S. Congress, the U.S. Treasury Department or the IRS, unexpected changes in foreign, state or local tax regimes in response to the Tax Act, and/or changes in estimates that may impact the calculation of the Company's tax provisions, as well as changes in circumstances that could adversely impact the Company's expectations regarding the establishment of additional valuation allowances on its deferred tax assets;

(xiii)unanticipated adverse effects on the Company's business, prospects, results of operations, financial condition and/or cash flows as a result of unexpected developments with respect to the Company's legal proceedings; and/or

(xiv)difficulties or delays that could affect the Company's ability to consummate one or more transactions pursuant to the Strategic Review, such as due to the Company's respective businesses experiencing disruptions due to transaction-related uncertainty or other factors.

Factors other than those listed above could also cause the Company's results to differ materially from expected results. This discussion is provided pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

5564

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Website Availability of Reports, Corporate Governance Information and Other Financial Information

The Company maintains a comprehensive corporate governance program, including Corporate Governance Guidelines for Revlon’s Board of Directors, Revlon’s Board Guidelines for Assessing Director Independence and charters for Revlon’s Audit Committee and Compensation Committee. Revlon maintains a corporate investor relations website, www.revloninc.com, where stockholders and other interested persons may review, without charge, among other things, Revlon's corporate governance materials and certain SEC filings (such as Revlon's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, current reports on Form 8-K, proxy statements, annual reports, Section 16 reports reflecting certain changes in the stock ownership of Revlon’s directors and Section 16 officers, and certain other documents filed with the SEC), each of which are generally available on the same business day as the filing date with the SEC on the SEC’s website http://www.sec.gov. Products Corporation's SEC filings are also available on the SEC's website http://www.sec.gov. In addition, under the section of the website entitled, "Corporate Governance," Revlon posts printable copies of the latest versions of its Corporate Governance Guidelines, Board Guidelines for Assessing Director Independence and charters for Revlon's Audit Committee and Compensation Committee, as well as the Company's Code of Conduct and Business Ethics, which includes the Company's Code of Ethics for Senior Financial Officers, and the Audit Committee Pre-Approval Policy. From time-to-time, the Company may post on www.revloninc.com certain presentations that may include material information regarding its business, financial condition and/or results of operations. The business and financial materials and any other statement or disclosure on, or made available through, the websites referenced herein shall not be deemed incorporated by reference into this report.

5665

Table of Contents of Contents

REVLON, INC. AND SUBSIDIARIES

(all tabular amounts in millions, except share and per share amounts)

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Item 1A. Risk Factors

In addition to the other information in this report, investors should consider carefully the risk factors discussed in Part I, Item 1A. "Risk Factors" in the Company's 2020 Form 10-K.

Item 5. Other Information

None.

5766

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Exhibits













4.			Instruments Defining the Rights of Security Holders, Including Indentures.





























































4.1			Amendment No. 7,8, dated as of ~~March 8,~~May 7, 2021, to the Asset-Based Revolving Credit Agreement, dated as of September 7, 2016 (as amended), by and among Products Corporation, Revlon, certain lenders party thereto and ~~Citibank, N.A.,~~MidCap Funding IV Trust, as administrative agent and collateral agent (incorporated by reference to Exhibit ~~4.61~~4.2 to Revlon’s Quarterly Report on Form 10-Q for the ~~Revlon 2020 Form 10-K)~~fiscal quarter ended March 31, 2021 filed with the SEC on May 10, 2021).
*4.2			Amendment No. 8, dated as of May 7, 2021, to the Asset-Based Revolving Credit Agreement, dated as of September 7, 2016 (as amended), by and among Products Corporation, Revlon, certain lenders party thereto and MidCap Funding IV Trust, as administrative agent and collateral agent.
10.			Material Contracts.






































10.1			Second Amendment ~~No. 2, dated as of March 10, 2021,~~ to the Fourth Amended and Restated ~~Consulting Agreement, dated as of March 11, 2020, between Products Corporation and E. Scott Beattie~~Revlon, Inc. Stock Plan (incorporated by reference to ~~Exhibit 10.22~~Annex B to Revlon’s Definitive Proxy Statement for its 2021 Annual Stockholders’ Meeting filed with the ~~Revlon 2020 Form 10-K)~~SEC on April 20, 2021 (File No. 001-11178)).
*31.1			Certification of Debra Perelman, Chief Executive Officer, dated ~~May 10,~~August 5 , 2021, pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.
*31.2			Certification of Victoria Dolan, Chief Financial Officer, dated ~~May 10,~~August 5 , 2021, pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.
*31.3			Certification of Debra Perelman, Chief Executive Officer, dated ~~May 10,~~August 5 , 2021, pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.
*31.4			Certification of Victoria Dolan, Chief Financial Officer, dated ~~May 10,~~August 5 , 2021, pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.
**32.1			Certification of Debra Perelman, Chief Executive Officer, dated ~~May 10,~~August 5 , 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
**32.2			Certification of Victoria Dolan, Chief Financial Officer, dated ~~May 10,~~August 5 , 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
**32.3			Certification of Debra Perelman, Chief Executive Officer, dated ~~May 10,~~August 5 , 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
**32.4			Certification of Victoria Dolan, Chief Financial Officer, dated ~~May 10,~~August 5 , 2021, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


*101.INS			Inline XBRL Instance Document
*101.SCH			Inline XBRL Taxonomy Extension Schema
*101.CAL			Inline XBRL Taxonomy Extension Calculation Linkbase
*101.DEF			Inline XBRL Taxonomy Extension Definition Linkbase
*101.LAB			Inline XBRL Taxonomy Extension Label Linkbase
*101.PRE			Inline XBRL Taxonomy Extension Presentation Linkbase
*104			Cover Page Interactive Data File, formatted in Inline XBRL and contained in Exhibit 101

*Filed herewith.

**Furnished herewith.

5867

S I G N A T U R E S

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, each Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: ~~May 10,~~August 5, 2021

Revlon, Inc.

(Registrant)

By: /s/ Debra Perelman

By: /s/ Victoria Dolan

~~By: /s/ Pamela Bucher~~

Debra Perelman

Victoria Dolan

~~Pamela Bucher~~

President, Chief Executive Officer &

Chief Financial Officer

~~Vice President,~~

Director

~~Chief Accounting Officer~~

~~& Controller~~

Revlon Consumer Products Corporation

(Registrant)

By: /s/ Debra Perelman

By: /s/ Victoria Dolan

~~By: /s/ Pamela Bucher~~

Debra Perelman

Victoria Dolan

~~Pamela Bucher~~

President, Chief Executive Officer &

Chief Financial Officer

~~Vice President,~~

Director

~~Chief Accounting Officer~~

~~& Controller~~

5968



	Charges incurred in the three months ended March 31, 2021		Cumulative charges incurred through March 31, 2021
Revlon	$	1.5	$	22.2
Elizabeth Arden	1.9		11.3
Portfolio	0.9		14.5
Fragrances	1.1		7.9
Total	$	5.4	$	55.9


	March 31,		December 31,
	2021		2020
Finished goods	337.3		$	356.7
Raw materials and supplies	87.9		97.1
Work-in-process	16.0		8.8
	$	441.2	$	462.6


	Three Months Ended March 31, 2020
		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area:
Net Sales
North America		99.1		21.4		70.8		42.2		$	233.5
EMEA*		37.3		25.9		30.6		16.3		110.1
Asia		14.7		43.1		0.5		3.4		61.7
Latin America*		14.0		0.8		4.9		0.8		20.5
Pacific*		16.7		4.0		3.2		3.3		27.2
		$	181.8	$	95.2	$	110.0	$	66.0	$	453.0


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of March 31, 2021
	Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS
Cash and cash equivalents	$	7.6	$	1.5	$	76.5	$	0	$	85.6
Trade receivables, less allowances for doubtful accounts	74.7		81.1		159.8		0		315.6
Inventories, net	114.4		149.1		177.7		0		441.2
Prepaid expenses and other	222.3		24.6		64.2		0		311.1
Intercompany receivables	3,754.7		3,692.3		746.3		(8,193.3)		0
Investment in subsidiaries	1,698.7		15.9		0		(1,714.6)		0
Property, plant and equipment, net	171.9		69.0		94.7		0		335.6
Deferred income taxes	0		3.4		20.5		0		23.9
Goodwill	48.9		264.0		250.3		0		563.2
Intangible assets, net	9.8		183.4		226.3		0		419.5
Other assets	66.8		8.7		29.4		0		104.9
Total assets	$	6,169.8	$	4,493.0	$	1,845.7	$	(9,907.9)	$	2,600.6
LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	$	0	$	0	$	0.3	$	0	$	0.3
Current portion of long-term debt	107.1		0		0.1		0		107.2
Accounts payable	84.4		41.0		70.2		0		195.6
Accrued expenses and other	120.0		64.1		221.6		0		405.7
Intercompany payables	4,138.8		3,295.4		758.9		(8,193.1)		0
Long-term debt	3,193.9		0		72.9		0		3,266.8
Other long-term liabilities	273.7		112.7		34.8		0		421.2
Total liabilities	7,917.9		3,513.2		1,158.8		(8,193.1)		4,396.8
Stockholder’s (deficiency) equity	(1,748.1)		979.8		686.9		(1,714.8)		(1,796.2)
Total liabilities and stockholder’s (deficiency) equity	$	6,169.8	$	4,493.0	$	1,845.7	$	(9,907.9)	$	2,600.6